As filed with the Securities and Exchange Commission on February 1, 2008
Registration No. 333
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM SB-2
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
HEALTH BENEFITS DIRECT CORPORATION
(Name of Small Business Issuer in Its Charter)
|
|
|
|
|
Delaware
|
|
6411
|
|
98-0438502
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification No.)
|
150 N. Radnor-Chester Road
Suite B-101
Radnor, Pennsylvania 19087
(484) 654-2200
(Address and Telephone Number of Registrants Principal Executive Offices)
Alvin H. Clemens
Chief Executive Officer
Health Benefits Direct Corporation
150 N. Radnor-Chester Road
Suite B-101
Radnor, Pennsylvania 19087
(484) 654-2200
(Name, Address and Telephone Number of Agent for Service)
Copy to:
James W. McKenzie, Jr., Esq.
Morgan, Lewis & Bockius LLP
1701 Market Street
Philadelphia, Pennsylvania 19103
(215) 963-5000
Approximate Date of Proposed Sale to the Public:
As soon as practicable after the effective
date of this registration statement.
If this form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.
o
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities
Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering.
o
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities
Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering.
o
If delivery of the prospectus is expected to be made pursuant to Rule 434, check the following
box.
o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed
|
|
|
Proposed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
maximum
|
|
|
maximum
|
|
|
|
|
|
Title of each class of
|
|
|
Amount to be
|
|
|
offering price
|
|
|
aggregate
|
|
|
Amount of
|
|
|
securities to be registered
|
|
|
registered (1)
|
|
|
per unit (2)
|
|
|
offering price
|
|
|
registration fee
|
|
|
Common Stock, par
value $0.001 per
share
|
|
|
|
2,589,913
|
|
|
|
$
|
1.40
|
|
|
|
$
|
3,625,878
|
|
|
|
$
|
143
|
|
|
|
(1) Pursuant to Rule 416, there are also being registered such additional shares as may be issued
as a result of stock splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee. Estimated pursuant to
Rule 457 under the Securities Act of 1933 solely for the purpose of computing the amount of the
registration fee. The fee for the common stock was based on the average of the closing bid and
asked price of the common stock reported on the OTC Bulletin Board on January 30, 2008.
The registrant hereby amends this registration statement on such date or dates as may be necessary
to delay its effective date until the registrant shall file a further amendment which specifically
states that this registration statement shall thereafter become effective in accordance with
Section
8(a)
of the Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said Section
8(a)
, may
determine.
|
|
|
PRELIMINARY PROSPECTUS
Subject to Completion
|
|
February 1, 2008
|
The information in this prospectus is not complete and may be changed. These securities may not be
sold until the registration statement filed with the Securities and Exchange Commission is
effective. This preliminary prospectus is not an offer to sell these securities and is not
soliciting an offer to buy the securities in any state where the offer or sale is not permitted.
2,589,913 shares of Common Stock
HEALTH BENEFITS DIRECT CORPORATION
This prospectus relates to offers and resales of up to 1,739,913 shares of our common stock,
par value $0.001 per share, including 850,000 shares issuable upon the exercise of warrants. We
will not receive any of the proceeds from the disposition of these shares by the selling
stockholders. We will bear all costs, expenses and fees relating to the registration of these
shares. The selling stockholders will bear all commissions and discounts, if any, attributable to
their respective sales of shares.
Our common stock is quoted on the over-the-counter bulletin board, or OTCBB, under the symbol
HBDT.OB.
The average of the bid and asked prices of our common stock on the OTCBB on January 30, 2008
was $1.40 per share.
INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD READ THIS ENTIRE
PROSPECTUS CAREFULLY, INCLUDING THE SECTION ENTITLED RISK FACTORS BEGINNING ON PAGE 5.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR
DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is , 2008
TABLE OF CONTENTS
You should rely only on the information contained in this prospectus. We have not authorized
anyone to provide you with information different from the information contained in this prospectus.
We will not make an offer to sell these securities in any jurisdiction where offers and sales are
not permitted. The information contained in this prospectus is accurate only as of the date of
this prospectus, regardless of when this prospectus is delivered or when any sale of our common
stock occurs. All dollar amounts in this prospectus are in U.S. dollars unless otherwise stated.
In this prospectus, unless the context specifically indicates otherwise:
|
|
|
with respect to periods following the closing on November 23, 2005 of the merger that
resulted in our current public company structure, all references to the Company, we,
us, and our refer to Health Benefits Direct Corporation and its subsidiaries; and
|
|
|
|
|
with respect to periods prior to the closing on November 23, 2005 of the merger that
resulted in our current public company structure, all references to the Company, we,
us, and our refer to the entity currently named HBDC II, Inc. as it existed prior to
such merger under the name Health Benefits Direct Corporation and prior to becoming a
wholly-owned subsidiary of Darwin Resources Corp., the Delaware corporation that currently
is named Health Benefits Direct Corporation.
|
i
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, including the sections entitled Prospectus Summary, Risk Factors,
Managements Discussion and Analysis or Plan of Operation and Our Business, contains
forward-looking statements. Forward-looking statements convey our current expectations or forecasts
of future events. All statements other than statements of historical fact are forward-looking
statements. Forward-looking statements herein include, among others, statements relating to:
|
|
|
our ability to obtain an increased market share in the rapidly expanding individual
health and life insurance markets;
|
|
|
|
|
the perceived benefits of our interactive insurance marketplace to consumers and
insurance carriers;
|
|
|
|
|
our ability to achieve growth;
|
|
|
|
|
our expansion of the number of insurance carriers we represent, the variety of
individual health and life insurance and related products that we offer or the number
of states in which we are able to offer insurance products;
|
|
|
|
|
the benefits of our interactive insurance marketplace in comparison with existing
methods of marketing and selling individual health and life insurance and related
products;
|
|
|
|
|
our ability to increase our customer base through various means;
|
|
|
|
|
the success of our future marketing and brand-building efforts;
|
|
|
|
|
the further development of our technologies;
|
|
|
|
|
our ability to protect our proprietary technologies;
|
|
|
|
|
our ability to compete successfully against new and existing competitors;
|
|
|
|
|
our future financial and operating results;
|
|
|
|
|
our ability to fund our current level of operations through our cash and cash
equivalents;
|
|
|
|
|
our anticipated use of cash resources;
|
|
|
|
|
projections and trends relating to cost of services;
|
|
|
|
|
our capital requirements and the possible impact on us if we are unable to satisfy
these requirements;
|
|
|
|
|
our ability to attract or retain key personnel; and
|
|
|
|
|
statements under the caption Risk Factors and other statements regarding matters
not of historical fact.
|
The words may, will, expect, intend, anticipate, estimate, believe, continue
and similar expressions may identify forward-looking statements, but the absence of these words
does not
1
necessarily mean that a statement is not forward-looking. Forward-looking statements involve
known and unknown risks, uncertainties and achievements, and other factors that may cause our or
our industrys actual results, levels of activity, performance, or achievements to be materially
different from the information expressed or implied by these forward-looking statements. While we
believe that we have a reasonable basis for each forward-looking statement contained in this
prospectus, we caution you that these statements are based on a combination of facts and factors
currently known by us and projections of the future about which we cannot be certain. Many factors,
including general business and economic conditions and the risks and uncertainties described in the
Risk Factors section of this prospectus, affect our ability to achieve our objectives. As a
result of these factors, we cannot assure you that the forward-looking statements in this
prospectus will prove to be accurate. In addition, if our forward-looking statements prove to be
inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these
forward-looking statements, you should not regard these statements as a representation or warranty
by us or any other person that we will achieve our objectives and plans in any specified time
frame, if at all. We may not update these forward-looking statements, even though our situation may
change in the future.
We do not, as a matter of course, publicly disclose financial forecasts or projections and
have recently adopted a policy against release of forward-looking revenue or earnings guidance.
You should not rely on any prior statements by us that could be deemed to represent forward-looking
statements of projected revenues or earnings, forecasts or projections. We do not deem any such
prior statements to be reliable.
2
PROSPECTUS SUMMARY
This summary highlights selected information contained elsewhere in this prospectus. This
summary is not complete and does not contain all of the information that you should consider before
investing in our common stock. You should read the entire prospectus carefully, including the
Risk Factors section, before making a decision to invest in our common stock.
Our Business
We are a contact center-based insurance agency that operates an online marketplace enabling
consumers to shop for, compare and purchase individual health and life insurance and related
products for individuals and families. We act as an independent agent, selling health and life
insurance and related products on behalf of a number of nationally-branded, highly-rated insurance
carriers.
Our streamlined sales process, supported by our proprietary online technology, dialing
application and voice signature process, ensures efficiency for consumers purchasing, and carriers
underwriting, insurance products. Through our proprietary online technology and our dialing
application, which we call Quick-to-Call, consumers who submit a request for quotes for health
insurance and related products through our website are connected with a licensed agent in one of
our contact centers in as little as 30 seconds from the time of submission. Our process enables us
to reduce the amount of time it takes from the moment a consumer expresses interest in purchasing
insurance to submission of an application to a carrier for underwriting to as little as 60 minutes.
Our common stock is currently publicly traded under the symbol HBDT.OB on the OTCBB.
The Shares Being Registered
On March 30, 2007, we completed a private placement of an aggregate of 5,000,000 shares of our
common stock and warrants to purchase 2,500,000 shares of our common stock to certain institutional
and individual accredited investors. We sold 5,000,000 investment units in the private placement
at a per unit purchase price equal to $2.25 for gross proceeds to us of $11.25 million. These sales
were made pursuant to a Securities Purchase Agreement that we entered into with certain
institutional and individual accredited investors, effective as of March 30, 2007. Each investment
unit sold in the private placement consisted of one share of our common stock and a warrant to
purchase one-half of one share of common stock at an exercise price of $3.00 per share, subject to
adjustment. A total of 6,000,000 of the shares issued in the private placement have already been
registered. Our Chairman and Chief Executive Officer, Alvin H. Clemens, who purchased 1.0 million
units in the private placement, had agreed to waive his registration rights for the 1.0 million
shares of common stock he purchased in the private placement and the 500,000 shares of common stock
underlying the warrant he purchased in the private placement until the later of six months
following the effective date of the registration statement to register the shares and shares
underlying warrants sold to other investors in the private placement, or the earliest date that may
be permitted by the Securities and Exchange Commission, or the Commission. Mr. Clemens shares are
being registered on this registration statement.
In connection with the private placement, we also issued to Oppenheimer & Co. Inc., Sanders
Morris Harris Inc. and Roth Capital Partners, as partial consideration for acting as placement
agents, warrants to purchase an aggregate of 350,000 shares of our common stock at an exercise
price of $2.80 per share. These placement agent shares also are being registered on this
registration statement.
On October 1, 2007, we acquired Atiam Technologies, L.P., or Atiam, pursuant to an Agreement
and Plan of Merger, whereby System Consulting Associates, Inc., or SCA, the majority owner of
Atiam,
3
was merged with and into one of our subsidiaries. We paid an aggregate amount of $2,000,000
for all outstanding shares of capital stock of SCA, which amount consisted of $850,000 in cash and
a total of 515,697 unregistered shares of our common stock, which number of shares had a value of
$1,150,000 based on the average closing price per share ($2.23) of our common stock on the OTCBB on
the five consecutive trading days preceding the closing date of the acquisition.
Immediately prior to the closing of the merger with SCA, we also entered into an Agreement to
Transfer Partnership Interests with the former partners of BileniaTech, L.P., or Bilenia, whereby
one of our subsidiaries purchased all of the outstanding general and limited partnership interests
of Atiam owned by Bilenia, the minority owner of Atiam. We paid a total of $1,000,000 to the
former partners of Bilenia for the Atiam partnership interests, which amount consisted of
$500,000.00 in cash and 224,216 unregistered shares of our common stock, which number of shares had
an aggregate value of $500,000 based on the average closing price per share ($2.23) of our common
stock on the OTCBB on the five consecutive trading days preceding the closing date of the
acquisition of the remaining Atiam partnership interests.
In connection with each of the acquisitions, we entered into Registration Rights Agreements
with each of the former shareholders of SCA and with Computer Command and Control Company, one of
the former partners of Bilenia. Under the terms of the Registration Rights Agreements, we agreed
to give prompt notice of the registration of any of our securities under the Securities Act of
1933, as amended, or the Securities Act, and the shareholders shall have the opportunity to have
their shares included in such registration statement. We agreed that it was our intention to begin
to prepare and file a registration statement within 60 days of the closing date.
Our Corporate Information
Our principal executive offices are located at 150 N. Radnor-Chester Road, Suite B-101,
Radnor, Pennsylvania 19087. The principal executive offices of our wholly-owned subsidiary, HBDC
II, Inc., are located at 2200 S.W. 10th Street, Deerfield Beach, Florida 33442. The principal
executive offices of our wholly-owned subsidiary, Atiam, are located at 350 Baldwin Tower,
Eddystone, PA 19022. Our telephone number is (484) 654-2200. Our website address is www.hbdc.com.
The information contained on our website is not incorporated by reference into, and does not form
any part of, this prospectus.
4
RISK FACTORS
Investing in our common stock involves significant risks. In addition to all of the other
information contained in this prospectus, you should carefully consider the risks and uncertainties
described below before deciding to invest in our common stock. If any of the following risks
actually occur, they may materially harm our business, our financial condition or our results of
operations. In this event, the market price of our common stock could decline and you could lose
all or part of your investment.
Risks Relating to our Company
We have a limited operating history and have incurred significant operating losses since our
inception, which we anticipate will continue for the foreseeable future.
We are an early stage company with a limited operating history, which makes it difficult for
investors to evaluate our business and prospects. Investors in our common stock must consider our
prospects in light of the risks, expenses and difficulties that we face as an early stage company
operating in a new, unproven and highly regulated business. There can be no assurance that we will
successfully overcome these difficulties.
Since our inception, we have incurred significant operating losses. As of September 30, 2007,
we had an accumulated deficit of approximately $27.7 million. We incurred operating losses of
approximately $9.8 million for the nine months ended September 30, 2007, $3.2 million for the year
ended December 31, 2005 and approximately $1.1 million for the period from our inception on January
27, 2004 through December 31, 2004. We expect to incur significant and increasing operating
expenses and capital expenditures relating to the development of our business, particularly as we
pursue growth both internally and through strategic acquisitions, expand our marketing efforts,
further the development of our technologies and add personnel. In addition, we will continue to
incur significant legal, accounting and other expenses associated with our status as a reporting
company under the Securities Exchange Act of 1934, as amended, or the Exchange Act. As a result,
we will need to generate significant revenues to achieve profitability. Even if we achieve
profitability, we may be unable to maintain or increase profitability on a quarterly or annual
basis. If we are unable to achieve and then maintain profitability, the market value of our common
stock will decline.
If we fail to increase our brand recognition, we may face difficulty in attracting new customers
and insurance carrier partners.
We believe that establishing, maintaining and enhancing our brand in a cost-effective manner
is critical to achieving widespread acceptance of our current and future products and services and
is an important element in our efforts to maintain and expand our relationships with insurance
carriers and to grow our customer base, particularly in light of the competitive nature of our
business. We believe that the importance of brand recognition will increase as competition in our
market develops. Some of our competitors already have well-established brands in the individual
health and life insurance market. Successful promotion of our brand will depend largely on our
ability to maintain a sizeable and active customer base, the success of our marketing efforts and
our ability to provide high quality individual health and life insurance and related products and
reliable and useful service to our customers. There can be no assurance that brand promotion
activities will yield increased revenue, and even if they do, any increased revenue may not offset
the expenses we incur in building our brand. If we fail to successfully promote and maintain our
brand, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our
brand, we may fail to attract enough new customers or retain our existing
5
customers to the extent necessary to realize a sufficient return on our brand-building
efforts, in which case our business, financial condition and results of operations could be
materially harmed.
We may be unable to obtain additional capital when necessary or on terms that are acceptable to us,
if at all.
Since our inception, we have used significant amounts of cash in our operations and in
investing activities. As of September 30, 2007, we had a cash balance of approximately $8.9
million. We used cash in operations of approximately $3.1 million for the nine months ended
September 30, 2007, approximately $6.5 million for the year ended December 31, 2006, $1.2 million
for the year ended December 31, 2005 and approximately $0.5 million for the period from our
inception on January 27, 2004 through December 31, 2004. We used cash in investing of
approximately $1.0 million for the nine months ended September 30, 2007, approximately $3.2 million
for the year ended December 31, 2006, $0.3 million for the year ended December 31, 2005 and
approximately $0.2 million for the period from our inception on January 27, 2004 through December
31, 2004.
We expect that we will need significant additional cash resources to operate and expand our
business in the future. Our future capital requirements will depend on many factors, including our
ability to maintain our existing cost structure and return on sales, fund obligations for
additional capital and execute our business and strategic plans as currently conceived. If these
resources are insufficient to satisfy our cash requirements, we may seek to sell additional equity
or debt securities or obtain a credit facility. The sale of additional equity securities would
result in additional dilution to our stockholders. Additional indebtedness would result in debt
service obligations and could result in operating and financing covenants that would restrict our
operations. In addition, financing might be unavailable in amounts or on terms acceptable to us, if
at all.
We may be unsuccessful in attracting or retaining key sales, marketing and other personnel or in
retaining the members of our senior management team.
The success of our business is dependent on our ability to attract and retain highly skilled
managers and sales and marketing personnel and to retain the members of our senior management team.
In particular, there is intense competition for qualified sales and marketing personnel in the
health and life insurance market, and we may be unable to attract, assimilate and retain qualified
sales and marketing personnel on a timely basis. Our inability to retain key personnel and attract
additional qualified personnel could harm our development and results of operations.
Our management team has limited experience managing a public company and regulatory compliance
could divert its attention from the day-to-day management of our business.
Prior to completing the merger transaction that resulted in our current public company
structure in November 2005, our management team operated our business as a private company.
Certain members of our current management team have little or no experience managing a public
company or complying with the increasingly complex laws pertaining to public companies. There can
be no assurance that our management team will continue to successfully or efficiently manage our
operations as a public company subject to significant regulatory oversight and reporting
obligations under the federal securities laws. In particular, our obligations as a public company
will continue to require substantial attention from our senior management and could divert its
attention away from the day-to-day management of our business, which could materially and adversely
impact our business and results of operations.
We may incur legal liability relating to information presented on our website or communicated
through our agents or otherwise.
6
Our customers rely on information we publish on our website or through our agents or otherwise
regarding the health and life insurance and related products we offer, including information
relating to insurance premiums, coverage, benefits, exclusions, limitations, availability and plan
comparisons. A significant amount of effort and training is required to maintain the considerable
amount of insurance plan information on our website and to educate our agents and oversee their
conduct with respect to such information. If the information we provide on our website, through our
agents or otherwise is not accurate, our customers, insurance carrier partners and regulatory
authorities in the jurisdictions in which we conduct business could seek legal damages or other
penalties as a result of any inaccuracy. In addition, these types of claims could be time-consuming
and expensive to defend, could divert our managements attention and other resources and could
cause a negative perception of our service or company in general. Regardless of whether we are
able to successfully resolve these claims or actions, they could harm our business, financial
condition and results of operations.
We may be unable to sufficiently protect our intellectual property.
Our business and competitive positions are dependent on our ability to use and protect our
proprietary technologies. Our patent applications may not protect our technologies because, among
other things:
|
|
|
there is no guarantee that any pending patent applications will result in issued
patents;
|
|
|
|
|
we may develop additional proprietary technologies that are not patentable;
|
|
|
|
|
there is no guarantee that any patent issued to us will provide us with any competitive
advantage;
|
|
|
|
|
there is no guarantee that any patents issued to us will not be challenged, circumvented
or invalidated by third parties; and
|
|
|
|
|
there is no guarantee that any patents previously issued to others or issued in the
future will not have an adverse effect on our ability to do business.
|
In addition, if we are unable to protect and control unpatented trade secrets, know-how and
other technological innovation, we may suffer competitive harm. We also rely on trade secrets,
know-how and technologies that are not protected by patents to maintain our competitive position.
Trade secrets are difficult to protect. To maintain the confidentiality of trade secrets and
proprietary information, we generally seek to enter into confidentiality agreements with our
employees, consultants and collaborators upon the commencement of a relationship with us. However,
we at times do not obtain these agreements, nor can we guarantee that these agreements will provide
meaningful protection, that these agreements will not be breached or that we will have an adequate
remedy for any such breach. In addition, adequate remedies may not exist in the event of
unauthorized use or disclosure of this information. Others may have developed, or may develop in
the future, substantially similar or superior know-how and technologies. The loss or exposure of
our trade secrets, know-how and other proprietary information, or independent development of
similar or superior know-how, could harm our business, financial condition and results of
operations.
We may become subject to intellectual property rights claims in the future, which are extremely
costly to defend, could require us to pay significant damages and could limit our ability to use
the affected technologies.
Our commercial success will depend in part on not infringing the patents or proprietary rights
of third parties. Third parties could bring legal actions against us claiming damages and seeking
to enjoin us
7
from using any technology found to be in violation of a third partys rights. If we become
involved in any litigation, it could consume a substantial portion of our resources, regardless of
the outcome of the litigation. If any of these actions are successful, in addition to any
potential liability for damages, we could be required to obtain a license to continue to use the
affected technology, in which case we may be required to pay substantial fees. There can be no
assurance that any such license will be available on acceptable terms or at all.
If we are unable to satisfy regulatory requirements relating to internal controls, or if our
internal controls over financial reporting are not effective, our stock price could decline.
As directed by Section 404 of the Sarbanes-Oxley Act of 2002, the Commission adopted rules
requiring public companies to include a report of management on the companys internal controls
over financial reporting in their annual reports required by Section 13(a) of the Exchange Act. In
addition, the public accounting firm auditing the companys financial statements must attest to and
report on managements assessment of the effectiveness of the companys internal controls over
financial reporting. Ensuring that we have adequate internal financial and accounting controls and
procedures in place to help ensure that we can produce accurate financial statements on a timely
basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Any failure
to maintain the adequacy of our internal controls, or the resulting inability to produce accurate
financial statements on a timely basis, could increase our operating costs and harm our ability to
operate our business. In addition, investor perception that our internal controls are inadequate or
that we are unable to produce accurate financial statements on a consistent basis may adversely
affect our stock price.
We may be unable to manage our growth effectively.
Our ability to compete effectively and to manage our future growth, if any, requires us to:
|
|
|
continue to improve our financial and management controls and reporting systems and
procedures to support the proposed expansion of our business operations; and
|
|
|
|
|
locate or hire, at reasonable compensation rates, qualified personnel and other
employees necessary to expand our capacity in order to accommodate the proposed
expansion of our business operations.
|
Our facilities and systems are vulnerable to natural disasters and other unexpected losses, and we
may not have adequate insurance to cover such losses.
Our computer hardware operations are located primarily in leased facilities in Deerfield
Beach, Florida. We also maintain an off-site backup system. Our geographic location is susceptible
to hurricanes and other natural disasters. If we experience a system failure or disruption, the
performance of our website would be harmed and our service could be shut down. These systems also
are vulnerable to damage or interruption from human error, fire, floods, power loss,
telecommunications failures, physical or electronic break-ins, computer viruses, other attempts to
harm our systems and similar events. If we seek to replicate our systems at other locations, we
will face a number of technical challenges, particularly with respect to database replications,
which we may be unable to address successfully. Although we maintain insurance to cover a variety
of risks, the scope and amount of our insurance coverage may not be sufficient to cover all losses
that we may incur.
We may be unable to find or complete strategic acquisitions of complementary businesses or
technologies or to integrate acquired businesses or technologies.
8
Our business strategy includes, among other things, achieving growth through the acquisition
and integration into our business of complementary businesses or technologies. We may be unable to
find additional complementary businesses or technologies to acquire. Future acquisitions may
result in substantial per share financial dilution of our common stock from the issuance of equity
securities. Completion of future acquisitions also would expose us to potential risks, including
risks associated with:
|
|
|
the assimilation of new operations, technologies and personnel;
|
|
|
|
|
unforeseen or hidden liabilities or other unanticipated events or circumstances;
|
|
|
|
|
the diversion of resources from our existing business;
|
|
|
|
|
the inability to generate sufficient revenue to offset the costs and expenses of
acquisitions, which may result in the impairment of assets acquired through
acquisitions; and
|
|
|
|
|
the potential loss of, or harm to, relationships with our employees, customers and
insurance carrier partners as a result of the integration of new businesses.
|
Our operating results may fluctuate as a result of factors beyond our control.
Our operating results may fluctuate significantly in the future as a result of a variety of
factors, many of which are beyond our control. These factors include, but are not limited to:
|
|
|
a reduction in commission rates from or loss of any of our insurance carrier
partners;
|
|
|
|
|
capital expenditures for the development of our technologies;
|
|
|
|
|
marketing and promotional activities and other costs;
|
|
|
|
|
changes in the pricing of our customers individual health and life insurance
policies by our insurance carrier partners;
|
|
|
|
|
changes in operating expenses;
|
|
|
|
|
increased competition in our market; and
|
|
|
|
|
other general economic and seasonal factors.
|
Risks Relating to Our Business
Our model of marketing and selling individual health and life insurance and related products
through our interactive insurance marketplace might not achieve and maintain widespread consumer
and insurance carrier acceptance.
Selling health and life insurance and related products through sales methods other than
traditional face-to-face methods, such as through the Internet or telephonically, is a relatively
new development. If consumers and insurance carriers do not widely adopt our model of selling and
purchasing such products through our interactive insurance marketplace, or if they determine that
traditional face-to-face sales methods or other methods for selling and purchasing health and life
insurance and related products are superior, our business, financial condition and results of
operations would be materially harmed.
9
If we fail to adequately maintain our existing insurance carrier relationships and develop new
insurance carrier relationships, our business could suffer.
Our business could suffer if we fail to attract new insurance carrier partners or maintain our
existing insurance carrier partners, by limiting the variety of health and life insurance and
related products that we offer to consumers. In addition, our agreements with our insurance carrier
partners typically are non-exclusive and terminable upon short notice by either party for any
reason. Our insurance carrier partners may discontinue sales of products through us for a number
of reasons, including, among others:
|
|
|
competitive or regulatory reasons;
|
|
|
|
|
reluctance to utilize non-traditional sales methods;
|
|
|
|
|
reluctance to be associated with our brand;
|
|
|
|
|
greater reliance by our insurance carrier partners on their internal distribution
channels to sell their products, including through traditional in-house agents and
carrier websites; or
|
|
|
|
|
a carriers decision to discontinue sales in the individual health and life
insurance market.
|
In addition, we may decide to terminate our relationship with certain insurance carriers for a
variety of reasons, including, among other things:
|
|
|
as a result of a reduction in a carriers financial rating;
|
|
|
|
|
a carriers reduction in commissions paid to us; or
|
|
|
|
|
a carriers insistence upon utilizing a sales process that we believe impairs the
value of our service or brand.
|
The termination of our relationship with any of our insurance carrier partners could reduce
the variety of insurance products we offer, which could harm our business, particularly in light of
our current dependence on a limited number of insurance carriers. Upon any such termination, we
also would lose a source of commissions for future sales, and, in certain cases, future commissions
for pre-termination sales.
In addition, we have agreements with certain of our insurance carries whereby certain of our
insurance carriers advance us first year premium commissions before the commissions are earned.
The unearned portion of premium commissions has been included in the consolidated balance sheet as
a liability for unearned commission advances. These advance agreements represent a material source
of cash to fund our operations. Our advance agreement with our largest insurance carrier is
contractually limited to a maximum of $9,000,000, can be terminated by either party, and in the
event of termination our outstanding advance balance can be called by the insurance carrier with
seven days written notice. As of September 30, 2007, our outstanding advance balance with this
carrier was $6,379,064. Our advance agreement with our second largest insurance carrier allows the
insurance carrier to terminate future advances and convert the outstanding advance balance into a
promissory note, which if not repaid within 30 days, would incur interest expense. As of September
30, 2007, our outstanding advance balance with this carrier was $1,554,234. During the third
quarter of 2007, we began receiving advances of first year premium commissions before the
commissions are earned from our third largest insurance carrier. Our understanding pertaining to
the advance from this carrier is that the carrier may terminate future advances and demand
repayment of the outstanding unearned commission advance balance if
10
certain performance standards are not met. We and this insurance carrier are working together
on reaching an agreement pertaining to these advances. As of September 30, 2007, our outstanding
advance balance with this carrier was $634,915. The termination of our relationship with any of
these three insurance carriers may result in the carrier demanding the repayment of the outstanding
advance balance. We may not have sufficient cash liquidity to repay our outstanding advance
balance if any of these three carriers demand repayment.
There could be a reduction in the quality and affordability of the individual health and life
insurance and related products that our insurance carrier partners offer.
The demand for individual health and life insurance and related products that we offer is
impacted by, among other things, the variety, quality and price of such products. If our insurance
carrier partners do not provide us with high-quality products or properly service the policies they
sell through us, our sales may decrease and our business, financial condition and results of
operations could be harmed.
Our insurance carrier partners might decide to reduce the commissions they pay to us or change
their underwriting practices in a way that reduces the number of insurance policies that we sell.
The commissions we receive from our insurance carrier partners are either set by the carrier
or negotiated between us and the carrier. Our insurance carrier partners could reduce the
commissions they pay to us either by renegotiation or, in certain cases, by unilateral action. In
addition, insurance carriers periodically change their underwriting criteria, any of which changes
could result in a decrease in the number of insurance policies we are able to sell. Any such
changes to our existing relationships with our insurance carrier partners could impact our sales
volume negatively and harm our business, financial condition and results of operations.
We rely on our insurance carrier partners to accurately and regularly prepare commission reports,
and if these reports are inaccurate or not sent to us in a timely manner, our results of operations
could suffer.
Our insurance carrier partners pay us a specified percentage of the premium amount collected
by the carrier during the period that a member maintains coverage under a policy. We rely on our
insurance carrier partners to report in a timely and accurate manner the amount of commissions
earned by us, and we calculate our commission revenue, prepare our financial reports, projections
and budgets and direct our marketing and other operating efforts based on these reports. It is
difficult for us to independently determine whether or not our insurance carrier partners are
reporting all commissions due to us, primarily because customers who terminate their policies often
do so by discontinuing their premium payments to the insurance carrier without informing us of the
cancellation. To the extent that our insurance carrier partners understate or fail to report the
amount of commissions due to us in a timely manner or at all, we will not collect and recognize
revenue to which we are entitled, which would adversely affect our results of operations and could
cause the value of our stock to decline.
We may experience technological problems or service interruptions with any of our insurance carrier
partners, which could negatively affect the quality of service on our website.
A significant portion of our processes for submitting insurance applications and other
information necessary to conduct business with carriers require that our web servers communicate
with carriers computer systems. A malfunction in an insurance carriers computer system or in the
Internet connection between our web servers and the insurance carriers system, or excess data
traffic, could result in a delay in processing business to one or more carriers. Also, a computer
malfunction could cause an insurance carrier to quote erroneous rates, in which case the insurance
carrier would be required to take itself offline
11
until the malfunction can be corrected. Technological problems with or interruption of
communications with insurance carriers computer systems could negatively affect the quality of
service we provide to consumers, which in turn could harm our business.
The level of business we expect to generate through online search engines could fluctuate due to
changes in search engine based algorithms.
We expect to derive an increased volume of customers in the future through Internet search
engines such as Google, MSN, AOL and Yahoo! A critical factor in attracting consumers to our
website will be whether we are prominently displayed in response to an Internet search relating to
health or life insurance or related products. Unpaid search result listings are determined and
displayed in accordance with a set of algorithms developed by the particular Internet search
engine. These algorithms determine the order of the listing of results in response to the
consumers Internet search. From time to time, search engines revise these algorithms, which may
cause our website to be listed less prominently in unpaid search results. Our website also may
become listed less prominently in unpaid search results for other reasons, such as search engine
technical difficulties, search engine technical changes and changes we decide to make to our
website. In addition, search engines could, for a variety of reasons, decide not to list our
website in search result listings. If we are not listed prominently in search result listings for
any reason, we will be unable to generate a sufficient amount of traffic to our website, which
could harm our business, financial condition and results of operations.
If we are unable to maintain our existing relationships with the various third parties that
currently provide us with consumer prospects, our business, financial condition and results of
operations could be harmed.
We currently rely on various third party services to provide us with a significant portion of
our leads of individuals interested in purchasing health and life insurance and related products.
We typically pay these parties a fixed fee for each prospect provided to us or resulting sale to
such prospect. If we are unable to maintain successful relationships with these third party
services or continue to generate a sufficient volume of prospects on terms acceptable to us through
these third parties, we will need to develop new methods for acquiring consumer prospects, in which
case our business, financial condition and results of operations could be harmed.
Risks Relating to Our Industry
Laws and regulations governing the insurance industry could expose us to legal penalties for
noncompliance, or could require changes to our business.
We are required to comply with myriad complex insurance laws, rules and regulations, which
vary, often dramatically, from state to state. For example, state regulators require us to
maintain a valid license in each state in which we transact insurance business and further require
that we adhere to sales, documentation and administration practices specific to that state. In
addition, each employee who transacts insurance business on our behalf must maintain a valid
license in one or more states. Because we conduct business in a majority of jurisdictions in the
United States, compliance with insurance laws, rules and regulations is difficult and imposes
significant costs on our business. In addition, we intend to expand the number of insurance
carriers we represent, the variety of individual health and life insurance and related products
that we offer and the number of states in which we are able to offer these products, any of which
may require us to comply with the insurance laws, rules and regulations of additional
jurisdictions. Each jurisdictions insurance department typically has the power, among other
things, to:
|
|
|
grant and revoke licenses to transact insurance business;
|
12
|
|
|
conduct inquiries into the insurance-related activities and conduct of agents and
agencies;
|
|
|
|
|
require and regulate disclosure in connection with the sale and solicitation of
insurance;
|
|
|
|
|
authorize how, by which personnel and under what circumstances insurance premiums
can be quoted and published and an insurance policy sold;
|
|
|
|
|
approve which entities can be paid commissions from insurance carriers;
|
|
|
|
|
regulate the content of insurance-related advertisements, including web pages;
|
|
|
|
|
approve policy forms, require specific benefits and benefit levels and regulate
premium rates;
|
|
|
|
|
impose fines and other penalties; and
|
|
|
|
|
impose continuing education requirements.
|
Due to the complexity, periodic modification and differing interpretations of insurance laws
and regulations, we might not have always been, and we may not always be, in compliance with these
laws and regulations. Noncompliance could result in significant liability, additional licensing
requirements or the revocation of licenses in a particular jurisdiction, which could significantly
increase our operating expenses, prevent us from transacting insurance business in a particular
jurisdiction and otherwise harm our business, financial condition and results of operations.
Additionally, an adverse regulatory action in one jurisdiction could result in penalties and
adversely affect our license status or reputation in other jurisdictions due to the requirement
that adverse regulatory actions in one jurisdiction be reported to other jurisdictions. Even if the
allegations in any regulatory or other action against us are proven false, any surrounding negative
publicity could harm the confidence of consumers and insurance carriers in us, which could
significantly damage our brand. Because some consumers and insurance carriers may be uncomfortable
with the concept of purchasing health or life insurance or related products through means other
than traditional, face-to-face means, any negative publicity may affect us more than it would
others in the insurance industry and would harm our business, financial condition and results of
operations.
Regulation of the sale of health insurance is subject to change, and future regulations could harm
our business and operating results.
The laws and regulations governing the offer, sale and purchase of health and life insurance
and related products are subject to change, and we may be adversely affected by such changes. For
example, once health insurance pricing is set by an insurance carrier and approved by state
regulators, it is fixed and generally not subject to negotiation or discounting by insurance
companies or agents.
Another example of a potentially adverse regulatory change relates to the adoption of
guaranteed issue laws and regulations in the individual and family health insurance markets.
These requirements, which are currently in effect in a limited number of states such as
Massachusetts, New Jersey and New York, prohibit insurance carriers from denying health insurance
coverage to individuals based on their health status. We believe that substantially fewer insurance
carriers offer plans in the individual and family health insurance market in states with guaranteed
issue requirements compared to other states. In addition, we believe that those insurance carriers
that offer individual and family plans in these states typically charge substantially higher
premiums and/or pay reduced commissions to agents. We believe that limited choice and high premiums
result in less demand for individual and family health insurance plans which, when coupled with
reduced commissions to agents, results in substantially less revenue for us in these states.
Although we currently do not expect a substantial number of states to adopt guaranteed
13
issue requirements for the individual and family market, our business, financial condition and
results of operations would be harmed if the adoption of these requirements becomes more
widespread.
We are subject to additional insurance regulatory risks due to our use of the Internet and
voice signature process in our interactive insurance marketplace. The manner and extent to which
existing insurance laws and regulations could be applied to Internet-related insurance
advertisements and transactions and voice signatures is largely unclear. To the extent that new
laws or regulations are adopted that conflict with the way we conduct our business, or to the
extent that existing laws and regulations are interpreted adversely to us, our business, financial
condition and results of operations would be harmed.
Do not call laws and requirements could limit our ability to market our products and services.
Our direct marketing operations are or may become subject to additional federal and state do
not call laws and requirements. In January 2003, the Federal Trade Commission amended its rules to
provide for a national do not call registry. Under these federal regulations, consumers may have
their phone numbers added to the national do not call registry. Generally, we are prohibited from
calling any consumer whose telephone number is listed in the registry unless the consumer has
requested or initiated the contact or given his or her prior consent. Enforcement of the federal
do not call provisions began in the fall of 2003, and the rule provides for fines of up to
$11,000 per violation and other possible penalties. Our current business model relies heavily on
outbound calls from our contact centers to consumers. The federal regulations and similar state
laws may restrict our ability to effectively market to new consumers the products we sell on behalf
of our insurance carrier partners. Furthermore, compliance with this rule may prove difficult, and
we may incur penalties for improperly conducting our marketing activities.
We may be unable to compete successfully against new and existing competitors.
We operate in a highly competitive market with few barriers to entry. We expect that
competition will continue to intensify. Some of our competitors are more established than we are,
and have significantly greater financial, technical, marketing, and other resources than we do. In
addition, many of our current and potential competitors can devote substantially greater resources
than we can to promotion, website development and systems development. Many of our competitors have
greater name recognition and a larger customer base than we do. These competitors may be able to
respond more quickly to new or changing opportunities and customer requirements and may be able to
undertake more extensive promotional activities and offer more attractive terms to insurance
carriers. Competition could reduce our market share in the individual health and life insurance
market.
Changes and developments in the structure of the health insurance system in the United States could
harm our business.
Fundamental changes to the health insurance system in the United States could reduce or
eliminate the demand for individual health insurance or increase our competition, which would harm
our business. In the United States, there have been, and we expect that there will continue to be,
a number of debates and legislative and regulatory proposals aimed at changing the healthcare
system. For example, some advocates promote a universal healthcare system that would be largely
underwritten by the government. The adoption of state or federal laws that promote or establish a
government-sponsored universal healthcare system could reduce or eliminate the number of
individuals seeking or permitted to purchase private health insurance or supplemental coverage,
which would substantially reduce the demand for our service and harm our business, financial
condition and results of operations.
14
If we are unable to safeguard the security and privacy of confidential online data, our business
may be harmed.
Our business involves the collection, storage and transmission of personally identifiable
information such as names, addresses, social security and credit card numbers and information
regarding the medical history of consumers over public networks. Although we utilize advanced
protection from the threat of improper access to our networks and transaction data, such protection
may be imperfect or inadequate. We may be required to expend significant additional capital and
other resources to protect against security breaches or to alleviate problems caused by security
breaches. Any compromise or perceived compromise of our security could damage our reputation and
our relationship with consumers and insurance carrier partners, could reduce demand for our service
and could subject us to significant liability and regulatory action, which would harm our business,
financial condition and results of operations.
Uncertainty in the marketplace regarding the use of personal information, or proposed legislation,
could reduce demand for our services and result in increased expenses.
Concern among consumers and legislators regarding the use of personal information gathered
from Internet users could create uncertainty in the marketplace. This could reduce demand for our
services, increase the cost of doing business as a result of new security measures, possible
litigation or otherwise, or increase service delivery costs, or otherwise adversely affect our
business in other ways. Many state insurance codes limit the collection and use of personal
information by insurance companies, agents, or insurance service organizations.
Governmental regulation of the Internet may adversely affect our business and operating results.
The laws governing general commerce on the Internet remain unsettled and it may take years to
fully determine whether and how existing laws such as those governing intellectual property,
privacy and taxation apply to the Internet. Due to the rapid growth and widespread use of the
Internet, federal and state governments have are considering enacting additional laws relating to
the Internet. Any of these existing laws or future laws relating to the Internet could expose us
to substantial compliance costs and liabilities and may impede the growth of Internet commerce.
Risks Relating to our Common Stock
Sales of substantial amounts of our common stock in the public market could depress the market
price of our common stock.
Our common stock currently is quoted on the OTCBB, which is a limited and illiquid market. If
our stockholders sell substantial amounts of our common stock in the public market, including the
shares being registered under this registration statement and shares issuable upon the exercise of
outstanding warrants and options, or the market perceives that such sales may occur, the market
price of our common stock could fall and we may be unable to sell our common stock in the future.
Our common stock may experience extreme price and volume fluctuations, which could lead to costly
litigation for us and make an investment in us less appealing.
The market price of our common stock may fluctuate substantially due to a variety of factors,
including:
|
|
|
our business strategy and plans;
|
15
|
|
|
announcements concerning our competitors or the individual health and life insurance
market;
|
|
|
|
|
rate of sales and customer acceptance;
|
|
|
|
|
changing factors related to doing business in various jurisdictions within the
United States;
|
|
|
|
|
interruption of supply from or changes in our agreements with our insurance carrier
partners;
|
|
|
|
|
new regulatory pronouncements and changes in regulatory guidelines and timing of
regulatory approvals;
|
|
|
|
|
general and industry-specific economic conditions;
|
|
|
|
|
additions to or departures of our key personnel;
|
|
|
|
|
variations in our quarterly financial and operating results;
|
|
|
|
|
changes in market valuations of other companies that operate in our business
segments or in our industry;
|
|
|
|
|
lack of adequate trading liquidity;
|
|
|
|
|
announcements about our business partners;
|
|
|
|
|
changes in accounting principles; and
|
|
|
|
|
general market conditions.
|
The market prices of the securities of early-stage companies, particularly companies like ours
without consistent product revenues and earnings, have been highly volatile and are likely to
remain highly volatile in the future. This volatility has often been unrelated to the operating
performance of particular companies. In the past, companies that experience volatility in the
market price of their securities have often faced securities class action litigation. Whether or
not meritorious, litigation brought against us could result in substantial costs, divert our
managements attention and resources and harm our financial condition and results of operations.
Our directors, executive officers and entities affiliated with them beneficially own a substantial
number of shares of our common stock, which gives them significant control over certain major
decisions.
As of January 21, 2008, our executive officers and directors and entities affiliated with them
beneficially owned, in the aggregate, approximately 28.3% of our outstanding shares of common
stock, based on a total of 35,026,384 shares outstanding. These executive officers, directors and
their affiliates may have different interests than you. For example, they could act to delay or
prevent a change of control of us, even if such a change of control would benefit our other
stockholders, could prevent or frustrate attempts to replace or remove current management or could
pursue strategies that are different from the wishes of other investors. This significant
concentration of stock ownership may adversely affect the trading price of our common stock due to
investors perception that conflicts of interest may exist or arise.
16
Transactions in which a privately-held company merges into a largely inactive company with publicly
traded stock are generally closely scrutinized by the Commission and we may encounter difficulties
or delays in obtaining future regulatory approvals.
Historically, the Commission and Nasdaq and securities exchanges have disfavored transactions
in which a privately-held company merges into a largely inactive company with publicly traded
stock, and there is a significant risk that we may encounter difficulties in obtaining the
regulatory approvals necessary to conduct future financing or acquisition transactions, or to
eventually achieve our common stock being quoted on Nasdaq or listed on a securities exchange.
Effective August 22, 2005, the Commission adopted rules dealing with private company mergers into
dormant or inactive public companies. As a result, it is likely that we will be scrutinized
carefully by the Commission and possibly by the National Association of Securities Dealers or
Nasdaq or a national securities exchange, which could result in difficulties or delays in achieving
Commission clearance of any future registration statements or other Commission filings that we may
pursue, in attracting NASD-member broker-dealers to serve as market-makers in our stock, or in
achieving admission to Nasdaq or a national securities exchange. As a result, our financial
condition and the value and liquidity of our shares may be negatively impacted.
As a stock quoted on the OTCBB, our common stock, which is deemed to be penny stock, currently
has limited liquidity.
Holders of shares of our common stock, which are quoted on the OTCBB, may find that the
liquidity of our common stock is impaired as compared with the liquidity of securities listed on
Nasdaq or one of the national or regional exchanges in the United States. This impairment of
liquidity may result from reduced coverage of us by security analysts and news media and lower
prices for our common stock than may otherwise be attained. In addition, our common stock is deemed
to be penny stock, as that term is defined in rules under the Exchange Act. Penny stocks
generally are equity securities that are not registered on certain national securities exchanges or
quoted by Nasdaq and have a price per share of less than $5.00. Penny stock may be difficult for
investors to resell. Federal rules and regulations impose additional sales practice requirements on
broker-dealers who sell the stock to persons other than established customers and accredited
investors. For transactions covered by these rules, the broker-dealer must make a special
suitability determination for the purchase of these securities and obtain the purchasers written
consent to the transaction prior to the sale. Prior to the sale, broker-dealers must also deliver
to the potential purchaser a disclosure schedule prescribed by the Commission, describing the penny
stock market and disclose the commissions payable to both the broker-dealer and the registered
representative and current quotations for the securities. Finally, broker-dealers must deliver to
penny stock investors monthly statements disclosing recent price information for penny stocks held
in the account and information on the limited market in penny stocks. These additional requirements
restrict the ability of broker-dealers to sell our common stock and make it more difficult for
investors to dispose of our common stock in the secondary market and may also adversely affect the
price of our common stock.
17
USE OF PROCEEDS
We will not receive any of the proceeds from the sale of shares of our common stock by the
selling stockholders. We will bear all costs, expenses and fees in connection with the registration
of shares of our common stock to be sold by the selling stockholders. The selling stockholders will
bear all commissions and discounts, if any, attributable to their respective sales of shares.
MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS
Market Information
The following table sets forth the high and low bid prices for our common stock for the
periods indicated, as reported by the OTCBB. The prices state inter-dealer quotations, which do not
include retail mark-ups, mark-downs or commissions. Such prices do not necessarily represent actual
transactions.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
Low
|
2005:
|
|
|
|
|
Fourth quarter (commencing December 13, 2005), ended
December 31, 2005
|
|
$
|
4.00
|
|
|
$
|
2.00
|
|
|
|
|
|
|
|
|
|
|
2006:
|
|
|
|
|
|
|
|
|
First quarter, ended March 31, 2006
|
|
$
|
3.69
|
|
|
$
|
1.84
|
|
Second quarter, ended June 30, 2006
|
|
$
|
4.00
|
|
|
$
|
2.60
|
|
Third quarter, ended September 30, 2006
|
|
$
|
3.15
|
|
|
$
|
1.90
|
|
Fourth quarter, ended December 31, 2006
|
|
$
|
3.09
|
|
|
$
|
2.22
|
|
|
|
|
|
|
|
|
|
|
2007:
|
|
|
|
|
|
|
|
|
First quarter, ended March 31, 2007
|
|
$
|
3.26
|
|
|
$
|
2.55
|
|
Second quarter, ended June 30, 2007
|
|
$
|
2.93
|
|
|
$
|
2.20
|
|
Third quarter, ended September 30, 2007
|
|
$
|
2.40
|
|
|
$
|
1.75
|
|
Fourth quarter, ended December 31, 2007
|
|
$
|
2.60
|
|
|
$
|
1.65
|
|
Holders of Record
Based on information furnished by our transfer agent, as of December 31, 2007, we had
approximately 161 holders of record of our common stock.
Penny Stock
Until our common stock qualifies for listing for Nasdaq, the American Stock Exchange, or
another national securities exchange, the trading of our securities will be on the OTCBB. As a
result, an investor may find it more difficult to dispose of, or to obtain accurate quotations as
to the price of, our common stock.
Dividend Policy
We have not declared or paid dividends on our common stock and do not anticipate declaring or
paying any cash dividends on our common stock in the foreseeable future. We currently expect to
retain future earnings, if any, for the development of our business. Any future determination to
pay cash dividends will be at the discretion of our board of directors and will be dependent on our
results of operations, financial condition, contractual restrictions and other factors that our
board of directors considers relevant.
18
Securities Authorized for Issuance under Equity Compensation Plans
The following table shows certain information concerning our common stock to be issued in
connection with our equity compensation plans as of December 31, 2007:
EQUITY COMPENSATION PLAN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Number of Securities
|
|
|
Securities to be
|
|
Weighted-
|
|
Remaining Available for
|
|
|
Issued upon
|
|
Average Exercise
|
|
Future Issuance
|
|
|
Exercise of
|
|
Price of
|
|
Under Equity
|
|
|
Outstanding
|
|
Outstanding
|
|
Compensation Plans
|
|
|
Options,
|
|
Options,
|
|
(Excluding Securities
|
|
|
Warrants and
|
|
Warrants and
|
|
Reflected in the first
|
Plan Category
|
|
Rights
|
|
Rights
|
|
Column)
|
Equity compensation
plans approved by
security holders
|
|
|
15,581,900
|
|
|
$
|
2.00
|
|
|
|
603,100
|
|
Equity compensation
plans not approved
by security holders
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
15,581,900
|
|
|
$
|
2.00
|
|
|
|
603,100
|
|
19
OUR BUSINESS
Overview
We are a contact center-based insurance agency that operates an online marketplace enabling
consumers to shop for, compare and purchase individual health and life insurance and related
products for individuals and families. Our sales platform combines our proprietary, integrated
online technology and dialing application to connect consumers who express an interest in
purchasing health or life insurance or related products with knowledgeable licensed agents housed
in our contact centers.
We act as an independent agent, selling health and life insurance and related products on
behalf of a number of nationally-branded, highly-rated insurance carriers. Our health insurance
carrier partners include:
|
|
|
Aetna, Inc.;
|
|
|
|
|
Colorado Bankers Life Insurance Company;
|
|
|
|
|
Golden Rule Insurance Company (a UnitedHealthcare company);
|
|
|
|
|
Humana, Inc.;
|
|
|
|
|
PacifiCare Life and Health Insurance Company (a UnitedHealthcare company);
|
|
|
|
|
Time Insurance Company (marketed under the brand name Assurant Health); and
|
|
|
|
|
UniCare Life and Health Insurance Company (a Wellpoint company).
|
Our life insurance carrier partners include:
|
|
|
AIG American General; and
|
|
|
|
|
Fidelity Life Insurance Company.
|
The primary product we sell on behalf of insurance carriers is major medical health insurance
for individuals and families. Annualized premium with respect to a specific insurance policy is the
sum of premium payments to be made by the insured over the 12-month period after the issuance of
the policy. We also sell short-term medical policies (term shorter than one year), health savings
accounts and term life insurance. We believe these additional products represent significant
cross-sell opportunities to our existing client base with minimal acquisition cost.
Our service is free to consumers and our principal source of revenue is commissions paid to us
by insurance carriers as compensation for policies sold. Our commissions are based on a percentage
of the premium amount collected by a carrier during the period that a customer maintains coverage
under a policy. These commissions include first year commissions and renewal commissions. First
year commission rates are significantly higher than renewal commission rates. We also are eligible
for incentive bonuses based on our ability to meet pre-determined criteria established by our
insurance carriers. The amounts of commissions and incentive bonuses for which we are eligible
vary, often significantly, by carrier and product.
20
Our streamlined sales process, supported by our proprietary online technology, dialing
application and voice signature process, ensures efficiency for consumers purchasing, and carriers
underwriting, insurance products. Through our proprietary online technology and our dialing
application, which we call Quick-to-Call, consumers who submit a request for quotes for health
insurance and related products through our website are connected with a licensed agent in one of
our contact centers in as little as 30 seconds from the time of submission. Our process enables us
to reduce the amount of time it takes from the moment a consumer expresses interest in purchasing
insurance to submission of an application to a carrier for underwriting to as little as 60 minutes.
This compares with up to six weeks under traditional face-to-face agency sales models.
Our licensed agents assist consumers in sorting through the complicated process of selecting
and obtaining health or life insurance or related products by:
|
|
|
explaining and clarifying complicated insurance concepts to the consumer;
|
|
|
|
|
providing useful information about the range of products that our insurance
carrier partners offer, including price and terms of coverage;
|
|
|
|
|
comparing plans and guiding the consumer to the product most suitable for the
consumers needs and preferences;
|
|
|
|
|
providing detailed answers to the consumers questions and addressing other
relevant concerns of the consumer; and
|
|
|
|
|
explaining the application, and verification, issuance and ongoing billing
procedures.
|
Following the consumers selection of a product, one of our trained representatives, following
a script pre-approved by the relevant carrier, completes the application with the consumer for
submission to the carriers underwriting department. The tele-call, which is recorded with the
consumers express consent, serves as the consumers voice signature on the application.
Assuming an applicant meets the insurance carriers initial underwriting criteria, the
application, along with the verification call recording, is submitted electronically to the
insurance carriers underwriting department. Upon carrier approval of the consumers application,
the carrier notifies us and, subsequently, our customer service department communicates this
approval to the consumer. Alternatively, if the tele-application representative determines that a
consumer does not meet a carriers underwriting criteria for a particular policy, we reconnect the
consumer with a licensed agent who reviews additional product alternatives with the consumer. The
goal of our sales and application process is to increase efficiency and enhance the likelihood that
the application for the consumers selected product will meet the insurance carriers underwriting
criteria and the policy will be issued.
We maintain a comprehensive process to ensure the highest standards of training and
professionalism for our sales agents. Newly-hired agents are immersed in various company- and
carrier-sponsored training programs and receive one-on-one instruction and support from our sales
managers and senior agents. Through our licensing department, we assist our agents in obtaining and
maintaining the requisite licenses and carrier appointments to conduct sales of health and life
insurance products in the various states in which we conduct business.
As an independent agency, our goal is to retain our customers for the duration of their health
insurance needs. We continuously evaluate customer retention initiatives, including regular
follow-up communication to ensure satisfaction with policies purchased. Moreover, we work with both
our
21
customers and carriers to determine how to improve the service we provide and how to make our
processes more efficient.
In April 2006, we and our wholly-owned subsidiary, ISG Merger Acquisition Corp., a Delaware
corporation, or the Merger Sub, entered into a Merger Agreement with Insurance Specialist Group
Inc., or ISG, and Ivan M. Spinner (the sole stockholder of ISG), pursuant to which, among other
things, the Merger Sub merged with and into ISG. As consideration for this merger, we made a cash
payment of $920,000 and issued 1,000,000 shares of our common stock to Mr. Spinner in exchange for
all of the outstanding stock of ISG. In connection with this merger, we entered into an Employment
Agreement with Mr. Spinner, under which he was appointed as an officer of HBDC II, LLC. As a result
of this merger, ISG became our wholly-owned subsidiary.
ISG provides sales support services to independent insurance agencies and agents in obtaining
additional insurance products and appointments with insurance carriers. We refer to these agencies
and agents as ISGs down-line. ISGs revenues consist primarily of override commissions from
carriers for sales of products by ISGs down-line agents. ISGs override commission rates are
significantly lower than the commissions we earn for products sold by our employee agents. ISG
currently has approximately 480 agents in its down-line.
Our Opportunity in the Insurance Industry
We believe that a significant opportunity exists to obtain an increased market share in the
rapidly expanding individual health insurance market and the low cost term life insurance market.
In recent years, the number of Americans seeking individual health insurance and related products
has increased dramatically, largely as a result of a decline in the availability and cost advantage
of employer-sponsored group plans.
Specifically, according to the 2006 Annual Employer Health Benefits Survey by the Kaiser
Family Foundation in Menlo Park, California, and the Health Research & Educational Trust in
Chicago, Illinois, employers in the U.S. offering health insurance dropped from 69% in 2000 to 61%
in 2006 and the percentage of U.S. workers covered by their employers health insurance plans
dropped from 63% in 2000 to 59% in 2006. In addition, according to the Current Population Survey,
the number of uninsured Americans rose from 15.3% in 2005 to 15.8% in 2006, the highest level since
1998. Insurance carriers and large agencies, which historically have focused their sales efforts
on employer-sponsored group plans, have been slow to react to this increasing demand.
Increasingly, individual consumers are utilizing the Internet to access useful information and
to purchase products. While the Internet represents a potentially efficient channel to connect
insurance carriers with this underserved market segment, we believe that the business model of
conducting sales of health and life insurance and other products exclusively through the Internet
has limitations. Most importantly, this model underestimates the effect of the complexity,
importance and cost of health and life insurance and related products on a consumers willingness
to purchase these products exclusively through the Internet. Consumers who are willing to purchase
relatively simple, inexpensive goods such as compact discs, flowers and books over the Internet may
be unwilling to purchase complicated and expensive items such as health and life insurance and
related products in the same manner. Additionally, consumers who may be inclined to purchase other
items on the Internet may prefer the guidance of a licensed agent in shopping for health or life
insurance. Finally, consumers may be unwilling to divulge highly personal medical, financial and
other information over the Internet.
By combining the expansive reach, speed and efficiency of the Internet with the comfort of
speaking to a knowledgeable live agent, we believe that our sales model overcomes the limitations
of both
22
traditional face-to-face and Internet-only sales models. Through the Internet, we can
instantly provide a prospective customer with product information regardless of his or her
location. At the same time, the prospective customer can initiate an online request for a phone
call from one of our knowledgeable licensed agents to receive additional guidance in connection
with making a purchase of health or life insurance or a related product.
We believe that our interactive insurance online marketplace provides the following benefits
to consumers:
|
|
|
assistance from a knowledgeable licensed agent conveniently accessible by phone;
|
|
|
|
|
one-stop comparison shopping from multiple high-quality insurance carriers for
multiple products;
|
|
|
|
|
accurate, insurance carrier-linked quotes;
|
|
|
|
|
easy access to insurance-related information and tools;
|
|
|
|
|
convenience and privacy; and
|
|
|
|
|
faster issuance of policies due to technological efficiencies.
|
In addition, we believe that our interactive online insurance marketplace provides the
following benefits to insurance carriers:
|
|
|
lower client acquisition cost made possible by an Internet-based marketplace;
|
|
|
|
|
scalable customer acquisition processes that allow substantial increases in
activity and productivity;
|
|
|
|
|
access to customers who have indicated initial purchasing intent, screened and
verified through an insurance providers underwriting criteria; and
|
|
|
|
|
improved timeliness and accuracy of information submitted to insurance carriers
for underwriting.
|
Currently, our primary customer acquisition method is through paid referrals from third-party
online lead aggregators. Consumers searching for health and life insurance and related products
also can speak to one of our licensed agents by calling a toll-free telephone number or by visiting
our website. Recently, we have begun evaluating marketing opportunities to assist us in developing
a broader mix of customer acquisition sources. Any proposed marketing and advertising will direct
consumers to both our website and a toll-free telephone number.
Traditional, offline marketing and advertising tactics currently being tested or considered
include, among other things, the following:
|
|
|
direct response television advertising;
|
|
|
|
|
print advertising in select media;
|
|
|
|
|
targeted direct mail initiatives; and
|
23
|
|
|
marketing partnerships with various companies.
|
Online marketing and advertising initiatives currently being tested or considered include,
among other things, the following:
|
|
|
affiliate marketing programs;
|
|
|
|
|
search engine marketing and website optimization;
|
|
|
|
|
banner advertising; and
|
|
|
|
|
e-mail campaigns.
|
Our Strategy
Our strategy is to become the premier individual health and life insurance agency for
individuals and families. The key elements of our strategy and solution include the following:
|
|
|
Potential Growth
. Our strategy includes internal growth as well as growth through
strategic acquisitions in the individual health and life insurance market. We believe that we can
benefit from strategic acquisitions, including acquisitions of existing call center operations, by
leveraging our sophisticated sales platform and proprietary online technology and dialing
application to increase the scale of our operations. Our growth strategy also includes increasing
the number of licensed sales agents we employ.
|
|
|
|
|
Expanded Products and Insurance Carrier Relationships
. We intend to expand the number
of insurance carriers we represent, the variety of individual health and life insurance and related
products that we offer and the number of states in which we are able to offer these insurance
products. We believe that each of these initiatives can provide us with additional sources of
revenue and enhance the consumers experience of purchasing health and life insurance and related
products through our interactive insurance marketplace.
|
|
|
|
|
Enhanced Customer Experience
. We seek to enhance the customers experience in shopping
for health and life insurance and related products through our interactive insurance marketplace by
providing service that is significantly more convenient, efficient and reliable than alternative
sales models. We intend to achieve these enhancements through technological and other efficiency
improvements to the process of selecting, applying for and purchasing health and life insurance and
related products. To date, we have been able to substantially reduce the amount of time that is
typically required from the time we receive an indication of a consumers interest in purchasing a
policy to the issuance of the policy. Our goal is to facilitate the issuance of most policies
within hours, rather than the days or weeks that traditional face-to-face methods generally
require.
|
|
|
|
|
Increased Marketing and Brand-Building Efforts
. We intend to increase our customer
base by increasing our marketing and brand-building efforts, as described above.
|
Competition
The individual health and life insurance agency market is highly competitive and has few
barriers to entry. We anticipate that competition in this market will continue to intensify. We are
not aware of any insurance sales agency that utilizes an interactive insurance marketplace
substantially similar to ours. However, significant competition exists from companies engaging in
traditional and Internet-only sales.
24
These competitors include large and small insurance carriers and agencies that operate on a
national and regional basis. We also anticipate substantial new competition in this market,
including from competitors with an interactive insurance marketplace substantially similar to ours.
We expect to compete on, among other things, our growth strategy, our ability to expand our
offerings, our relationships with insurance carriers and the number of jurisdictions in which we
are able to offer products, our ability to enhance a customers experience of shopping for health
and life insurance and related products through our interactive insurance marketplace and our
ability to increase our customer base by increasing our marketing and brand-building efforts.
Many of our competitors are more established than we are, and have significantly greater
financial, technical, marketing, and other resources than we do. Many of our competitors have
greater name recognition and a larger customer base than we do. These competitors may be able to
respond more quickly to new or changing opportunities and customer requirements and may be able to
undertake more extensive promotional activities and offer more attractive terms to insurance
carriers.
Employees
As of December 31, 2007, we had 272 employees. None of our employees are members of any labor
union and we are not a party to any collective bargaining agreement. We believe that the
relationship between our management and our employees is good.
Intellectual Property and Proprietary Rights
We rely on a combination of trademark, copyright and trade secret laws in the United States
and other jurisdictions as well as confidentiality procedures and contractual provisions to protect
our proprietary technology and our brand. We also have filed patent applications that relate to
certain of our technologies and business processes. We currently utilize proprietary software to
support our online platform and proprietary processes and procedures related to customer
acquisitions and insurance product sales.
Governmental Regulation
Our insurance activities are subject to governmental regulation at both the state and federal
level. Our non-insurance activities are subject to governmental regulation much like many other
non-insurance companies. Our insurance carrier partners also are subject to governmental regulation
at both the state and federal level. In addition, there are still relatively few laws or
regulations specifically addressing our Internet activities. As a result, the manner in which
existing laws and regulations could be applied to the Internet in general, and how they relate to
our businesses in particular, is unclear in many cases. Such uncertainty arises under existing laws
regulating matters including user privacy, defamation, pricing, advertising, taxation, gambling,
sweepstakes, promotions, content regulation, quality of products and services, and intellectual
property ownership and infringement.
We expect to post privacy policy and practices concerning the use and disclosure of any user
data on our websites. Failure to comply with posted privacy policies, Federal Trade Commission
requirements, or other domestic or international privacy-related laws and regulations could result
in governmental proceedings. There are multiple legislative proposals before federal and state
legislative bodies regarding privacy issues. It is not possible to predict whether or when such
legislation may be adopted, and certain proposals, if adopted, could harm our business through a
decrease in use and revenue.
25
Our direct marketing operations are or may become subject to additional federal and state do
not call laws and requirements. In January 2003, the Federal Trade Commission amended its rules to
provide for a national do not call registry. Under these federal regulations, consumers may have
their phone numbers added to the national do not call registry. Generally, we are prohibited from
calling any consumer whose telephone number is listed in the registry unless the consumer has
requested or initiated the contact or given his or her prior consent. Enforcement of the Federal
do not call provisions began in the fall of 2003, and the rule provides for fines of up to
$11,000 per violation and other possible penalties. Our current business model relies heavily on
outbound calls from our contact centers to consumers. The federal regulations and similar state
laws may restrict our ability to effectively market to new consumers the products we sell on behalf
of our insurance carrier partners. Furthermore, compliance with these rules may prove difficult,
and we may incur penalties for improperly conducting our marketing activities.
Corporate Information
Our principal executive offices are located at 150 N. Radnor-Chester Road, Suite B-101,
Radnor, Pennsylvania 19087. The principal executive offices of our wholly-owned subsidiary, HBDC
II, Inc., are located at 2200 S.W. 10th Street, Deerfield Beach, Florida 33442. Our telephone
number is (484) 654-2200. Our website address is www.hbdc.com. The information contained on our
website is not incorporated by reference into, and does not form any part of, this prospectus.
We were incorporated under the laws of the state of Nevada on October 21, 2004 as Darwin
Resources Corp., or Darwin-NV, an exploration stage company engaged in mineral exploration. On
November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary, Darwin
Resources Corp., a Delaware corporation, or Darwin-DE, solely for the purpose of changing the
companys state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation engaged in direct marketing and distribution of
health and life insurance and related products primarily over the Internet, and the name of the
resulting entity was changed from Health Benefits Direct Corporation to HBDC II, Inc. Following
this merger, Darwin-DE changed its name to Health Benefits Direct Corporation and, as a result,
HBDC II, Inc. became our wholly-owned subsidiary.
DESCRIPTION OF PROPERTY
We currently lease approximately 50,000 square feet of office space in Deerfield Beach,
Florida. We lease this office space under a lease agreement with FG 2200, LLC. On March 19, 2007,
the lease was assigned by FG 2200 LLC to 2200 Deerfield Florida LLC. The lease expires on March 31,
2016 and we have the option to extend the term for two additional 36-month periods, as well as the
right to terminate the lease within the first five years. The monthly rent increases every 12
months, starting at $62,500 and ending at approximately $81,550.
We also lease 7,414 square feet of office space in Radnor, Pennsylvania. We lease this office
space under a lease agreement with Radnor Properties-SDC, L.P. The term of the lease commenced on
November 1, 2006, and will expire on March 31, 2017. The monthly rent increases every 12 months,
starting at approximately $13,466 and ending at approximately $21,531. Under the terms of the lease
agreement, rent is waived for the first five months of the lease term with respect to 5,238 square
feet and for the first 12 months for the remaining 2,176 square feet.
We also sublease approximately 14,000 square feet of office space located in New York, New
York. We sublease this office space under a sublease agreement with World Travel Partners I, LLC.
The
26
initial term of the sublease terminates on December 30, 2010. The monthly rent increases every
12 months, starting at approximately $25,250 and ending at approximately $28,420.
We also lease approximately 5,524 square feet of space in Eddystone, Pennsylvania. We lease
this office space under a lease agreement with BPG Officer VI Baldwin Tower L.P. The term of this
lease commenced on August 1, 2007, and will expire on December 31, 2012. The monthly rent
increases every 12 months, starting at approximately $8,516 and ending at approximately $9,667.
LEGAL PROCEEDINGS
We are not a party to any material legal proceedings. However, we may become involved in
litigation from time to time in the ordinary course of our business. We do not believe that the
resolution of these matters will have a significant, adverse impact on our consolidated financial
position and/or results of operations.
27
MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The following discussion of our financial condition and results of operations should be read
in conjunction with our financial statements and notes thereto appearing elsewhere in this
document.
Overview
Health Benefits Direct Corporation specializes in the direct marketing of health and life
insurance and related products to individuals, families and groups. We have developed proprietary
technologies and processes to connect prospective insurance customers with our agents and service
personnel using an integrated on-line platform with call center follow up. We employ licensed
agents supported by verification, customer service and technology employees for the purpose of
providing immediate information to prospective customers and selling insurance products. We receive
commission and other fees from the insurance companies for the sale of their products.
We were originally incorporated under the laws of the state of Nevada on October 21, 2004 as
Darwin Resources Corp., or Darwin-NV, an exploration stage company engaged in mineral exploration.
On November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary,
Darwin Resources Corp., a Delaware corporation, or Darwin-DE, solely for the purpose of changing
our state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation, and the name of the resulting entity was
changed from Health Benefits Direct Corporation to HBDC II, Inc. Following the merger, Darwin-DE
then changed its name to Health Benefits Direct Corporation.
Critical Accounting Policies
Financial Reporting Release No. 60, which was released by the Commission, encourages all
companies to include a discussion of critical accounting policies or methods used in the
preparation of financial statements. Our consolidated financial statements include a summary of the
significant accounting policies and methods used in the preparation of the consolidated financial
statements. Management believes the following critical accounting policies affect the significant
judgments and estimates used in the preparation of the financial statements.
Use of Estimates
Managements Discussion and Analysis is based upon our consolidated
financial statements, which have been prepared in accordance with accounting principles generally
accepted in the United States of America. The preparation of these consolidated financial
statements requires management to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and
liabilities. On an ongoing basis, management evaluates these estimates, including those related to
allowances for doubtful accounts receivable and long-lived assets. Management bases these estimates
on historical experience and on various other assumptions that are believed to be reasonable under
the circumstances, the results of which form the basis of making judgments about the carrying value
of assets and liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions.
28
We generate revenues primarily from the receipt of commissions paid to us by insurance
companies based upon the insurance policies sold to consumers through our service. These revenues
are in the form of first year, bonus and renewal commissions that vary by company and product. We
recognize commission revenue from the sale of primarily health insurance, after we receive notice
that the insurance company has received payment of the related premium. First year commission
revenues per policy can fluctuate due to changing premiums, commission rates, and types or amount
of insurance sold. We receive bonuses based upon individual criteria set by insurance companies. We
recognize bonus revenues when we receive notification from the insurance company of the bonus due
to us. Bonus revenues are typically higher in the fourth quarter of our fiscal year due to the
bonus system used by many health insurance companies, which pay greater amounts based upon the
achievement of certain levels of annual production. Revenues for renewal commissions are recognized
after we receive notice that the insurance company has received payment for a renewal premium.
Renewal commission rates are significantly less than first year commission rates and may not be
offered by every insurance company. We also generate revenue from the sale of leads to third
parties. Such revenues are recognized when we receive notification from those sources of the
revenue due to us. Our revenue recognition accounting policy has been applied to all periods
presented in this report. The timing between when we submit a consumers application for insurance
to the insurance company and when we generate revenues has varied over time. The type of insurance
product and the insurance companys backlog are the primary factors that impact the length of time
between submitted applications and revenue recognition. Any changes in the amount of time between
submitted application and revenue recognition, which will be influenced by many factors not under
our control, will create fluctuations in our operating results and could affect our business,
operating results and financial condition.
Under the criteria set forth in SOP 98-1, Accounting for the Costs of Computer Software
Developed or Obtained for Internal Use capitalization of software development costs begins upon
the establishment of technological feasibility of the software. The establishment of technological
feasibility and the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but not limited to,
anticipated future gross product revenues, estimated economic life, and changes in software and
hardware technology. Capitalized software development costs are amortized utilizing the
straight-line method over the estimated economic life of the software not to exceed three years. We
regularly review the carrying value of software development assets and a loss is recognized when
the unamortized costs are deemed unrecoverable based on the estimated cash flows to be generated
from the applicable software.
On April 3, 2006 we entered into a merger agreement with ISG Merger Acquisition Corp., a
Delaware corporation and one of our wholly-owned subsidiaries, or Merger Sub, Insurance Specialist
Group Inc., a Florida corporation, or ISG, and Ivan M. Spinner. As a result of the merger
agreement, we acquired all of the outstanding stock of ISG, an insurance agency involved in the
business of selling health insurance to small business owners and individuals. On October 6, 2006,
we entered into a working capital settlement and release agreement with Mr. Spinner whereby we
agreed to pay Mr. Spinner $65,000 as settlement of the working capital provision of the ISG merger
agreement.
29
We have accounted for the acquisition of ISG using the purchase method of accounting in
accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. The
results of ISGs operations have been included in our statement of operations as of April 4, 2006.
ISGs operations for the period April 1 through April 4, 2006 are considered immaterial. We
calculated the fair value of ISG based on the fair value of the consideration paid for ISG and
assigned fair values to the individual tangible and intangible assets purchased based on
managements estimates. Our preliminary calculation for the consideration paid for ISG in aggregate
was $5,154,329 and was made up of the following:
|
|
|
|
|
Cash payment to seller
|
|
$
|
1,135,000
|
|
Fair value of common stock issued to seller
|
|
|
3,310,806
|
|
payments to seller
|
|
|
225,212
|
|
Fair value of stock option issued to seller
|
|
|
425,381
|
|
Estimated direct transaction fees and expenses
|
|
|
57,930
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,154,329
|
|
|
|
|
|
We estimated the fair values of ISGs assets acquired and liabilities assumed at the date of
acquisition as follows:
|
|
|
|
|
Cash
|
|
$
|
111,024
|
|
Accounts receivable
|
|
|
210,889
|
|
Deferred compensation advances
|
|
|
256,775
|
|
Prepaid expenses and other assets
|
|
|
957
|
|
Property and equipment, net
|
|
|
600
|
|
Intangible assets
|
|
|
4,964,330
|
|
Accrued expenses
|
|
|
(164,549
|
)
|
Unearned commission advances
|
|
|
(225,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,154,329
|
|
|
|
|
|
We acquired intangible assets from ISG, which consisted of the following; value of purchased
commission override revenue with an assigned value of $1,411,594 amortized over five years in
proportion to expected future value, value of acquired carrier contracts and agent relationships
with an assigned value of $2,752,143 amortized straight line over the expected useful life of 5
years and value of employment and non-compete agreement acquired with an assigned value of $800,593
amortized straight line over a weighted average useful life of 3.1 years.
We review the carrying value of property and equipment and intangible assets for impairment at
least annually or whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Recoverability of long-lived assets is measured by comparison of
its carrying amount to the undiscounted cash flows that the asset or asset group is expected to
generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the property, if any, exceeds its fair market value.
30
Effective January 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based
Payment, under the modified prospective method. SFAS No. 123(R) eliminates accounting for
share-based compensation transactions using the intrinsic value method prescribed under APB Opinion
No. 25, Accounting for Stock Issued to Employees, and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective method, we are
required to recognize compensation cost for share-based payments to employees based on their
grant-date fair value from the beginning of the fiscal period in which the recognition provisions
are first applied. For periods prior to adoption, the financial statements are unchanged, and the
pro forma disclosures previously required by SFAS No. 123, as amended by SFAS No. 148, will
continue to be required under SFAS No. 123(R) to the extent those amounts differ from those in the
Statement of Operations.
31
RESULTS OF OPERATIONS
THREE MONTHS ENDED SEPTEMBER 30, 2007 COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2006
Revenues
For the three months ended September 30, 2007 (third quarter 2007), we earned revenues of
$5,048,139 compared to $3,222,434 for the three months ended September 30, 2006 (third quarter
2006), an increase of $1,825,705 or 57%. Revenues include the following:
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Commission revenue from carriers excluding
periodic bonuses and ISG
|
|
$
|
4,064,572
|
|
|
$
|
2,224,224
|
|
Periodic bonus revenue from carriers
|
|
|
340,864
|
|
|
|
|
|
ISG commission revenue
|
|
|
432,714
|
|
|
|
668,253
|
|
Lead sale revenue
|
|
|
209,989
|
|
|
|
329,957
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,048,139
|
|
|
$
|
3,222,434
|
|
|
|
|
|
|
|
|
|
|
|
In third quarter 2007 we earned revenues of $4,064,572 excluding revenue associated with
ISG and lead revenue as compared to $2,224,224 in third quarter 2006. The primary reasons
for the increase is the increase sales, which was the result of the increase in number of
licensed insurance agents employed by the Company from 90 at September 30, 2006 to 111 at
September 30, 2007 and the increase of the number of insurance products being sold.
|
|
|
|
|
In third quarter 2007 we earned periodic bonuses from carriers of $340,864 as compared
to $0 in 2006. The Company receives bonuses from certain carriers, which are based
primarily on the Companys sales performance and criteria established by carriers, which
varies over time and generally do not extend beyond the current calendar year. Accordingly
the Company cannot determine what criteria, if any, may be offered by its carriers
pertaining to bonuses beyond the current calendar year.
|
|
|
|
|
In third quarter 2007 we earned revenues of $432,714 relating to ISG as compared to
$668,253 in third quarter 2006. We acquired ISG during the second quarter 2006. ISG
revenue declined as a result of excess lapsation of inforce business that was caused by
significant rate increases implemented by a carrier no longer actively sold by the Company,
and to a lesser extent reduced commission rates earned by the Company on new and inforce
business.
|
|
|
|
|
In third quarter 2007 we earned revenues of $209,989 relating to the sale of leads to
third parties as compared to $329,957 in third quarter 2006. We re-sell certain leads
purchased in order to recoup a portion of our lead cost. The primary reason for the
decrease is an increased emphasis on retaining leads for sale by the Companys employee
agents and to a lesser extent better targeting of leads purchased, which results in fewer
leads available for resale.
|
32
Total Operating Expenses
The Companys total operating expenses for third quarter 2007 was $8,640,135 as compared to
$7,334,578 for third quarter 2006 or an increase of $1,305,557 or 18% as compared to third quarter
2006. Total operating expenses consisted of the following:
|
|
|
In third quarter 2007 we incurred salaries, commission and related taxes of $4,413,794
as compared to $3,917,483 for third quarter 2006. Salaries, commission and related taxes
consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Salaries, wages and bonuses
|
|
$
|
2,806,818
|
|
|
$
|
2,311,342
|
|
Share based employee and director compensation
|
|
|
309,157
|
|
|
|
694,556
|
|
Commissions to employees
|
|
|
653,774
|
|
|
|
449,826
|
|
Commissions to non-employees
|
|
|
62,878
|
|
|
|
85,159
|
|
Employee benefits
|
|
|
104,321
|
|
|
|
94,019
|
|
Payroll taxes
|
|
|
221,448
|
|
|
|
200,021
|
|
Severance and other compensation
|
|
|
231,397
|
|
|
|
14,060
|
|
Directors compensation
|
|
|
24,001
|
|
|
|
68,500
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
4,413,794
|
|
|
$
|
3,917,483
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and wages in third quarter 2007 were $2,806,818 as compared to $2,311,342 for
third quarter 2006, an increase of $495,476 or 21%. This increase is the result of the
hiring of additional personnel employed by the Company. The Company had 263 and 232
employees at September 30, 2007 and 2006, respectively.
|
|
|
|
|
Share based employee and director compensation expense was $309,157 in third quarter
2007 as compared to $694,556 in third quarter 2006. Share based employee and director
compensation consists of stock option and restricted stock grants, which are valued at
fair-value at the date of the grant and expensed over the stock options vesting period or
the duration of employment, whichever is shorter. The decrease in expense in third
quarter 2007 as compared to third quarter 2006 is the result of the vesting schedules of
stock options issued in 2005 and the first quarter of 2006.
|
|
|
|
|
Commissions to employees were $653,774 in third quarter 2007 as compared to $449,826 in
third quarter 2006, an increase of $203,948 or 45%. This increase was the result of an
increase in sales that resulted in higher sales commission expense.
|
|
|
|
|
Commissions to non employees were $62,878 in third quarter 2007 as compared to $85,159
in third quarter 2006. We pay commissions to non employee ISG agents. This decrease was
the result of decreased in ISG revenue.
|
33
|
|
|
Severance and other compensation expense was $231,397 in third quarter 2007 as compared
to $14,060 in third quarter 2006. The increase was the result of $180,736 higher
severance, vehicle and equipment allowances.
|
|
|
|
|
Lead, advertising and other marketing was $2,177,789 in third quarter 2007 as compared
to $1,511,262 in third quarter 2006, an increase of $666,527 or 44%.
|
|
|
|
In third quarter 2007 we had an increase in lead expense of $620,895 as
compared to third quarter 2006. As we increase the number of licensed agents we
employ, we expect our lead expense to increase in the future in order to
facilitate the flow of quality leads to our sale agents.
|
|
|
|
|
In third quarter 2007 we had an increase in advertising and other marketing of
$45,632 as compared to third quarter 2006. The increase is the result of direct
mail marketing activities in 2007.
|
|
|
|
Depreciation and amortization expense was $518,088 in third quarter 2007 as compared to
$645,802 in third quarter 2006. Depreciation and amortization expense consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Amortization of intangibles acquired as a
result of the ISG acquisition
|
|
$
|
302,515
|
|
|
$
|
425,685
|
|
Amortization of intangibles acquired as a
result of the HealthPlan Choice Asset Purchase
|
|
|
|
|
|
|
18,985
|
|
Amortization of software and website development
|
|
|
49,543
|
|
|
|
69,853
|
|
Amortization of Internet domain name
|
|
|
13,433
|
|
|
|
|
|
Depreciation expense
|
|
|
152,607
|
|
|
|
131,279
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
518,098
|
|
|
$
|
645,802
|
|
|
|
|
|
|
|
|
|
|
|
In third quarter 2007 we incurred amortization expense of $302,515 as compared to
$425,685 for the intangible assets acquired from ISG. The reason for the decrease in
expense is the decline in the purchased commission override revenue due to lapsation and
aging of the underlying insurance book of business, which was anticipated in the
amortization implemented at the time of the Companys acquisition of ISG. The ISG
acquisition was effective April 3, 2006. The intangible assets acquired from ISG
represent the value of purchased commission override revenue with an assigned value of
$1,411,594 amortized over five years in proportion to expected future value, value of
acquired carrier contracts and agent relationships with an assigned value of $2,752,143
amortized straight line over the expected useful life of 5 years and value of employment
and non-compete agreement acquired with an assigned value of $800,593 amortized straight
line over a weighted average useful life of 3.1 years.
|
34
|
|
|
In third quarter 2006 we recorded amortization expense of $18,985 for the intangible
assets acquired as a result of the HealthPlan Choice asset purchase, which was fully
amortized in third quarter 2006.
|
|
|
|
|
In third quarter 2007 we incurred amortization expense of $49,543 compared to $69,853
in third quarter 2006 for the software and website development. Expense in third quarter
2007 pertains to the Companys new web site whereas third quarter 2006 expense pertains to
the Companys old web site.
|
|
|
|
|
In third quarter 2007 we incurred amortization expense of $13,433 pertaining to the
Companys July 17, 2006 purchase of the Internet domain name www.healthbenefitsdirect.com.
|
|
|
|
|
In third quarter 2007 we incurred depreciation expense of $152,607 as compared to
$131,279 in third quarter 2006. The increase pertains to the depreciation of fixed assets
acquired subsequent to September 30, 2006.
|
|
|
|
|
In third quarter 2007 we incurred rent, utilities, telephone and communications
expenses of $669,847 as compared to $536,267 in third quarter 2006. Rent, utilities,
telephone and communications expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Rent, utilities and other occupancy
|
|
$
|
469,427
|
|
|
$
|
350,579
|
|
Telephone and communications
|
|
|
200,420
|
|
|
|
185,688
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
669,847
|
|
|
$
|
536,267
|
|
|
|
|
|
|
|
|
|
|
|
In third quarter 2007 we had increases in rent, utilities and other occupancy as
compared to third quarter 2006 attributable to the cost of new and larger facilities. We
relocated our New York sales office to a larger office in the third quarter of 2006. In
November, 2006 we moved our corporate offices in Radnor to a new and larger office.
|
|
|
|
|
In third quarter 2007 we had an increase in telephone and communications expense as
compared to third quarter 2006 due to the increase in the number of sales agents.
|
|
|
|
|
In third quarter 2007 we incurred professional fees of $383,617 as compared to $206,273
in third quarter 2006, an increase of $177,344. The increase was attributable to legal,
accounting, employee recruiting and technology outsourcing fees.
|
35
|
|
|
In third quarter 2007 we incurred other general and administrative expenses of $476,990
as compared to $517,491 in third quarter 2006, a decrease of $40,501 or 8%. Other general
and administrative expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Licensing and appointment
|
|
$
|
115,227
|
|
|
$
|
209,789
|
|
Travel and entertainment
|
|
|
83,993
|
|
|
|
70,807
|
|
Office expense
|
|
|
212,496
|
|
|
|
178,074
|
|
Other
|
|
|
65,274
|
|
|
|
58,821
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
476,990
|
|
|
$
|
517,491
|
|
|
|
|
|
|
|
|
|
|
|
We incur licensing and appointment costs associated with the licensing of our employee
insurance agents. In third quarter 2007 we had a decrease in licensing and appointment
costs as compared to 2006 due to decreased new agent recruiting and licensing.
|
|
|
|
|
In third quarter 2007 we had an increase in office expense as compared to 2006 due to
increase in office space and operations.
|
Other income (expenses)
Interest income in third quarter 2007 and third quarter 2006 was attributable to interest-bearing
cash deposits resulting from the capital raised in private placements.
Interest expense pertains to imputed interest on certain employee obligations.
Net loss
As a result of these factors, we reported a net loss of $3,493,081 or $.10 loss per share in third
quarter 2007 as compared to a net loss of $4,061,475 or $0.14 loss per share in third quarter 2006.
36
NINE MONTHS ENDED SEPTEMBER 30, 2007 COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2006
Revenues
For the nine months ended September 30, 2007 (2007), we earned revenues of $14,704,547 compared
to $7,082,413 for the nine months ended September 30, 2006 (2006), an increase of $7,622,134 or
107%. The primary reasons for the increase in revenues is the increase in number of licensed
insurance agents employed by the Company, the increase of the number of insurance products being
sold and increased lead revenue. Revenues include the following:
|
|
|
|
|
|
|
|
|
|
|
For the Nine months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Commission revenue from carriers excluding
periodic bonuses and ISG
|
|
$
|
11,736,573
|
|
|
$
|
5,128,417
|
|
Periodic bonus revenue from carriers
|
|
|
853,477
|
|
|
|
172,858
|
|
ISG commission revenue
|
|
|
1,408,571
|
|
|
|
1,252,688
|
|
Lead sale revenue
|
|
|
705,926
|
|
|
|
528,450
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
14,704,547
|
|
|
$
|
7,082,413
|
|
|
|
|
|
|
|
|
|
|
|
In 2007 we earned commission revenue from carriers excluding periodic bonuses and ISG
revenues of $11,736,573 as compared to $5,128,417 in 2006. The primary reasons for the
increase is the increase in number of licensed insurance agents employed by the Company
from 90 at September 30, 2006 to 111 at September 30, 2007 and the increase of the number
of insurance products being sold.
|
|
|
|
|
In 2007 we earned periodic bonuses from carriers of $853,477 as compared to $172,858 in
2006. The Company receives bonuses from certain carriers, which are based primarily on the
Companys sales performance and criteria established by carriers and generally do not
extend beyond the current calendar year. Accordingly the Company cannot determine what
criteria, if any, may be offered by its carriers pertaining to bonuses beyond the current
calendar year.
|
|
|
|
|
In 2007 we earned revenue of $1,408,571 relating to ISG as compared to $1,252,688 in
2006. We acquired ISG during the second quarter of 2006 and we only recognized ISG revenue
in the second and third quarters of 2006 whereas we recognized ISG revenue in first, second
and third quarters of 2007.
|
|
|
|
|
In 2007 we earned revenues of $705,926 relating to the sale of leads to third parties as
compared to $528,450 in 2006. We re-sell certain leads purchased in order to recoup a
portion of our lead cost. The primary reasons for the increase is an increased emphasis on
identifying leads suitable for sale and the increased number of leads purchased.
|
37
Total Operating Expenses
The Companys total operating expenses for 2007 was $24,428,812 as compared to $17,721,684 for 2006
or an increase of $6,707,128 or 38% as compared to 2006. Total operating expenses consisted of the
following:
|
|
|
In 2007 we incurred salaries, commission and related taxes of $12,329,418 as compared
to $9,455,841 for 2006. Salaries, commission and related taxes consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Salaries, wages and bonuses
|
|
$
|
7,571,207
|
|
|
$
|
5,615,458
|
|
Share based employee and director compensation
|
|
|
1,124,370
|
|
|
|
1,539,507
|
|
Commissions to employees
|
|
|
1,957,612
|
|
|
|
1,114,067
|
|
Commissions to non-employees
|
|
|
272,516
|
|
|
|
229,410
|
|
Employee benefits
|
|
|
322,528
|
|
|
|
204,875
|
|
Payroll taxes
|
|
|
683,293
|
|
|
|
574,130
|
|
Severance and other compensation
|
|
|
305,725
|
|
|
|
26,560
|
|
Directors compensation
|
|
|
92,167
|
|
|
|
151,834
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
12,329,418
|
|
|
$
|
9,455,841
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and wages were $7,571,207 as compared to $5,615,458 for 2006, an increase of
$1,955,749 or 35%. This increase is the result of the hiring of additional personnel
employed by the Company.
|
|
|
|
|
Share based employee and director compensation expense was $1,124,370 in 2007 as
compared to $1,539,507 in 2006. Share based employee and director compensation consists
of stock option and restricted stock grants, which are valued at fair-value at the date of
the grant and expensed over the stock options vesting period or the duration of
employment, whichever is shorter. The decrease in expense in 2007 as compared to 2006 is
the result of the vesting schedules of stock options issued in 2005 and the first quarter
of 2006.
|
|
|
|
|
Commissions to employees were $1,957,612 in 2007 as compared to $1,114,067 in 2006.
The increase was the result of an increase in sales that resulted in higher sales
commission expense.
|
|
|
|
|
Commissions to non employees were $272,516 in 2007 as compared to $229,410 in 2006. We
pay commissions to non employee ISG agents. We acquired ISG during the second quarter of
2006 and we only recognized commission expense to non employees in the second and third
quarters of 2006 whereas we recognized commission expense to non employees in first,
second and third quarters of 2007.
|
|
|
|
|
Employee benefits expense was $322,528 in 2007 as compared to $204,875 in 2006. The
Company implemented an expanded employee benefits package during 2006, which included
group medical, dental and life insurance coverage and further enhanced employee benefits
in 2007 with the addition of a 401(k) plan. The employee pays the majority of the cost of
group insurance coverage.
|
38
|
|
|
Payroll taxes expense was $683,293 in 2007 as compared to $574,130 in 2006. The
increase was the result of higher salaries, wages, bonuses and commissions to employees.
|
|
|
|
|
Severance and other compensation expense was $305,725 in 2007 as compared to $26,560 in
2006. The increase was the result of $180,736 higher severance, vehicle and equipment
allowances.
|
|
|
|
|
Lead, advertising and other marketing was $5,973,442 in 2007 as compared to $3,082,819
in 2006, an increase of $2,890,623 or 94%.
|
|
|
|
In 2007 we had an increase in lead expense of $2,729,057 as compared to 2006.
As we increase the number of licensed agents we employ, we expect our lead expense
to increase in the future in order to facilitate the flow of quality leads to our
sale agents.
|
|
|
|
|
In 2007 we had an increase in advertising and other marketing of $161,566 as
compared to 2006, which increased as a result of direct mail marketing activities
in 2007.
|
|
|
|
Depreciation and amortization expense was $1,631,172 in 2007 as compared to $1,485,115
in 2006. Depreciation and amortization expense consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Amortization of intangibles acquired as a
result of the ISG acquisition
|
|
$
|
966,415
|
|
|
$
|
905,821
|
|
Amortization of intangibles acquired as a
result of the HealthPlan Choice Asset Purchase
|
|
|
|
|
|
|
186,518
|
|
Amortization of software and website development
|
|
|
186,040
|
|
|
|
103,332
|
|
Amortization of Internet domain name
|
|
|
40,300
|
|
|
|
|
|
Depreciation expense
|
|
|
438,417
|
|
|
|
289,444
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,631,172
|
|
|
$
|
1,485,115
|
|
|
|
|
|
|
|
|
|
|
|
In 2007 we incurred amortization expense of $966,415 as compared to $905,821 for the
intangible assets acquired from ISG. The ISG acquisition was effective April 3, 2006.
The intangible assets acquired from ISG represent the value of purchased commission
override revenue with an assigned value of $1,411,594 amortized over five years in
proportion to expected future value, value of acquired carrier contracts and agent
relationships with an assigned value of $2,752,143 amortized straight line over the
expected useful life of 5 years and value of employment and non-compete agreement acquired
with an assigned value of $800,593 amortized straight line over a weighted average useful
life of 3.1 years.
|
|
|
|
|
In 2006 we recorded amortization expense of $186,518 for the intangible assets acquired
as a result of the HealthPlan Choice asset purchase, which was fully amortized in 2006.
|
39
|
|
|
In 2007 we incurred amortization expense of $186,040 compared to $103,332 in 2006 for
the software and website development. As of September 30, 2006, the Company determined
that intangible assets pertaining to the Companys former website were impaired. Expense
in 2007 pertains to the Companys new web site whereas 2006 expense pertains to the
Companys old web site.
|
|
|
|
|
In 2007 we incurred amortization expense of $40,300 pertaining to the Companys July
17, 2006 purchase of the Internet domain name
www.healthbenefitsdirect.com
.
|
|
|
|
|
In 2007 we incurred depreciation expense of $438,417 as compared to $289,444 in 2006
period. The increase pertains to the depreciation of fixed assets acquired subsequent to
September 30, 2006.
|
|
|
|
|
In 2007 we incurred rent, utilities, telephone and communications expense of $1,934,299
as compared to $1,323,462 in 2006. Rent, utilities, telephone and communications expenses
consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Rent, utilities and other occupancy
|
|
$
|
1,348,518
|
|
|
$
|
903,857
|
|
Telephone and communications
|
|
|
585,781
|
|
|
|
419,605
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,934,299
|
|
|
$
|
1,323,462
|
|
|
|
|
|
|
|
|
|
|
|
In 2007 we had increases in rent, utilities and other occupancy as compared to 2006
attributable to the cost of new and larger facilities. We relocated our New York sales
office to a larger office in the third quarter of 2006. In November, 2006 we moved our
corporate offices in Radnor to a new and larger office.
|
|
|
|
|
In 2007 we had an increase in telephone and communications expense as compared to 2006
due to the increase in the number of sales agents.
|
|
|
|
|
In 2007 we incurred professional fees of $1,277,345 as compared to $994,535 in 2006, an
increase of $282,810 primarily attributable to technology outsourcing fees and to a lesser
extent employee recruiting, legal, and accounting fees.
|
40
|
|
|
In 2007 we incurred other general and administrative expenses of $1,283,126 as compared
to $1,379,912 in 2006, a decrease of $96,786 or 7%. Other general and administrative
expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine months
|
|
|
|
Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
Licensing and appointment fees
|
|
$
|
325,832
|
|
|
$
|
466,573
|
|
Travel and entertainment
|
|
|
250,703
|
|
|
|
276,050
|
|
Office expense
|
|
|
579,678
|
|
|
|
430,543
|
|
Cost of integrating HealthPlan Choice Atlanta
office as a satellite sales office
|
|
|
|
|
|
|
102,615
|
|
Other
|
|
|
126,913
|
|
|
|
104,131
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,283,126
|
|
|
$
|
1,379,912
|
|
|
|
|
|
|
|
|
|
|
|
We incur licensing and appointment costs associated with the licensing of our employee
insurance agents. In 2007 we had a decrease in licensing and appointment costs as compared
to 2006 due to decreased growth rate in new agent recruiting and licensing.
|
|
|
|
|
During 2006 we incurred $102,615 pertaining to the cost of integrating HealthPlan
Choices office as our Atlanta satellite sales office, which we subsequently closed in the
fourth quarter of 2006.
|
|
|
|
|
In 2007 we had an increase in office expense as compared to 2007 due to increase in
office space and operations.
|
Other income (expenses)
In 2006 we reported income of $60,537 from the reversal of the registration rights penalty accrued
at December 31, 2005. The registration of the shares was effective July 7, 2006, which was prior
to the date after which a penalty would have been incurred.
Interest income in 2007 and 2006 was attributable to interest-bearing cash deposits resulting from
the capital raised in private placements.
Interest expense in 2007 pertains to imputed interest on certain employee obligations whereas
interest expense in 2006 pertains to both our closed line of credit, which was repaid in full
during the second quarter of 2006, and imputed interest on certain employee obligations.
Net loss
As a result of these factors, we reported a net loss of $9,468,718 or $0.29 loss per share in 2007
as compared to a net loss of $10,338,320 or $0.38 loss per share in 2006.
41
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 2007, we had a cash balance of $8,868,990 and working capital of $467,940.
On March 30, 2007, we entered into a Securities Purchase Agreement (the Purchase Agreement) and
completed a private placement with certain institutional and individual accredited investors and
issued 5,000,000 shares of our Common Stock, par value $0.001 per share and warrants to purchase
2,500,000 shares of our Common Stock. Pursuant to the Purchase Agreement, we sold investment units
(each, a Unit) in the Private Placement at a per Unit purchase price equal to $2.25. Each Unit
sold in the Private Placement consisted of one share of Common Stock and a Warrant to purchase
one-half (1/2) of one share of Common Stock at an initial exercise price of $3.00 per share,
subject to adjustment (the Warrant). The gross proceeds from the Private Placement were
$11,250,000 and we intend to use the net proceeds of the Private Placement for working capital
purposes. The Companys Chief Executive Officer and Chairman, Alvin H. Clemens, purchased
1,000,000 Units in the Private Placement.
In connection with the 2007 private placement, the Company paid the placement agents an aggregate
placement fee equal to $787,500 plus the reimbursement of certain expenses in the amount of
$42,500. The Company also issued to the placement agents Warrants (the Placement Agent Warrants)
to purchase in the aggregate 350,000 shares of the Companys Common Stock with an exercise price of
$2.80 and exercisable from September 30, 2007 through March 30, 2010. The Company also incurred
legal and other expenses in the amount of $65,240 in connection with the 2007 private placement.
On January 11, 2006, we completed the closing of a private placement of a total of 169 units, each
unit (2006 Unit) consisting of 50,000 shares of our common stock and a detachable, transferable
warrant to purchase shares of our common stock, at a purchase price of $50,000 per 2006 Unit. Each
warrant issued in the private placement entitles the holder to purchase shares of our common stock
at an exercise price of $1.50 per share and expires on the three-year anniversary of the date of
issuance, subject to certain redemption provisions. We received aggregate net proceeds from the
private placement of $7,240,502 in 2005 and aggregate net proceeds of $6,164,174 in 2006. During
2007 certain holders of the warrants issued in connection with the private placement completed in
2006 exercised their warrants to purchase in aggregate 225,000 shares of our common stock at an
exercise price of $1.50 per share for an aggregate exercise price of $337,500.
At September 30, 2007, we had a restricted cash balance of $1,150,000, which represents money
market account balances with a restricted balance pertaining to 2 letters of credit for the benefit
of the landlords of the Companys Deerfield Beach Florida and New York offices. The money market
accounts are on deposit with the issuer of the letters of credit. The terms of the Companys money
market accounts and letters of credit allow the Company to receive the interest on the money market
accounts but prohibits the Companys use of the balance.
42
Net cash used by operations was $3,146,280 in 2007 as compared to net cash used in operations of
$5,798,650 in 2006. In 2007 the Company used cash to fund the Companys net loss of $9,468,718
and:
|
|
|
Decreases in accounts receivable of $227,675 related to the collection of bonus
commissions earned in the fourth quarter of 2006, increased unearned commission advances
and to a lesser extent increased earned revenues;
|
|
|
|
|
Increases in unearned commission advances of $3,619,793 relating to increased
commission payments from certain of the Companys insurance carriers that advance the
Company future commission revenue. The Company has agreements with certain of its
insurance carriers whereby the Companys insurance carriers advance the Company first year
premium commissions before the commissions are earned. The unearned portion of premium
commissions has been included in the consolidated balance sheet as a liability for
unearned commission advances. These advance agreements represent a material source of
cash to fund the Companys operations. The Companys advance agreement with its largest
insurance carrier cannot exceed $9,000,000, can be terminated by either party and in the
event of termination the Companys outstanding advance balance can be called by the
insurance carrier with 7 days written notice. As of September 30, 2007, the Companys
outstanding advance balance with this carrier was $6,379,064. The Companys advance
agreement with its second largest insurance carrier allows the insurance carrier to
terminate future advances and convert the outstanding advance balance into a promissory
note, which if not repaid within 30 days, would incur interest expense. As of September
30, 2007, the Companys outstanding advance balance with this carrier was $1,554,234.
During the third quarter of 2007 the Company began receiving first year premium
commissions before the commissions are earned from its third largest insurance carrier.
The Companys understanding pertaining to the advance from this carrier is that the
carrier may terminate future advances and demand repayment of the outstanding unearned
commission advance balance if certain performance standards are not met. As of September
30, 2007, the Companys outstanding advance balance with this carrier was $634,915.
|
In addition to cash used in operating activities, during the nine months ended September 30, 2007
we:
|
|
|
Recorded $1,144,845 of stock-based compensation and consulting expense. Effective
January 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based Payment, under
the modified prospective method. SFAS No. 123(R) eliminates accounting for share-based
compensation transactions using the intrinsic value method prescribed under APB Opinion No.
25, Accounting for Stock Issued to Employees, and requires instead that such transactions
be accounted for using a fair-value-based method. Under the modified prospective method, we
are required to recognize compensation cost for share-based payments to employees based on
their grant-date fair value from the beginning of the fiscal period in which the
recognition provisions are first applied.
|
|
|
|
|
On February 15, 2007, the Company granted 125,000 restricted shares of Common Stock to
each of Charles A. Eissa, the Companys President and Chief Operating Officer, and Ivan M.
Spinner, the Companys Senior Vice President, in accordance with the terms of the Companys
2006 Omnibus Equity Compensation Plan (the Plan). The shares granted to Messrs. Eissa
and Spinner were valued at $3.00 per share and will vest as follows: 50,000 shares on
February 15, 2008; 50,000 additional shares on February 15, 2009; 2,083 shares per month on
the 15th day of each month thereafter beginning on March 15, 2009 through January 15, 2010;
and 2,087 shares on February 15, 2010. The expense pertaining to these restricted stock
grants is included in the aforementioned stock based compensation and consulting expense.
|
43
Net cash used by investing activities in 2007 was $1,045,022 as compared to $2,896,716 in 2006. The
decrease in cash used was primarily attributable to the 2006 purchase of ISG. During the second
quarter of 2006 we completed the acquisition of ISG for approximately $1.2 million, capitalization
of software development costs of $81,596 and the acquisition of property and equipment of $958,340
including assets acquired as a result of HealthPlan Choice asset purchase. Investing activities in
2007 pertain to internal development of software and the purchase of property and equipment
supporting current and future operations.
Net cash provided by financing activities in 2007 was $10,748,510 as compared to $5,335,040 in
2006.
|
|
|
In 2007 we completed a private placement with certain institutional and individual
accredited investors and issued 5,000,000 shares of our Common Stock, par value $0.001 per
share and warrants to purchase 2,500,000 shares of our Common Stock. Gross proceeds were
$11,250,000 and placement and other fees paid in connection with the 2007 private placement
were $895,240.
|
|
|
|
|
In 2007 certain holders of the Companys warrants exercised their warrants to purchase
in aggregate 262,500 shares of the Companys common stock at an exercise price of $1.50 per
share and the Company received $393,750.
|
|
|
|
|
In 2006 the Company completed a private placement, which began in 2005. During the
first quarter of 2006 we received net proceeds from the sale of common stock of $6,164,174.
|
|
|
|
|
In 2006 Alvin Clemens exercised an option to purchase 200,000 shares of the Companys
common stock at an exercise price of $1 per share and the Company received $200,000.
|
|
|
|
|
In 2006 we disbursed $1,150,000 from cash and deposited this amount into a certificate
of deposit, which is reported as restricted cash. The certificate of deposit, which was
subsequently converted into an interest bearing money market account, on deposit with the
same bank that issued 2 letters of credit for the benefit of the Companys landlords of our
new Florida and New York offices.
|
|
|
|
|
In 2006 we repaid our $399,630 outstanding balance of a line of credit with Regions Bank
dated August 2004. The Company has no further obligations regarding this line of credit and
this line of credit is not available for future borrowing.
|
Acquisition of ATIAM
On October 1, 2007, HBDC Acquisition, LLC (HBDC Sub), a Delaware limited liability company and
wholly-owned subsidiary of Health Benefits Direct Corporation, a Delaware corporation (the
Company), entered into an Agreement to Transfer Partnership Interests (the Bilenia Agreement)
with the former partners (the Bilenia Partners) of BileniaTech, L.P., a Delaware limited
partnership (Bilenia), whereby HBDC Sub purchased all of the outstanding general and limited
partnership interests of Atiam Technologies, L.P., a Delaware limited partnership (Atiam), owned
by the Bilenia Partners. The execution of the Bilenia Agreement and the transfer of the Atiam
partnership interests to HBDC Sub there under were conditions precedent to the closing of the
Merger Agreement (as defined below) on October 1, 2007 (the Closing Date).
44
The aggregate amount paid by HBDC Sub to the Bilenia Partners for the Atiam partnership interests
under the Bilenia Agreement was $1,000,000, consisting of $500,000 in cash and 224,216 shares of
Common Stock, which shares had an aggregate value of $500,000 based on the average closing price
per share ($2.23) of Company Common Stock on The Over the Counter Bulletin Board on the five
consecutive trading days preceding the Closing Date.
In connection with the Bilenia Agreement, the Company and Computer Command and Control Company, a
Pennsylvania corporation (CCCC), also entered into a Registration Rights Agreement (the Bilenia
Registration Rights Agreement). Under the terms of the Bilenia Registration Rights Agreement, the
Company has agreed to give prompt written notice to CCCC of the registration of any of the
Companys securities under the Securities Act, and CCCC shall have the opportunity, upon 20 days
written notice to the Company, to request that the shares of Company Common Stock issued to CCCC
under the Bilenia Agreement be included in such registration statement. The Company agreed that its
current intention is to begin to prepare and file a registration statement with the Commission
within 60 days of the Closing Date.
On September 21, 2007, the Company entered into an Agreement and Plan of Merger (the Atiam Merger
Agreement) by and among the Company, HBDC, System Consulting Associates, Inc., a Pennsylvania
corporation (SCA), and the shareholders of SCA party thereto (the Shareholders). The Company
and SCA closed on the Merger on October 1, 2007.
The Atiam Merger Agreement provided for a business combination whereby SCA would be merged with and
into HBDC Sub, with HBDC Sub continuing as the surviving corporation and as a wholly-owned
subsidiary of the Company (the Merger). The aggregate amount paid by the Company with respect to
all outstanding shares of capital stock of SCA (such amount, the Atiam Merger Consideration) was
$2,000,000, consisting of (a) $850,000 in cash and (b) 515,697 unregistered shares of Common Stock,
which number of shares had a value of $1,150,000 based on the average closing price per share
($2.23) of Common Stock on The Over the Counter Bulletin Board on the five consecutive trading days
preceding the closing date. Upon the effectiveness of the Merger, each share of SCA Common Stock
issued and outstanding immediately prior to the closing date was converted into the right to
receive a pro rata portion of the Merger Consideration. The Company placed certificates
representing 134,529 shares, or an amount equal to $300,000, of the Company Common Stock that
otherwise would be payable to the Shareholders as Merger Consideration into an escrow account,
which shares will be held in escrow for a period of one year to satisfy any indemnification claims
by the Company or HBDC Sub under the Atiam Merger Agreement.
In connection with the Atiam Merger Agreement, the Company and Shareholders also entered into a
Registration Rights Agreement (the Shareholder Registration Rights Agreement). Under the terms of
the Shareholder Registration Rights Agreement, the Company has agreed to give prompt written notice
to each Shareholder of the registration of any of the Companys securities under the Securities Act
and the Shareholders shall have the opportunity, upon 20 days written notice to the Company, to
request that the shares of Company Common Stock issued to the Shareholders under the Atiam Merger
Agreement be included in such registration statement. The Company agreed that its current intention
is to begin to prepare and file a registration statement with the Commission within 60 days of the
Closing Date.
45
The Company estimates the fair value of SCA, which accounted for Atiam as a majority owned
subsidiary, and the remaining minority interest in Atiam not owned by SCA based on the fair value
of the aggregate consideration paid by the Company in connection with the Bilenia Agreement and
Atiam Merger Agreement, which is estimated at $3,000,000 and will be accounted for using the
purchase method of accounting in accordance with SFAS No. 141. We will assign fair values to the
individual tangible and intangible assets purchased based on managements estimates. As a result
of the Bilenia Agreement and Atiam Merger Agreement, the Company acquired tangible assets valued at
$1,400,000, short-term liabilities valued at $380,000 and long term liabilities consisting of
deferred tax liabilities of $197,000. The excess of $3,000,000 over the tangible assets acquired
net of liabilities assumed will be allocated to intangible assets with useful lives not anticipated
to exceed 5 years. The estimated purchase price, estimated purchase price allocation and estimated
useful lives of intangible assets acquired are preliminary and the final purchase accounting
adjustments may differ from aforementioned.
In connection with the ATIAM acquisition, ATIAM entered into three-year employment agreements with
four key employees of ATIAM effective October 1, 2007. These employment agreements provide that
these four key employees will be compensated at an aggregate annual base salary of $700,000 with
bonus compensation at the discretion of the Companys board. These agreements may be terminated by
the Company for cause (as such term is defined in the agreements) and without cause upon 30
days notice. These agreements may be terminated by the Company without cause, in which case the
terminated employee will be entitled to their base salary for a period ranging from 6 to 12 months.
These agreements also contain non-competition and non-solicitation provisions for the duration of
the agreements plus a period ranging from 6 to 12 months after termination of employment.
46
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
The following table sets forth the name, age, position, and a brief account of the business
experience of each of our executive officers and directors.
Directors serve until the next annual meeting of stockholders, until their successors are elected
or appointed or qualified, or until their prior resignation or removal. Our executive officers are
appointed by, and serve at the discretion of, our board of directors.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
Alvin H. Clemens
|
|
|
70
|
|
|
Chairman and Chief Executive Officer
|
Charles A. Eissa
|
|
|
35
|
|
|
President, Chief Operating Officer and Director
|
Anthony R. Verdi
|
|
|
58
|
|
|
Chief Financial Officer
|
Ivan M. Spinner
|
|
|
33
|
|
|
Senior Vice President
|
Warren V. Musser
|
|
|
81
|
|
|
Vice Chairman of the Board of Directors
|
John Harrison
|
|
|
64
|
|
|
Director
|
C. James Jensen
|
|
|
66
|
|
|
Director
|
Sanford Rich
|
|
|
49
|
|
|
Director
|
L.J. Rowell
|
|
|
75
|
|
|
Director
|
Paul Soltoff
|
|
|
53
|
|
|
Director
|
Frederick C. Tecce
|
|
|
72
|
|
|
Director
|
There are no material proceedings known to us to which any of our directors, officers or
affiliates, or any owner of record or beneficially of more than 5% of any class of our voting
securities, or any affiliate of such persons, is a party adverse to us or has a material interest
adverse to our interests. The following brief biographies contain information about our directors
and our executive officers. The information includes each persons principal occupation and
business experience for at least the past five years. This information has been furnished to us by
the individuals named. There are no family relationships known to us between the directors and
executive officers. We do not know of any legal proceedings that are material to the evaluation of
the ability or integrity of any of the directors or executive officers.
Alvin H. Clemens
has served as one of our directors since November 2005 and as Executive Chairman
of our board of directors since January 2006. Since 2001, Mr. Clemens has performed business and
insurance industry consulting services in addition to managing his private investments. In 1998, he
founded HealthAxis Inc., a publicly-traded company specializing in direct sales of insurance
products utilizing the Internet, as a subsidiary of Provident American Corporation. In 1989, Mr.
Clemens acquired a controlling interest in Provident American Corporation, an insurance holding
company, and he served as its Chairman and Chief Executive Officer until 2001. In 1970, Mr.
Clemens founded Academy Insurance Group, a company specializing in direct marketing of life and
health insurance products. He currently serves on the board of trustees and the Building, Finance,
and Executive Committees of The Pennsylvania State University.
Charles A. Eissa
has served as our President and Chief Operating Officer, and as one of our
directors since November 2005 and is our co-founder. In April 2004, Mr. Eissa founded InTransit
Media, a specialized advertising and marketing services company, and served as its President and
Chief Executive Officer until the sale of the company in February 2006. He was involved in the
1998 inception of Seisint Inc., a leading database and technology services company subsequently
acquired by Lexis Nexis. From 1998 until 2004, Mr. Eissa was part of the team at Seisint Inc. that
co-founded and spun off a division named eDirect.com, which went on to make several key mergers and
acquisitions consolidating under the name of Naviant, a company specializing in permission-based
Internet marketing that was subsequently acquired by Equifax. From 1989 until 1997, Mr. Eissa
served as Vice President Sales for Lens Express
47
Inc. During Mr. Eissas tenure, Lens Express Inc. earned its place on the Inc. 500 for three
consecutive years, and was subsequently acquired by 1-800-Contacts.
Anthony R. Verdi
has served as our Chief Financial Officer and Assistant Secretary since November
2005. From 2001 until November 2005, Mr. Verdi has provided consulting services to life, health
and property and casualty insurance company agency and venture capital clients. From December 1998
until March 2001, Mr. Verdi served as Chief Operating Officer of Provident and Chief Financial
Officer of HealthAxis. From January 1990 until December 1998 Mr. Verdi served as Chief Financial
Officer of Provident American Corporation. From July 1986 until January 1990, he was the Vice
President and Controller of InterCounty Hospitalization and Health Plans, a nonprofit group medical
insurer. From April 1971 until July 1986, he served in various finance and accounting capacities
for the Academy Insurance Group, ultimately serving as the Assistant Controller.
Ivan M. Spinner
has served as our Senior Vice President since April 2006 and as our Executive Vice
President since December 2007. In 1999, he founded Insurance Specialist Group Inc. and he served
as its President and Chief Executive Officer from 1999 until Insurance Specialist Group Inc. was
acquired by us in April 2006. From 1995 until 1999, Mr. Spinner served as an independent licensed
insurance agent.
Warren V. Musser
has served as one of our directors since January 2006 and as the Vice Chairman of
our board of directors since March 2006. He also has served as President of The Musser Group, a
financial consulting company, since 2001. Mr. Musser served as Chairman and Chief Executive Officer
of Safeguard Scientifics, Inc. from 1953 until 2001. Mr. Musser is a director of Internet Capital
Group, Inc. and Chairman of the board of directors of each of Telkonet, Inc. and InfoLogix, Inc.
Mr. Musser serves on a variety of civic, educational and charitable boards of directors.
John Harrison
has served as one of our directors since November 2005. He is a founding Partner and
Executive Director of The Keystone Equities Group, Inc., a full service investment banking group
and a registered NASD broker-dealer founded in 2003. Mr. Harrison also is a Managing Director of
Covenant Partners, a hedge fund that invests in direct marketing services companies. In 1999, Mr.
Harrison became a founding Partner of Emerging Growth Equities, Ltd., a full service investment
banking and brokerage firm focused on raising capital for emerging technology companies addressing
high-growth industry sectors. From 1985 to 2000, Mr. Harrison served as President of DiMark, a
direct marketing agency that was subsequently acquired by Harte-Hanks in 1996. He also has held
senior management positions with CUNA Mutual, RLI Insurance and CNA Insurance where he directed
their direct marketing practice. Mr. Harrison is Chairman of the board of Professional Insurance
Marketing Association (PIMA) and is on the advisory board of DePaul Universitys Interactive and
Direct Marketing Institute. He serves as a director of The Credo Group, a digital insurance agency,
IXI Corporation, a database marketing company that uses proprietary wealth and asset information,
and Solutionary, Inc., a full-service provider of managed security services.
C. James Jensen
has served as one of our directors since April 2006. He is the co-founder and
managing partner of Mara Gateway Associates, L. P., a privately owned real estate investment
company that owns real estate properties in the western United States and Hawaii. Additionally, Mr.
Jensen is the co-managing partner of Stronghurst, LLC, which provides advisory and financial
services to emerging growth companies. Mr. Jensen previously has served as Chairman and Chief
Executive Officer of Thousand Trails, Inc., a national network and the industry leader of private
campground resorts, as President of Grantree Furniture Rental Corporation, and as National Sales
Manager of Australia and New Zealand, International Sales Manager and Senior Vice President and
Chief Operating Officer of the Great Books Division of the Western World for Encyclopedia
Britannica, Inc. Mr. Jensen also has served as President of J J Advisors, LLC, where he provided
full service sales and marketing support to select
48
luxury master-planned communities. Mr. Jensen is an active member of the World Presidents
Organization and a past director of the Boys and Girls Club and the Leukemia Society of America.
Sanford Rich
has served as one of our directors since April 2006. He is currently the Senior Vice
President of Investments and Portfolio Manager at GEM Capital Management Inc., a specialist manager
of High Yield and Convertible Securities portfolios for institutions, and has held this position
since November 1995. From 1993 to 1995, Mr. Rich was a Managing Director of High Yield Finance,
Capital Markets & North American Loan Syndicate, Sales and Trading at Citicorp Securities. From
1985 to 1993, he served as Managing Director of Debt Capital Markets at Merrill Lynch. From 1978 to
1985, Mr. Rich held various Analyst positions in numerous companies, including Cypress Capital
Management, Inc. (Vice President and Analyst from 1983 to 1985), FIAMCO (Distressed/High Yield Bond
Analyst from 1981 to 1983), Progressive Corporation (Financial Analyst from 1980 to 1981) and
Prescott, Ball and Turben (Distressed/High Yield Bond Analyst from 1978 to 1980).
L.J. Rowell
has served as one of our directors since April 2006. He is a past President
(1984-1996), Chief Executive Officer (1991-1996) and Chairman of the Board (1993-1996) of Provident
Mutual Life Insurance Company, where he also held various other executive and committee positions
from 1980 until his retirement in 1996. Mr. Rowell currently serves on the boards of directors of
the Southeast Pennsylvania Chapter of the American Red Cross, The PMA Group, the American College,
The Foundation at Paoli, and The Milton S. Hershey Medical Center. Mr. Rowell also has served on
the Board of Trustees of The Pennsylvania State University as a business and industry trustee since
1992. In 1991, he served as the Chairman of the Major Business Division for the United Way of
Southeastern Pennsylvania. Mr. Rowell also has served as chairman of The American Red Cross Ad
Blood Campaign and has previously served on its Major Contributions Donor Campaign.
Paul Soltoff
has served as one of our directors since November 2005. He also has served as
Chairman and Chief Executive Officer of SendTec, Inc. since its inception in February 2000. From
1997 until February 2000, Mr. Soltoff served as Chief Executive Officer of Soltoff Direct
Corporation, a specialized direct marketing consulting company. From September 2004 until October
2005, Mr. Soltoff served as a director of theglobe.com.
Frederick C. Tecce
has served as one of our directors since August 2007. He currently serves as of
counsel with Buchanan Ingersoll & Rooney. He was an attorney with Klett Rooney Lieber & Schorling
when it joined Buchanan in 2006. Mr. Tecce also serves as of counsel to Cross Atlantic Capital
Partners and has served on the investment committees of three of the funds managed by Cross
Atlantic Partners. Mr. Tecce previously served as Senior Vice President and General Counsel of
Academy Life Insurance Company. Mr. Tecce served on the transition team for Pennsylvania Governor
Tom Ridge and was appointed by Governor Ridge to serve as a member of the board of the $50 billion
Public School Employees Retirement System (PSERS), where he served as chairman of the Finance
Committee until his retirement in September of 2001. He was appointed by U.S. Senator Rick Santorum
to the Federal Judicial Nominating Committee where he served for several terms and also served on
Dr. Robert Gallos Board of Visitors at the University of Maryland Institute for Human Virology. He
has served on the board of directors of several listed companies.
Board Independence
The Board has determined that Messrs. Harrison, Jensen, Rich, Rowell, Tecce and Soltoff are
independent directors as defined by Rule 4200(a)(15) of the Nasdaq listing standards and as
defined by Rule 10A-3(b)(1)(ii) promulgated by the Commission.
49
EXECUTIVE COMPENSATION
Summary Compensation Table
The following table summarizes the compensation paid to, awarded to or earned during the fiscal
years ended December 31, 2007 and 2006 by our Chief Executive Officer and each of our two other
most highly compensated executive officers whose total salary and bonus exceeded $100,000 for
services rendered to us in all capacities during 2007. The executive officers listed in the table
below are referred to in this prospectus as our named executive officers. There were no non-equity
incentive plan compensation, or non-qualified deferred compensation earnings for any of the named
executives for the three years ended December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
Option Awards
|
|
|
|
|
|
Compensation
|
|
|
Name and Principal Position
|
|
Fiscal Year
|
|
Salary ($)
|
|
($)
|
|
($) (7)
|
|
Bonus ($)
|
|
($) (8)
|
|
Total ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Frohman (1)
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
Former Chief Executive Officer
|
|
|
2006
|
|
|
|
236,500
|
|
|
|
|
|
|
|
17,792
|
|
|
|
|
|
|
|
453,742
|
|
|
|
708,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens (2)
|
|
|
2007
|
|
|
|
360,577
|
|
|
|
|
|
|
|
41,250
|
|
|
|
|
|
|
|
44,866
|
|
|
|
446,693
|
|
Chariman & Chief Executive Officer
|
|
|
2006
|
|
|
|
267,287
|
|
|
|
|
|
|
|
106,834
|
|
|
|
|
|
|
|
16,010
|
|
|
|
390,131
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa (3)
|
|
|
2007
|
|
|
|
278,846
|
|
|
|
131,250
|
(5)
|
|
|
3,750
|
|
|
|
50,000
|
|
|
|
13,204
|
|
|
|
477,050
|
|
President and Chief Operating Officer
|
|
|
2006
|
|
|
|
241,050
|
|
|
|
|
|
|
|
3,889
|
|
|
|
|
|
|
|
6,749
|
|
|
|
251,688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner (4)
|
|
|
2007
|
|
|
|
356,731
|
|
|
|
131,250
|
(5)
|
|
|
156,186
|
|
|
|
|
|
|
|
19,071
|
|
|
|
663,238
|
|
Executive Vice President
|
|
|
2006
|
|
|
|
278,240
|
(6)
|
|
|
|
|
|
|
79,759
|
(6)
|
|
|
150,000
|
(6)
|
|
|
10,923
|
|
|
|
518,922
|
|
|
|
|
(1)
|
|
On December 7, 2006, Scott Frohman resigned as our Chief Executive Officer and as one of our
directors. In connection with Mr. Frohmans resignation, we and Mr. Frohman entered into a
separation agreement dated December 7, 2006.
|
|
(2)
|
|
Mr. Clemens was appointed as the Executive Chairman of our board of directors on January 12,
2006 and as our Chairman and Chief Executive Officer on December 7, 2006 upon the resignation of
Mr. Frohman.
|
|
(3)
|
|
Mr. Eissa was appointed as our President and Chief Operating Officer on November 18, 2005.
|
|
(4)
|
|
Mr. Spinner was appointed as our Senior Vice President on April 3, 2006 concurrently with the
closing of our acquisition of ISG and has served as our Executive Vice President since December
2007.
|
|
(5)
|
|
On February 15, 2007, we made restricted stock grants of 125,000 shares of our common stock
to each of Mr. Eissa and Mr. Spinner in accordance with the terms of our 2006 Omnibus Equity
Compensation Plan. These grants are subject to certain restrictions, including a restriction on
transfer prior to the shares becoming fully vested. These shares will vest as follows: 50,000
shares on the first anniversary of the grant date; 50,000 additional shares of the second
anniversary of the grant date; 2,083 shares per month on the 15th day of each month beginning on
March 15, 2009 through January 15, 2009; and 2,087 on the third anniversary of the grant date. The
value of the restricted stock grants were based on the closing price per share ($3.00) of our
common stock on the OTCBB on the date of the grant. Stock award expense for the most recently
completed fiscal year pertaining to named executive officers is based on the value of the
restricted stock grants amortized straight line over their vesting period.
|
|
(6)
|
|
On April 3, 2006, Mr. Spinner received a $150,000 cash signing bonus and an option to
purchase 150,000 shares of our common stock, which were accounted for as part of the consideration
paid for the acquisition of ISG,.
|
50
|
|
|
(7)
|
|
Stock option expense for the two most recently completed fiscal years pertaining to the named
executive officers is based on the estimated fair value of the stock option as of the date of grant
using the Black-Scholes option-pricing model amortized over the vesting period of the option or the
duration of employment, whichever is shorter. We recorded $17,792 of expense pertaining to Mr.
Frohmans stock option in 2006, which included $6,038 pertaining to the accelerated vesting of
225,000 shares, $3,354 pertaining to the expensing of the unamortized portion of 125,000 shares
terminated and $8,400 of amortization of the fair value over the vesting contained in the stock
option grant. Fair value is estimated based on an expected life of five years, an assumed dividend
yield of 0% and the assumptions below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Expensed in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expensed in
|
|
Financial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial
|
|
Statements
|
|
Fair Value at
|
|
Number of
|
|
Option
|
|
Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
Statements
|
|
Based on
|
|
Date of Grant
|
|
Options
|
|
Exercise
|
|
on the Date
|
|
Date of
|
|
Expected
|
|
Risk Free
|
Name
|
|
Fiscal Year
|
|
$
|
|
Vesting
|
|
($)
|
|
Granted (#)
|
|
Price ($)
|
|
of Grant ($)
|
|
Grant
|
|
Volatility
|
|
Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Frohman
|
|
|
2007
|
|
|
|
0
|
|
|
|
0.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
17,792
|
|
|
|
98.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
208
|
|
|
|
1.2
|
%
|
|
|
18,000
|
|
|
|
600,000
|
|
|
|
2.50
|
|
|
|
1.00
|
|
|
|
11/10/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
2007
|
|
|
|
41,250
|
|
|
|
27.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
106,834
|
|
|
|
71.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
1,916
|
|
|
|
1.3
|
%
|
|
|
150,000
|
|
|
|
500,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/23/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
2007
|
|
|
|
3,750
|
|
|
|
25.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
3,889
|
|
|
|
25.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
173
|
|
|
|
1.2
|
%
|
|
|
15,000
|
|
|
|
500,000
|
|
|
|
2.50
|
|
|
|
1.00
|
|
|
|
11/10/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
2007
|
|
|
|
156,186
|
|
|
|
36.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
79,759
|
|
|
|
18.8
|
%
|
|
|
425,381
|
|
|
|
150,000
|
|
|
|
3.50
|
|
|
|
3.50
|
|
|
|
4/3/2006
|
|
|
|
111
|
%
|
|
|
4.55
|
%
|
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective January 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based
Payment, under the modified prospective method. SFAS No. 123(R) eliminates accounting for
share-based compensation transactions using the intrinsic value method prescribed under APB Opinion
No. 25, Accounting for Stock Issued to Employees, and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective method, we are
required to recognize compensation cost for share-based payments to employees based on their
grant-date fair value from the beginning of the fiscal period in which the recognition provisions
initially are applied. For periods prior to adoption, the financial statements are unchanged, and
the pro forma disclosures previously required by SFAS No. 123, as amended by SFAS No. 148, will
continue to be required under SFAS No. 123(R) to the extent those amounts differ from those in the
Statement of Operations. Expense in 2006 pertaining to employee stock options for all named
executive officers other than Mr. Spinner is recorded in salaries, commissions and related taxes.
Expense pertaining to Mr. Spinners stock option is recorded in depreciation
and amortization expense as part of the value of the employment and non-compete agreement acquired
as a result of our acquisition of ISG.
Through December 31, 2005, we accounted for stock options issued to employees in accordance
with the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock
Issued to Employees, and related interpretations. As such, compensation cost is measured on the
date of grant as the excess of the current market price of the underlying stock over the exercise
price. Such compensation amounts are amortized over the respective vesting periods of the option
grant. The Company adopted the disclosure provisions of SFAS No. 123, Accounting for Stock-Based
Compensation and SFAS 148, Accounting for Stock-Based Compensation -Transition and Disclosure,
which permits entities to provide pro forma net income (loss) and pro forma earnings (loss) per
share disclosures for employee stock option grants as if the fair-valued based method defined in
SFAS No. 123 had been applied. We account for stock options and stock issued to non-employees for
goods or services in accordance with the fair value method of SFAS 123.
51
(8) All other compensation paid to our named executive officers in the fiscal year ended December
31, 2007 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for
|
|
Company Paid
|
|
|
|
|
|
Company
|
|
Company Paid
|
|
|
|
|
|
|
Personal Use of
|
|
Health, Life and
|
|
Company Paid
|
|
Matching of
|
|
Personal
|
|
Company Paid
|
|
|
|
|
Auto and
|
|
Disabilitly
|
|
Golf Club Dues ($)
|
|
Employee 401(k)
|
|
Secretarial
|
|
Entertainment
|
|
|
Name
|
|
Equipment ($) (a)
|
|
Insurance ($) (b)
|
|
(c)
|
|
Contributions (d)
|
|
Support (e)
|
|
and Meals ($) (f)
|
|
Total ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Frohman
|
|
|
|
|
|
|
5,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
5,800
|
|
|
|
16,831
|
|
|
|
7,200
|
|
|
|
583
|
|
|
|
14,452
|
|
|
|
|
|
|
|
44,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
2,859
|
|
|
|
6,854
|
|
|
|
|
|
|
|
2,711
|
|
|
|
|
|
|
|
780
|
|
|
|
13,204
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
680
|
|
|
|
14,877
|
|
|
|
|
|
|
|
2,734
|
|
|
|
|
|
|
|
780
|
|
|
|
19,071
|
|
|
|
|
(a)
|
|
Payments for personal use of auto and equipment represent the taxable portion of monthly
auto allowances and company payments for cell phones and other equipment for the portion of
our named executive officers personal use of automobiles, cell phones and other equipment.
Starting in April 2006, we paid each of the named executive officers, except Mr. Spinner, a
$1,000 per month auto allowance for a total of $12,000 in 2007. The portion of the $12,000
pertaining to business travel was considered a reimbursement for business expenses and
excluded from compensation. Starting in December 2007, we initiated the payment of a $1,000
monthly auto allowance to Mr. Spinner.
|
|
(b)
|
|
Company-paid health, life and disability insurance represents the cost of company-paid
insurance premiums covering the named executive officers and, in the case of health insurance
premiums, their dependents. We pay 100% of these insurance premiums for the named executive
officers. Health insurance premiums vary based on several factors, including the age of the
named executive officer and the number of their covered dependents.
|
|
(c)
|
|
Company reimbursement of golf club membership dues for the above named Executive
Officer.
|
|
(d)
|
|
The Company implemented a 401(k) plan on January 1, 2007 and implemented an elective
contribution to the Plan of 25% of the employees contribution up to 4% of the employees
compensation, which amounts were fully vested for the above named executive officers.
|
|
(e)
|
|
Value of Company provided administrative and secretarial support pertaining to non
Company activities
for the above named executive officer.
|
|
(f)
|
|
Company-paid lunches for the named executive officers.
|
52
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information for the outstanding equity awards for our named
executive officers for the year ended December 31, 2007. The information below pertains to stock
options, which were granted under 2005 Incentive Stock Plan, and restricted stock grants, which
were granted accordance with the terms of our 2006 Omnibus Equity Compensation Plan. The number of
shares of stock that have not vested pertains to the February 15, 2007 restricted stock grant to
the named executive officers below. The market value of the number of shares of stock that have
not vested was based on the closing price per share ($1.86) of our common stock on the OTCBB on
December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
Option Awards
|
|
|
|
|
|
Market
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Value of
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
|
|
|
|
Shares or
|
|
Shares or
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
Units of
|
|
Units of
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
|
|
Stock That
|
|
Stock That
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Frohman
|
|
|
375,000
|
|
|
|
|
|
|
|
2.50
|
|
|
|
12/07/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
300,000
|
|
|
|
|
|
|
|
1.00
|
|
|
|
11/22/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
500,000
|
|
|
|
218,760
|
|
|
|
2.50
|
|
|
|
11/9/2015
|
|
|
|
125,000
|
|
|
|
232,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
150,000
|
|
|
|
112,500
|
|
|
|
3.50
|
|
|
|
04/03/2016
|
|
|
|
125,000
|
|
|
|
232,500
|
|
Employment, Severance and Other Agreements
Scott Frohman
Pursuant to a written employment agreement, Mr. Frohman served as our Chief Executive Officer
effective October 10, 2005 through December 7, 2006. He was paid an annual base salary of $258,300
and was entitled to receive such bonus compensation as a majority of our board of directors would
determine. On December 7, 2006, Scott Frohman resigned as our Chief Executive Officer and as one of
our directors. In connection with Mr. Frohmans resignation, we and Mr. Frohman entered into a
separation agreement dated December 7, 2006.
Under the separation agreement, Mr. Frohmans employment with us ceased to be effective on
December 7, 2006, or the separation date. The separation agreement provides for the resolution of
all matters with respect to Mr. Frohmans employment, including all obligations to Mr. Frohman
under his employment agreement with us dated as of October 10, 2005, with respect to his
outstanding options to purchase shares of our common stock and with respect to any other similar
amounts or benefits payable to Mr. Frohman pursuant to the employment agreement or otherwise.
53
The separation agreement provides for the payment to Mr. Frohman of his monthly salary
immediately preceding his resignation for a period of 18 months, less taxes, in satisfaction of all
obligations under his employment agreement, and in recognition that a material portion is in
consideration of Mr. Frohmans confidentiality, non-competition and non-solicitation obligations.
In addition, under the separation agreement, Mr. Frohman was entitled to receive (i) a lump sum
payment equal to $21,525 for four weeks of accrued but unused vacation, less $8,075 for certain
business expenses and (ii) payment of, or reimbursement for, monthly COBRA premiums for a period of
18 months following the separation date. The separation agreement further provides that upon his
termination of employment, Mr. Frohmans option to purchase 600,000 shares of our common stock,
exercisable at $2.50 per share and originally granted on November 10, 2005, would become vested as
to 375,000 shares (150,000 of which were already vested immediately prior to his resignation and
225,000 of which became vested on December 7, 2006). These 375,000 shares shall remain exercisable
by Mr. Frohman for one year following the separation date. The option would terminate with respect
to the remaining 225,000 shares that would not become vested under the separation agreement.
Certain of Mr. Frohmans shares of our common stock (1,566,007 shares) remained locked up
until November 23, 2007 under the terms of a lock-up agreement with us, dated as of November 23,
2005. A portion of Mr. Frohmans shares (1,191,006 shares) and his option to acquire 375,000 shares
of our common stock were released from his original lock-up agreement. Under the separation
agreement, Mr. Frohman has agreed that the released securities will remain subject to general
lock-up terms for a period of 18 months following the separation date, subject to certain
exceptions as set forth in the separation agreement.
The separation agreement also provides for mutual non-disparagement by Mr. Frohman and us. Mr.
Frohman also is subject to confidentiality provisions and an 18 month non-competition,
non-solicitation and no-hire period under the separation agreement.
On April 5, 2007, we entered into a Consent and Lock-Up Agreement with Scott Frohman. Under
the Consent and Lock-Up Agreement, we consented to the release from lock-up of 1,300,000 shares out
of 1,559,007 shares of Common Stock (or securities exercisable for or convertible into shares of
Common Stock) held by Mr. Frohman, or the Released Securities, that were locked up in favor of us
until June 7, 2008 pursuant to the Separation Agreement between us and Mr. Frohman dated December
7, 2006. We consented to this release in consideration for a lock-up until May 23, 2008 by Mr.
Frohman in favor of us of 50% of Mr. Frohmans remaining 1,566,007 shares of Common Stock (or
securities exercisable for or convertible into shares of Common Stock) that were otherwise locked
up until November 23, 2007 under the Lock-Up Agreement between us and Mr. Frohman dated November
23, 2005. Prior to the Consent and Lock-Up Agreement, the lock-up restrictions in the Separation
Agreement allowed Mr. Frohman to sell or otherwise transfer up to 50,000 shares of Released
Securities in any given month. Under the Lock-Up Agreement, Mr. Frohman will not be entitled to
this 50,000 share exception until on or after July 5, 2007 as it relates to the 259,007 shares of
Released Securities that were not released from lock-up under the Consent and Lock-Up Agreement.
On May 1, 2007, we entered into an Amendment to Consent and Lock-Up Agreement with Mr.
Frohman. Under the Amendment to the Consent and Lock-Up Agreement, we consented to the release
from lock-up of 200,000 shares that were locked up until July 5, 2007 under the Consent and Lock-Up
Agreement. In consideration for this release, Mr. Frohman agreed that 200,000 shares of Common
Stock that were locked up until November 23, 2007 under the Lock-Up Agreement between us and Mr.
Frohman dated November 23, 2005 would continue to be locked up until February 21, 2008.
54
On December 7, 2007, we entered into an Amendment Agreement to the Separation Agreement with
Mr. Frohman. Under this agreement, Mr. Frohman agreed to forego any rights he had to receive the
approximately 6 remaining months of severance to which he was entitled under the Separation
Agreement in consideration for our extension of the post-termination exercise period of Mr.
Frohmans option to purchase 375,000 shares of Common Stock for an additional year. According to
this agreement, if the closing bid price of the Common Stock on any trading following December 7,
2007 is $5.00 or more, Mr. Frohman shall be obligated to exercise the option within five business
days of such trading date. If Mr. Frohman fails to exercise any or all of the options, the options
will terminate within five business days of the trading date with regard to the unexercised shares.
Alvin H. Clemens and Ivan M. Spinner
On November 27, 2007 we entered into amended and restated employment agreements with each of
Alvin H. Clemens and Ivan M. Spinner. The employment agreements replaced and superseded the
executives existing employment agreements.
Each employment agreement has an initial term of three years beginning on November 27, 2007.
The employment agreements automatically renew for successive additional one-year periods each
unless either we or the executive gives the other 60 days written notice prior to the end of the
then current term.
Under the respective employment agreements, (i) Mr. Clemens would continue to serve as our
Executive Chairman and Chief Executive Officer with a base salary equal to his existing base salary
of $450,000 per year and (ii) Mr. Spinner would serve as our Executive Vice President with a base
salary of $371,000 per year until April 2, 2007 and a base salary of $300,000 thereafter.
Each executive also is entitled to receive annual bonus compensation in cash, capital stock or
other property as determined by our board of directors and to participate in all benefit plans
offered from time to time to our senior executives. In addition, each executive is entitled to a
car allowance of at least $1,000 per month and reimbursement for up to $15,000 in dues associated
with the executives membership in professional and business organizations.
Certain other terms are identical among all of the employment agreements and are set forth
below:
|
|
|
We may terminate the employment agreements (i) for Cause (as defined in the
employment agreements), (ii) upon 60 days prior written notice to the executive if
without Cause, or (iii) upon the executives Permanent Disability as defined in the
employment agreements. Each executive may terminate his employment agreement (i) for
Good Reason as defined in the employment agreements or (ii) upon 30 days prior
written notice to us for any reason.
|
|
|
|
|
If (i) we terminate an executives employment without Cause or (ii) the executive
terminates his employment agreement for Good Reason, the executive will be entitled to
receive (x) 18 months base salary at the then current rate, payable in accordance with
our usual practices, (y) continued participation for 18 months in our benefit plans and
(z) payment, within a commercially reasonable time and on a prorated basis, of any
bonus or other payments earned in connection with our bonus plan existing at the time
of termination. In addition, if an employment agreement is terminated in accordance
with the foregoing sentence within two months prior to, or 24 months following, a
change in control (as described in the employment agreement), the executive will be
entitled to receive 18 months base salary at the then current rate upon the date of
termination, regardless of our usual practices, and all stock options held by the
executive at the date of termination will immediately become 100%
|
55
|
|
|
vested and all restrictions on such options will lapse.
|
|
|
|
|
If we terminate an executives employment for Cause or the executive terminates his
employment agreement without Good Reason, the executive will be entitled to receive (i)
all accrued and unpaid salary and vacation pay through the date of termination and (ii)
continued participation for one month in our benefit plans.
|
|
|
|
|
If we terminate an executives employment due to a Permanent Disability, the
executive will be entitled to receive (i) 18 months base salary at the then current
rate, payable in accordance with our usual practices, (ii) continued participation for
18 months in our benefit plans and (iii) payment, within a commercially reasonable time
and on a prorated basis, of any bonus or other payments earned in connection with our
bonus plan existing at the time of termination. We may credit any such amounts against
any proceeds paid to the executive with respect to any disability policy maintained and
paid for by us for the executives benefit.
|
|
|
|
|
If an executive dies during the term of his employment agreement, the employment
agreement will automatically terminate and the executives estate or beneficiaries will
be entitled to receive (i) three months base salary at the then current rate, payable
in a lump sum and (ii) continued participation for one year in our benefit plans.
|
|
|
|
|
Each executive is prohibited from competing with us or soliciting our employees,
independent contractors, or outside agents, directly or indirectly, for another
business and is subject to standard confidentiality obligations during the term of the
employment agreements and for a period of 18 months thereafter.
|
|
|
|
|
We and each executive will be prohibited, following a termination of the executives
employment with us from disparaging each other.
|
Charles A. Eissa
Pursuant to a written employment agreement, Mr. Eissa serves as our President and Chief
Operating Officer. Pursuant to his employment agreement, his annual base salary was initially
$214,200 per year through April, 1, 2006, was then increased to $250,000 through March 19, 2007 and
then increased to $300,000 thereafter. He is entitled to receive such bonus compensation as a
majority of the members of our board of directors may determine from time to time. Mr. Eissas
employment agreement automatically renewed on November 18, 2007 and expires on November 18, 2008.
In the event of Mr. Eissas termination without cause or for good reason, he or his estate
would receive his then current base annual salary, plus unpaid accrued employee benefits, which is
primarily accrued vacation, plus the continuation of his employee benefits for a period of one
year, less all applicable taxes. In the event of his voluntary termination, death or disability,
he or his estate would receive unpaid accrued employee benefits, plus the continuation of his
employee benefits for a period of 1 month, less all applicable taxes.
56
Compensation of Directors
The following table sets forth information concerning the compensation of all individuals who
served on our board of directors during the fiscal year ended December 31, 2007. There were no
non-equity incentive plan compensation or nonqualified deferred compensation earnings to any of our
directors for the year ended December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
Paid in Cash
|
|
Stock Awards
|
|
Option Awards
|
|
Compensation
|
|
Total
|
Name
|
|
($) (1)
|
|
($) (2)
|
|
($) (3)
|
|
($)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
$
|
39,250
|
|
|
$
|
21,500
|
|
|
|
210,391
|
|
|
|
|
|
|
|
271,141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
8,500
|
|
|
|
21,500
|
|
|
|
23,250
|
|
|
|
|
|
|
|
53,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
13,000
|
|
|
|
32,250
|
|
|
|
23,250
|
|
|
|
53,077
|
(4)
|
|
|
121,577
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen
|
|
|
11,500
|
|
|
|
21,500
|
|
|
|
193,817
|
|
|
|
|
|
|
|
226,817
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
16,000
|
|
|
|
32,250
|
|
|
|
193,817
|
|
|
|
|
|
|
|
242,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
L.J. Rowell
|
|
|
12,000
|
|
|
|
32,250
|
|
|
|
193,817
|
|
|
|
|
|
|
|
238,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frederick C. Tecce
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Represents board and committee meeting and retainer fees paid to our directors under our
Compensation Plan for Directors and our 2005 Non-Employee Directors Stock Option Plan. Fees earned
or paid to Mr. Musser also includes a one-time payment of $250,000 to Mr. Musser under our
Compensation Plan for Directors as Vice Chairman of our board of directors, $125,000 of which was
payable upon adoption of the director compensation plan and $125,000 of which was payable in 12
equal monthly installments commencing on March 31, 2006.
|
|
(2)
|
|
Stock award expense for the most recently completed fiscal year pertaining to directors, which
is detailed by director in the following tables, was based on the closing price per share ($2.15)
of our common stock on the OTCBB on the date of the grant.
|
57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of
|
|
|
|
|
|
Aggregate
|
|
|
Date of Stock
|
|
Common
|
|
Value Per
|
|
Value of Stock
|
|
|
Grant
|
|
Stock Granted
|
|
Share
|
|
Granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
12/15/2007
|
|
|
|
10,000
|
|
|
$
|
2.15
|
|
|
$
|
21,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
12/15/2007
|
|
|
|
10,000
|
|
|
|
2.15
|
|
|
|
21,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
12/15/2007
|
|
|
|
15,000
|
|
|
|
2.15
|
|
|
|
32,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen
|
|
|
12/15/2007
|
|
|
|
10,000
|
|
|
|
2.15
|
|
|
|
21,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
12/15/2007
|
|
|
|
15,000
|
|
|
|
2.15
|
|
|
|
32,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
L.J. Rowell
|
|
|
12/15/2007
|
|
|
|
15,000
|
|
|
|
2.15
|
|
|
|
32,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frederick C. Tecce
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
|
Stock option expense for the most recently completed fiscal year pertaining to directors is
based on the estimated fair value as of the date of grant using the Black-Scholes option-pricing
model based on the terms of each option amortized over the vesting period of the option or the
duration of board membership, whichever is shorter. Fair value was estimated based on an assumed
dividend yield of 0% and the assumptions below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Expensed in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expensed in
|
|
Financial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial
|
|
Statements
|
|
Fair Value
|
|
Number of
|
|
Option
|
|
Stock Price
|
|
|
|
|
|
|
|
|
|
|
Statements
|
|
Based on
|
|
of Option
|
|
Options
|
|
Exercise
|
|
on the Date
|
|
Date of
|
|
Expected
|
|
Risk Free
|
|
Expected
|
Name
|
|
($)
|
|
Vesting
|
|
Award ($)
|
|
Granted (#)
|
|
Price ($)
|
|
of Grant ($)
|
|
Grant
|
|
Volatility
|
|
Interest Rate
|
|
Life in years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
57,979
|
|
|
|
30
|
%
|
|
|
193,264
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
01/11/2006
|
|
|
|
103
|
%
|
|
|
3.75
|
%
|
|
|
5
|
|
|
|
|
152,412
|
|
|
|
17
|
%
|
|
|
896,542
|
|
|
|
425,000
|
|
|
|
2.70
|
|
|
|
2.90
|
|
|
|
03/14/2006
|
|
|
|
105
|
%
|
|
|
3.75
|
%
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
23,250
|
|
|
|
31
|
%
|
|
|
75,000
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/23/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
4.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
23,250
|
|
|
|
31
|
%
|
|
|
75,000
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/22/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
4.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen
|
|
|
193,817
|
|
|
|
33
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
193,817
|
|
|
|
33
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
L. J. Rowell
|
|
|
193,817
|
|
|
|
33
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
|
(4)
|
|
Mr. Harrison provides marketing consulting services to the Company pursuant to a verbal
agreement. Mr. Harrisons consulting services commenced on January 29, 2007
|
58
2005 Non-Employee Director Stock Option Plan
Effective November 23, 2005, we adopted the 2005 Non-Employee Director Stock Option Plan, or
the Directors Option Plan, which plan was approved by written consent of a majority of our
stockholders. Key features of the Directors Option Plan include:
|
|
|
Non-employee directors are eligible to participate in the Directors Option Plan. The
term of the Directors Option Plan is eight years. 1,500,000 shares of common stock have
been reserved for issuance under the Directors Option Plan.
|
|
|
|
|
Options are issued at the minimum of Fair Market Value as such term is defined in the
Directors Option Plan.
|
|
|
|
|
Options may only be issued as non-qualified stock options.
|
|
|
|
|
Each newly elected or appointed non-employee director shall be granted an option to
purchase 250,000 shares of common stock, of which 100,000 shares are exercisable
immediately (however, no option shall be exercisable until such time as any vesting
limitation required by Section 16 of the Exchange Act has terminated); 75,000 shares on the
first anniversary of the grant and the remaining 75,000 shares in 12 equal increments at
the end of each calendar month thereafter.
|
|
|
|
|
Each non-employee director who is appointed Chairman of our board of directors receives
an additional option to purchase 250,000 shares of common stock, exercisable on the same
terms as the other non-employee director options.
|
|
|
|
|
Stockholder approval is required in order to replace or reprice options.
|
|
|
|
|
The Directors Option Plan is administered by the board of directors or a committee
designated by the board of directors.
|
|
|
|
|
Options have a maximum of ten years.
|
|
|
|
|
Upon a change in control, any unvested position of outstanding options shall vest and
become immediately exercisable ten days prior to such change in control.
|
2005 Incentive Stock Plan
Effective November 23, 2005, we adopted the 2005 Incentive Stock Plan, or the Incentive Plan,
which was approved by written consent of a majority of our stockholders. The purpose of the
Incentive Plan is to encourage stock ownership by our officers, directors, key employees and
consultants, and to give such persons a greater personal interest in the success of the business
and an added incentive to continue to advance and contribute to us and to attract new directors,
officers, consultants, advisors and employees whose services are considered valuable. As of March
31, 2006, options to purchase 2,685,000 shares were granted under the Incentive Plan. Key features
of the Incentive Plan include:
|
|
|
The Incentive Plan provides for the grant of options and the issuance of restricted
shares.
|
|
|
|
|
An aggregate of 2,750,000 shares of common stock have been reserved for issuance under
the Incentive Plan.
|
59
|
|
|
Options are issued at the minimum of Fair Market Value as such term is defined in the
Incentive Plan.
|
|
|
|
|
Both incentive and nonqualified stock options may be granted under the Incentive Plan.
|
|
|
|
|
The Incentive Plan terminates on November 18, 2015.
|
|
|
|
|
The exercise price of options granted pursuant to the Incentive Plan is determined by a
committee but the option term may not exceed 10 years.
|
|
|
|
|
For holders of 10% or more of the combined voting power of all classes of our stock,
options may not be granted at less than 110% of the fair market value of the common stock
at the date of grant and the option term may not exceed eight years.
|
Directors Compensation Plan
On March 14, 2006, our board of directors adopted a Compensation Plan for Directors, or the
Directors Compensation Plan. An aggregate of 1,000,000 shares of our common stock has been reserved
for issuance under the Directors Compensation Plan, in addition to any authorized and unissued
shares of common stock available for issuance under the Directors Option Plan. The purpose of the
Directors Compensation Plan is to provide a comprehensive compensation program to attract and
retain qualified individuals to serve as directors. We are authorized to award cash fees and issue
non-qualified stock options under the Directors Compensation Plan. The Directors Compensation Plan
is administered by our board of directors, or the compensation committee of our board of directors.
The Directors Compensation Plan provides for:
|
|
|
a one-time payment of $250,000 to each non-employee director who serves as Vice Chairman
of our board of directors (who is not also Chairman or an Executive Chairman), $125,000 of
which is payable upon the adoption of the Directors Compensation Plan and $125,000 of which
is payable in twelve equal monthly installments commencing March 31, 2006, so long as such
person remains a director and is serving in such capacity on the date of each such
installment;
|
|
|
|
|
a one-time grant of an additional option to purchase 425,000 shares of our common stock
to each non-employee director who is or has been appointed or elected as Vice Chairman of
our board of directors (who is not also Chairman or an Executive Chairman) on the later of
the date of such appointment or election, or adoption of the Plan;
|
|
|
|
|
the payment of $1,000 to each director for each special or committee meeting of our
board of directors attended, in person or by telephone, as reimbursement of fees and
expenses of attendance and participation by such director at such meeting;
|
|
|
|
|
an annual retainer of $1,000 payable to each director upon appointment as chairperson of
a committee of our board of directors;
|
|
|
|
|
an automatic initial grant of an option to purchase 100,000 shares of our common stock
to each director who joins our board of directors, at an exercise price equal to the fair
market value on the date of such election to our board of directors;
|
|
|
|
|
the grant of an option to purchase 10,000 shares of our common stock to each director
re-elected to our board of directors, at an exercise price equal to the fair market value
on the date of such reelection to our board of directors;
|
60
|
|
|
except for the one-time grants to our Vice Chairmen, which option shall vest and become
exercisable as to one-half of the shares subject to the option six months from the date of
grant, and the other half of the shares six months thereafter, all options granted under
the Directors Compensation Plan shall vest as follows: one-third of the shares shall be
exercisable on the first anniversary of the date of grant, an additional one-third of the
shares on the second year anniversary, and the remaining one-third of the shares on the
third anniversary of the date of grant; and
|
|
|
|
|
a term of each option under the Directors Compensation Plan of five years.
|
2006 Omnibus Equity Compensation Plan
On April 27, 2006, our board of directors adopted the 2006 Omnibus Equity Compensation Plan,
or the Omnibus Plan. The purpose of the Omnibus Plan is to attract, retain and motivate the
employees, non-employee members of our board of directors and consultants of ours and our
subsidiaries and to focus their efforts on the long-term enhancement of stockholder value.
The Incentive Plan, the Directors Option Plan and the Directors Compensation Plan, or,
collectively, the Prior Plans, were merged with and into the Omnibus Plan as of the effective date
of the Omnibus Plan, and no additional grants were made thereafter under the Prior Plans.
Outstanding grants under the Prior Plans will continue in effect according to their terms as in
effect before the Prior Plans merger (subject to such amendments as our board of directors
determines, consistent with the Prior Plans, as applicable), and the shares with respect to
outstanding grants under the Prior Plans will be issued or transferred under the Omnibus Plan.
|
|
Key terms of the Omnibus Plan are as follows:
|
|
|
|
Administration
. The Omnibus Plan is administered and interpreted by our board of
directors. The Board has the authority to: (i) determine the individuals to whom grants
will be made under the Omnibus Plan; (ii) determine the type, size and terms of the grants;
(iii) determine the time when grants will be made and the duration of any applicable
exercise or restriction period, including the criteria for exercisability and the
acceleration of exercisability; (iv) amend the terms of any previously issued grant,
subject to the limitations described below; and (v) deal with any other matters arising
under the Omnibus Plan. The determinations of our board of directors are made in its sole
discretion and are final, binding and conclusive.
|
|
|
|
Eligibility
. All of the employees of ours and our subsidiaries, as well as advisors and
consultants of ours and our subsidiaries, are eligible for grants under the Omnibus Plan.
Non-employee directors of ours are also eligible to receive grants under the Omnibus Plan.
|
|
|
|
Types of Awards
. The Omnibus Plan provides that grants may be in any of the following
forms: (i) incentive stock options; (ii) nonqualified stock options (incentive stock
options and nonqualified stock options collectively are referred to as options); (iii)
stock appreciation rights, or SARs; (iv) stock units; (v) stock awards; (vi) dividend
equivalents; and (vii) other stock-based awards.
|
|
|
|
Shares Subject to the Omnibus Plan
. The Omnibus Plan authorizes up to 7,050,000 shares
of our common stock for issuance, subject to adjustment in certain circumstances. The
maximum number of authorized shares includes shares to be issued or transferred pursuant to
outstanding grants under the Prior Plans that are to be merged into this Omnibus Plan as of
the effective date of the Omnibus Plan. The Omnibus Plan provides that the maximum
aggregate number of shares
|
61
|
|
of common stock that may be made with respect to grants, other than dividend equivalents, to
any individual during any calendar year is 1,000,000 shares, subject to adjustment as
described below. Grantees may not accrue dividend equivalents during any calendar year under
the Omnibus Plan in excess of $1,000,000. These limits may be adjusted by reason of a stock
dividend, spin-off, recapitalization, stock split, or combination or exchange of shares, by
reason of a merger, reorganization or consolidation, by reason of a recapitalization or
change in par value or by reason of any other extraordinary or unusual event affecting the
outstanding shares of common stock as a class without our receipt of consideration, or if
the value of outstanding shares of common stock is substantially reduced as a result of a
spin-off or our payment of an extraordinary dividend or distribution.
|
|
|
|
Change of Control
. If a change of control of us occurs, unless our board of directors
determines otherwise, all outstanding options and SARs will automatically accelerate and
become fully exercisable, the restrictions and conditions on all outstanding stock awards
will immediately lapse, all outstanding stock units will become payable in cash or shares
of common stock in an amount not less than their target amount (as determined by our board
of directors), and dividend equivalents and other-stock based awards will become fully
payable in cash or shares of common stock (in amounts determined by our board of
directors).
|
|
|
|
Upon a change of control, our board of directors may also take any of the following actions
with respect to outstanding grants, without the consent of the grantee: (i) require that
grantees surrender their outstanding options and SARs in exchange for payment by us, in
cash or shares of common stock as determined by our board of directors, in an amount equal
to the amount by which the then fair market value subject to the grantees unexercised
options and SARs exceeds the exercise price of the option or the base amount of the SAR, as
applicable; (ii) after giving grantees the opportunity to exercise their outstanding
options and SARs, our board of directors may terminate any or all unexercised options and
SARs at such time as our board of directors determines appropriate; and (iii) determine
that outstanding options and SARs that are not exercised shall be assumed by, or replaced
with comparable options or rights by, the surviving corporation (or a parent or subsidiary
of the surviving corporation), and other outstanding grants that remain in effect after the
change of control will be converted to similar grants of the surviving corporation (or a
parent or subsidiary of the surviving corporation).
|
|
|
|
Amendment and Termination of the Omnibus Plan
. Our board of directors may amend or
terminate the Omnibus Plan at any time, subject to stockholder approval if such approval is
required under any applicable laws or stock exchange requirements. No grants may be issued
under the Omnibus Plan after April 27, 2016.
|
62
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Security Ownership of Certain Beneficial Owners and Management
The following table shows information known by us with respect to the beneficial ownership of
our common stock as of January 21, 2008, for each of the following persons:
|
|
|
each of our directors;
|
|
|
|
|
each of our named executive officers;
|
|
|
|
|
all of our directors and executive officers as a group; and
|
|
|
|
|
each person or group of affiliated persons or entities known by us to
beneficially own 5% or more of our common stock.
|
The number of shares beneficially owned, beneficial ownership and percentage ownership are
determined in accordance with the rules of the Commission. Under these rules, beneficial ownership
includes any shares as to which the individual or entity has sole or shared voting power or
investment power and includes any shares that an individual or entity has the right to acquire
beneficial ownership of within 60 days of January 21, 2008 through the exercise of any warrant,
stock option or other right. In computing the number of shares beneficially owned by a person and
the percentage ownership of that person, shares underlying options and warrants that are
exercisable within 60 days of January 21, 2008 are considered to be outstanding. To our knowledge,
except as indicated in the footnotes to the following table and subject to community property laws
where applicable, the persons named in this table have sole voting and investment power with
respect to all shares shown as beneficially owned by them. The following table is based on
35,026,384 shares outstanding as of January 21, 2008. Unless otherwise indicated, the address of
all individuals and entities listed below is Health Benefits Direct Corporation, 150 Radnor-Chester
Road, Suite B-101, Radnor, Pennsylvania 19087.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Percent of Shares
|
Name and Address of Beneficial Owner
|
|
Beneficially Owned
|
|
Beneficially Owned
|
|
|
|
|
|
|
|
|
|
Directors and Named Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
4,350,000
|
(1)
|
|
|
11.9
|
%
|
Charles A. Eissa
|
|
|
1,902,186
|
(2)
|
|
|
5.4
|
%
|
Warren V. Musser
|
|
|
1,135,000
|
(3)
|
|
|
3.1
|
%
|
John Harrison
|
|
|
466,750
|
(4)
|
|
|
1.3
|
%
|
L.J. Rowell
|
|
|
390,600
|
(5)
|
|
|
1.1
|
%
|
C. James Jensen
|
|
|
360,000
|
(5)(10)
|
|
|
1.0
|
%
|
Paul Soltoff
|
|
|
345,000
|
(6)
|
|
|
1.0
|
%
|
Ivan M. Spinner
|
|
|
312,500
|
(7)
|
|
|
*
|
|
Sanford Rich
|
|
|
295,000
|
(5)(11)
|
|
|
*
|
|
Frederick C. Tecce
|
|
|
1,650,000
|
(12)
|
|
|
*
|
|
All directors and named executive officers as a group (11 persons)
|
|
|
11,207,036
|
(1)(2)(3)(4)(5)(6)(7)(8)(10)(11)(12)
|
|
|
28.3
|
%
|
|
|
|
|
|
|
|
|
|
Holders of More than Five Percent of Our Common
Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Percent of Shares
|
Name and Address of Beneficial Owner
|
|
Beneficially Owned
|
|
Beneficially Owned
|
Gerald Unterman
|
|
|
3,000,000
|
(8)
|
|
|
8.3
|
%
|
Arthur J. Nagle and Paige L. Nagle JTWROS
|
|
|
1,830,000
|
(9)
|
|
|
5.1
|
%
|
Marlin
Capital Partners I, LLC.
|
|
|
1,813,882
|
(13)
|
|
|
5.2
|
%
|
|
|
|
*
|
|
Less than 1%
|
|
(1)
|
|
Includes 1,000,000 shares and 500,000 shares underlying warrants exercisable within 60 days
of January 21, 2008 held by The Clemens-Beaver Creek Limited Partnership, of which Alvin H.
Clemens is the general partner. Mr. Clemens disclaims beneficial ownership of these shares,
except to the extent of his pecuniary interest therein. Also includes 100,000 shares held by
Mr. Clemenss minor children. Also includes 300,000 shares underlying options and 700,000
shares underlying warrants, all of which are exercisable within 60 days of January 21, 2008.
|
|
(2)
|
|
Includes 281,240 shares underlying options, all of which are exercisable within 60 days of
January 21, 2008. Excludes 218,760 shares underlying options that are not exercisable within
60 days of January 21, 2008.
|
|
(3)
|
|
Includes 440,000 shares underlying warrants and 675,000 shares underlying options, all of
which are exercisable within 60 days of January 21, 2008.
|
|
(4)
|
|
Includes 250,000 shares underlying options and 86,750 shares underlying warrants, all of
which are exercisable within 60 days of January 21, 2008.
|
|
(5)
|
|
Includes 190,000 shares underlying options that are exercisable within 60 days of January
21, 2008. Excludes 10,000 shares underlying options that are not exercisable within 60 days
of January 21, 2008.
|
|
(6)
|
|
Includes 150,000 shares underlying options and 25,000 shares underlying warrants, all of
which are exercisable within 60 days of January 21, 2008.
|
|
(7)
|
|
Includes 37,500 shares underlying options that are exercisable within 60 days of January 21,
2008. Excludes 112,500 shares underlying options that are not exercisable within 60 days of
January 21, 2008.
|
|
(8)
|
|
According to the Schedule 13G/A filed with the Commission by Mr. Unterman on April 18, 2007.
Includes 1,000,000 shares underlying warrants that are exercisable within 60 days of January
21, 2008.
|
|
(9)
|
|
Includes 220,000 shares held by Arthur J. Nagle in his individual capacity. Includes
610,000 shares underlying warrants that are exercisable within 60 days of January 21, 2008,
110,000 of which are held by Arthur J. Nagle in his individual capacity.
|
|
(10)
|
|
Includes 50,000 shares held by Mara Gateway Associates. Mr. Jensen disclaims beneficial
ownership of these shares except to the extent of his pecuniary interest therein.
|
|
(11)
|
|
Includes 25,000 shares underlying warrants that are exercisable within 60 days of January 21,
2008.
|
|
(12)
|
|
Includes 50,000 shares underlying warrants that are exercisable within 60 days of January 21,
2008. Also includes 1,000,000 shares and 500,000 shares underlying warrants that are
exercisable within 60 days of January 21, 2008, that are beneficially owned by Co-Investment
Trust II, L. P., designee of Cross Atlantic Capital Partners, Inc. Mr. Tecce is a managing
partner of Cross Atlantic Capital Partners, Inc. Mr. Tecce disclaims beneficial ownership of
these securities, except to the extent of his pecuniary interest therein.
|
|
(13)
|
|
According to the Schedule 13G filed with the Commission by Marlin Capital Partners I, LLC on
September 1, 2006. Betsy Brauser is the natural person with voting and investment control
over these shares.
|
64
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
From the beginning of our last fiscal year until the date of this registration statement,
there has been no transaction, nor is there any transaction currently proposed, to which we were,
are, or would be a participant, in which the amount involved exceeded or would exceed $120,000 and
in which any of our directors or executive officers, any holder of more than 5% of our common stock
or any member of the immediate family of any of these persons or entities had or will have a direct
or indirect material interest, other than the compensation and compensation arrangements (including
with respect to equity compensation and board compensation) described below.
We believe that we have executed all of the transactions described below on terms no less
favorable to us than we could have obtained from unaffiliated third parties. It is our intention to
ensure that all future transactions between us and our officers, directors and principal
stockholders and their affiliates are approved by a majority of our board of directors, including a
majority of the independent and disinterested members of our board of directors, and are on terms
no less favorable to us than those that we could obtain from unaffiliated third parties.
In March 2006, we entered into Marketing Services Agreement with SendTec, Inc., or SendTec.
Paul Soltoff, one of our directors, is the Chief Executive Officer of SendTec. SendTec provided
certain marketing and advertising services and received a flat fee of $7,500 per month plus
commissions on services rendered. For the year ended December 31, 2006, we paid SendTec $352,740
and have recorded other general and administrative expense of $324,282, intangible assets
pertaining to website development of $50,000 and due to related parties of $21,542.
From time to time, we use a business credit card in the name of ISG Partners, Inc., which is
an entity owned by Mr. Ivan Spinner, one of our executive officers, for travel expenses, purchases
and operating purposes. This account is personally guaranteed by Mr. Spinner. Mr. Spinner does
not incur any interest or expense in connection with our use of his credit card account. We do not
pay Mr. Spinner interest or fees in connection with our use of his credit card account. At
December 31, 2006, we owed Mr. Spinner $42,130 for charges incurred on his credit card, which
amount was paid in full in January 2007.
We have engaged in the following transactions regarding sales of our common stock with our
executive officers and directors, and with the beneficial holders of 5% or more of our common
stock:
|
|
|
In January 2006, we completed a private placement of an aggregate of 14,700,000 shares
of our common stock and warrants exercisable for 7,350,000 shares of our common stock. In
connection with this private placement:
|
|
|
|
Beaver Creek Limited Partnership, an affiliate of Alvin H. Clemens, our Chief
Executive Officer, purchased 1,000,000 shares of our common stock and warrants
exercisable for 500,000 shares of our common stock;
|
|
|
|
|
John Harrison, one of our directors, purchased 100,000 shares of our common stock
and warrants exercisable for 50,000 shares of our common stock;
|
|
|
|
|
Keystone Equities Group, L.P., of which John Harrison is an Executive Director,
served as placement agent and received a total cash fee of $558,000 (4% of the gross
proceeds), and five-year warrants to purchase 735,000 shares of our common stock (5% of
the shares sold in the private placement) at an exercise price of $1.50 per share.
|
65
|
|
|
Mara Gateway Associates, L.P., an affiliate of C. James Jensen, one of our
directors, purchased 250,000 shares of our common stock and warrants exercisable for
125,000 shares of our common stock; and
|
|
|
|
|
Sanford Rich, one of our directors, purchased 50,000 shares of our common stock and
warrants exercisable for 25,000 shares of our common stock.
|
|
|
|
In April 2006, we and our wholly-owned subsidiary, ISG Merger Acquisition Corp., a
Delaware corporation, or Merger Sub, entered into a merger agreement with ISG and Ivan M.
Spinner, pursuant to which, among other things, the Merger Sub merged with and into ISG. As
consideration for the merger, we made a cash payment of $920,000 and issued 1,000,000
shares to Mr. Spinner, the sole stockholder of ISG prior to the merger, in exchange for all
of the outstanding stock of ISG. The shares issued to Mr. Spinner have the same
registration rights and lock-up restrictions as applicable to the shares held by our
founders. In connection with this merger, we entered into an employment agreement with Mr.
Spinner, under which he was appointed as our Senior Vice President.
|
|
|
|
|
On February 15, 2007, we made restricted stock grants of 125,000 shares of our common
stock to each of Mr. Eissa and Mr. Spinner in accordance with the terms of our 2006 Omnibus
Equity Compensation Plan. These grants are subject to certain restrictions, including a
restriction on transfer prior to the shares becoming fully vested. These shares will vest
as follows: 50,000 shares on the first anniversary of the grant date; 50,000 additional
shares of the second anniversary of the grant date; 2,083 shares per month on the 15th day
of each month beginning on March 15, 2009 through January 15, 2009; and 2,087 on the third
anniversary of the grant date.
|
|
|
|
|
On March 30, 2007, we completed a private placement of an aggregate of 5,000,000 shares
of our common stock and warrants exercisable for 2,500,000 shares of our common stock. We
sold 5,000,000 investment units in the private placement, each investment unit consisting
of one share of our common stock and a warrant to purchase one-half (1/2) of one share of
common stock. In connection with this private placement:
|
|
|
|
Alvin H. Clemens, our Chief Executive Officer and Chairman, purchased
1.0 million investment units. Mr. Clemens agreed to waive his registration rights
for the 1.0 million shares of common stock he purchased in the private placement
and the 500,000 shares of common stock underlying the warrant until the later of
six months following the effectiveness of this registration statement or the
earliest date that may be permitted by the Commission.
|
|
|
|
|
Co-Investment Trust II, L.P., designee of Cross Atlantic Capital
Partners, Inc. purchased 1.0 million investment units. Mr. Tecce, who is one of
our directors, is a managing partner of Cross Atlantic Partners, Inc.
|
66
SELLING STOCKHOLDERS
The following table sets forth information as of January 21, 2008, to our knowledge, about the
beneficial ownership of our common stock by the selling stockholders both before and immediately
after the offering. Pursuant to Rules 13d-3 and 13d-5 of the Securities Exchange Act of 1934, as
amended, beneficial ownership includes any shares of common stock as to which a stockholder has
sole or shared voting power or investment power, and also any shares of common stock that the
stockholder has the right to acquire within 60 days.
The following table assumes that the selling stockholders will sell all of the shares of our
common stock offered by them in this offering. However, the selling stockholders may offer all or
some portion of our shares of common stock or any shares of common stock issuable upon exercise of
outstanding options or warrants held by them. Accordingly, no estimate can be given as to the
amount or percentage of our common stock that will be held by the selling stockholders upon
termination of sales pursuant to this prospectus. In addition, the selling stockholders identified
below may have sold, transferred or disposed of all or a portion of their shares since the date on
which they provided the information regarding their holdings in transactions exempt from the
registration requirements of the Securities Act.
Unless otherwise described below or elsewhere in this prospectus, the selling stockholders
have confirmed to us that they are not broker-dealers or affiliates of a broker-dealer with the
meaning of Rule 405 of the Securities Act of 1933, as amended, or the Securities Act.
We will bear all costs, expenses and fees in connection with the registration of shares of our
common stock to be sold by the selling stockholders. The selling stockholders will bear all
commissions and discounts, if any, attributable to their respective sales of shares.
Information about the selling stockholders may change over time. Any changed information will
be set forth in an amendment to the registration statement or supplement to this prospectus, to the
extent required by law.
Except as set forth in the footnotes to the table below, no selling stockholder has held any
position or had any material relationship with us or our predecessors or affiliates during the past
three years
As of January 21, 2008, there were 35,026,384 shares of our common stock outstanding. Unless
otherwise indicated, the selling stockholders have the sole power to direct the voting and
investment over shares owned by them.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Common
|
|
|
|
|
|
Shares of Common
|
|
Percentage of
|
|
|
Stock Owned Prior
|
|
Shares of Common
|
|
Stock Owned after
|
|
Common Stock Owned
|
Name
|
|
to Offering
|
|
Stock to be Sold
|
|
the Offering
|
|
After the Offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
2,850,000
|
|
|
|
1,000,000
|
|
|
|
1,850,000
|
|
|
|
8.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beaver Creek Limited Partnership
|
|
|
1,500,000
|
|
|
|
500,000
|
(1)
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oppenheimer & Co. Inc.
|
|
|
210,000
|
|
|
|
210,000
|
(2)
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanders Morris Harris Inc.
|
|
|
87,500
|
|
|
|
87,500
|
(3)
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Roth Capital Partners
|
|
|
52,500
|
|
|
|
52,500
|
(4)
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert J. Oakes
|
|
|
397,086
|
|
|
|
397,086
|
|
|
|
0
|
|
|
|
*
|
|
67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Common
|
|
|
|
|
|
Shares of Common
|
|
Percentage of
|
|
|
Stock Owned Prior
|
|
Shares of Common
|
|
Stock Owned after
|
|
Common Stock Owned
|
Name
|
|
to Offering
|
|
Stock to be Sold
|
|
the Offering
|
|
After the Offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeff Brocco
|
|
|
51,570
|
|
|
|
51,570
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tim Savery
|
|
|
51,570
|
|
|
|
51,570
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lisa Roetz
|
|
|
15,471
|
|
|
|
15,471
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computer Command and Control
Company
|
|
|
224,216
|
|
|
|
224,216
|
(5)
|
|
|
0
|
|
|
|
*
|
|
|
|
|
*
|
|
Represents less than 1% of outstanding shares of common stock
|
|
(1)
|
|
Includes 500,000 shares underlying warrants exercisable within 60 days of January 21, 2008.
Mr. Clemens is the natural person with voting and investment power over these shares.
|
|
(2)
|
|
Includes 210,000 shares underlying warrants exercisable within 60 days of January 21, 2008.
Albert Lowenthal and Dennis McNamara are the natural persons with voting and investment
control over these shares.
|
|
(3)
|
|
Includes 87,500 shares underlying warrants exercisable within 60 days of January 21, 2008.
Ben T. Morris is the natural person with voting and investment control over these shares.
|
|
(4)
|
|
Includes 52,500 shares underlying warrants exercisable within 60 days of January 21, 2008.
Byron Roth and Gordon Roth arethe natural persons with voting and investment control over
these shares.
|
|
(5)
|
|
Noah Prywes is the natural person with voting and investment control over these shares.
|
DESCRIPTION OF SECURITIES
Our authorized capital stock consists of 90,000,000 shares of common stock, par value $0.001
per share, and 10,000,000 shares of preferred stock, par value $0.001 per share. As of January 21,
2008, there were 35,026,384 shares of our common stock outstanding, outstanding options to purchase
4,831,900 shares of our common stock and outstanding warrants to purchase 10,750,000 shares of our
common stock.
Common Stock
Each stockholder is entitled to one vote for each share of common stock held on all matters
submitted to a vote of stockholders. Our certificate of incorporation does not provide for
cumulative voting. The holders of our common stock are entitled to receive ratably such dividends,
if any, as may be declared by the board of directors out of legally available funds. However, the
current policy of the board of directors is to retain earnings, if any, for operations and growth.
Upon liquidation, dissolution or winding-up, the holders of common stock are entitled to share
ratably in all assets that are legally available for distribution. The holders of common stock
have no preemptive, subscription, redemption or conversion rights. The rights, preferences and
privileges of holders of common stock are subject to, and may be adversely affected by, the rights
of the holders of any series of preferred stock, which may be designated solely by action of the
board of directors and issued in the future.
Preferred Stock
The board of directors is authorized, subject to any limitations prescribed by law, without
further vote or action by the stockholders, to issue from time to time shares of preferred stock in
one or more series. Each such series of preferred stock shall have such number of shares,
designations, preferences, voting powers, qualifications, and special or relative rights or
privileges as shall be determined by the board of directors, which may include, among others,
dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.
68
Options
As of January 21, 2008, options to purchase a total of 4,831,900 shares of our common stock
were outstanding and options to purchase 603,100 additional shares of our common stock were
available for future grant under our 2006 Omnibus Equity Compensation Plan.
Warrants
As of January 21, 2008, there were outstanding (i) warrants to purchase up to 7,900,000 shares
of our common stock at an exercise price per share of $1.50; (ii) warrants to purchase up to
2,500,000 shares of our common stock at an exercise price per share of $3.00; and (iii) warrants to
purchase up to 350,000 shares of our common stock at an exercise price per share of $2.80.
In connection with our private placement in January 2006, we issued to investors three-year
warrants to purchase up to 7,350,000 shares of common stock at $1.50 per share, three-year warrants
to purchase up to 735,000 shares of our common stock to Keystone Equities Group, L.P., as placement
agent, and three-year warrants to purchase 440,000 shares of our common stock to Warren V. Musser.
In addition, at the closing of the private placement, we issued a warrant to acquire 50,000 shares
of common stock to a previous investor under the same terms as the warrants issued to investors in
the private placement. We also issued a three-year warrant to purchase 75,000 shares of our common
stock at an exercise price of $1.50 to Alvin H. Clemens.
In connection with our private placement in March 2007, we issued to investors five-year
warrants to purchase up to 2,500,000 shares of our common stock at $3.00 per share. In addition,
we also issued to each of the placement agents in the private placement warrants to purchase in the
aggregate 350,000 shares of our common stock at an exercise price of $2.80 per share.
Prior to exercise, the warrants do not confer upon holders any voting or any other rights as a
stockholder.
Lock-up Agreements
All shares of common stock held by Charles Eissa (together with the shares held by his
affiliates) are subject to lock-up provisions that provide restrictions on the future sale of
common stock by the holders and their transferees. These lock-up provisions provide, in general,
that these shares may not directly or indirectly be offered, sold, offered for sale, contracted for
sale, hedged, or otherwise transferred or disposed of for a period of 12 months following the
purchase of such shares in our private placement completed in January 2006, and for an additional
12 months thereafter each holder may only sell up to 50% of its portion of these shares. We agreed
that within 12 months following our private placement completed in January 2006, subject to these
lock-up restrictions, we would file a registration statement with the Commission covering the
resale of these shares of common stock held by our founders and for management shares issued and
issuable under options and other awards, which shares were subsequently registered.
All shares of common stock held by Scott Frohman also were subject to the lock-up provisions
described above. On April 5, 2007, we entered into a new Consent and Lock-Up Agreement, or new
lock-up arrangement, with Mr. Frohman. Under the new lock-up arrangement, we consented to the
release from lock-up of 1,300,000 shares out of 1,566,007 shares of our common stock held by Mr.
Frohman that were locked up in our favor until June 7, 2008 pursuant to Mr. Frohmans Separation
Agreement. We consented to this release in consideration for a lock-up until May 23, 2008 by Mr.
Frohman in favor of us of 50% of Mr. Frohmans remaining 1,566,007 shares of Common Stock (or
securities exercisable for or
69
convertible into shares of Common Stock) that were otherwise locked up until November 23, 2007
under Mr. Frohmans prior Lock-Up Agreement with us. Prior to this new lock-up arrangement, the
lock-up restrictions in the Separation Agreement allowed Mr. Frohman to sell or otherwise transfer
up to 50,000 shares of the 1,300,000 shares in any given month. Under the new lock-up arrangement,
Frohman was not entitled to transfer any 50,000 monthly tranches of shares until on or after July
5, 2007 as these transfers relate to the 259,007 shares of that were not released from lock-up
under the new lock-up arrangement.
On May 1, 2007, the new lock-up arrangement was further amended. Under this most recent
amendment, we consented to the release from lock-up of 200,000 of Mr. Frohmans shares of Common
Stock that were locked up until July 5, 2007 under the new lock-up arrangement. We consented to
this release in consideration for a lock-up until February 21, 2008 by Mr. Frohman of 200,000 of
his shares of Common Stock that, under the new lock-up arrangement, were previously locked-up until
November 23, 2007.
In connection with our private placement in March 2007, certain of our directors and executive
officers also entered into lock-up agreements, dated March 30, 2007, with Oppenheimer & Co., Inc.,
under which these certain directors and executive officers agreed, among other things, not to sell
or transfer any shares of our common stock during the period from March 28, 2007 until and through
the later of three months from the closing of the private placement or 45 days following the
effective date of any registration statement.
Anti-Takeover Effects of Provisions of our Bylaws and Delaware Law
Certain provisions of our bylaws could discourage potential acquisition proposals and could
delay or prevent a change in control. Such provisions also may have the effect of preventing
changes in our management. These include provisions providing that:
|
|
|
only business brought before an annual meeting by our board of directors or by a
stockholder who complies with the procedures set forth in our bylaws may be transacted
at an annual meeting of stockholders;
|
|
|
|
|
directors shall hold office for two-year periods; and
|
|
|
|
|
advance notice of certain stockholder actions, such as the nomination of directors
and stockholder proposals, is required.
|
In addition, we are subject to Section 203 of the Delaware General Corporation Law, which,
subject to certain exceptions, generally prohibits a Delaware corporate from engaging in any
business combination with any interested stockholder for a period of three years following the time
that such stockholder became an interested stockholder, unless:
|
|
|
prior to the business combination, our board of directors approved either the
business combination or the transaction that resulted in the stockholder becoming an
interested stockholder; or
|
|
|
|
|
upon consummation of the transaction that resulted in the stockholder becoming an
interested stockholder, the interested stockholder owned at least 85% of our voting
stock outstanding at the time the transaction commenced, excluding, for purposes of
determining the voting stock outstanding (but not the outstanding voting stock owned by
the interested stockholder), those shares owned:
|
70
|
|
|
by persons who are directors and also officers;
|
|
|
|
|
by employee stock plans in which employee participants do not have the
right to determine confidentially whether shares held subject to the plan will be
tendered in a tender or exchange offer; or
|
|
|
|
|
at or after the time the stockholder became an interested stockholder,
the business combination is approved by our board of directors and authorized at an
annual or special meeting of our stockholders, and not by written consent, by the
affirmative vote of at least 66 2/3% of our outstanding voting stock that is not
owned by the interested stockholder.
|
In general, the Delaware General Corporation Law defines an interested stockholder as an
entity or person (other than the corporation and any direct or indirect majority-owned subsidiaries
of the corporation) that beneficially owns 15% or more of the outstanding voting stock of the
corporation or any entity or person that is an affiliate or associate of such entity or person.
The Delaware General Corporation Law generally defines a business combination to include the
following:
|
|
|
any merger or consolidation involving the corporation and the interested
stockholder;
|
|
|
|
|
any sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or
more of the aggregate market value of all the assets of the corporation or its
majority-owned subsidiary that involves the interested stockholder;
|
|
|
|
|
subject to certain exceptions, any transaction that results in the issuance or
transfer by the corporation of any stock of the corporation to the interested
stockholder;
|
|
|
|
|
subject to certain exceptions, any transaction involving the corporation that has
the effect of increasing the interested stockholders proportionate share of the stock
of any class or series of the corporation; and
|
|
|
|
|
the receipt by the interested stockholder of the benefit of any loans, advances,
guarantees, pledges or other financial benefits provided by or through the corporation.
|
71
PLAN OF DISTRIBUTION
The shares of common stock covered by this prospectus may be offered and sold from time to
time by the selling stockholders. As used in this prospectus, selling stockholders includes
transferees, donees, pledgees, or other successors-in-interest to the named selling stockholders.
The selling stockholders may sell all or a portion of the shares of our common stock beneficially
owned by them and offered by this prospectus from time to time:
|
|
|
directly; or
|
|
|
|
|
through underwriters, broker-dealers, or agents, who may receive compensation in the
form of discounts, commissions or concessions from the selling stockholder or from the
purchasers of the shares for whom such underwriters, broker-dealers, or agents may act
as agent.
|
The shares may be sold from time to time in one or more transactions at:
|
|
|
fixed prices, which may be changed;
|
|
|
|
|
prevailing market prices at the time of sale;
|
|
|
|
|
varying prices determined at the time of sale; or
|
|
|
|
|
negotiated prices.
|
The sales described in the preceding paragraph may be effected in transactions:
|
|
|
on any national securities exchange or quotation service on which the shares of our
common stock may be listed or quoted at the time of sale, including the Nasdaq Stock
Market;
|
|
|
|
|
in the over-the-counter market;
|
|
|
|
|
otherwise than on such exchanges or services or in the over-the-counter market; or
|
|
|
|
|
through the writing of options.
|
These transactions may include block transactions or crosses. Crosses are transactions in
which the same broker acts as an agent on both sides of the trade.
In connection with sales of the shares of our common stock or otherwise, the selling
stockholders may enter into hedging transactions with broker-dealers. These broker-dealers may in
turn engage in short sales of the shares of our common stock in the course of hedging their
positions. The selling stockholders also may sell the shares of our common stock short and deliver
shares of our common stock to close out short positions, or loan or pledge shares to broker-dealers
that in turn may sell the shares. The selling stockholders may pledge or grant a security interest
in some or all of the shares of our common stock owned by it, and, upon a default in performance of
the secured obligation, the pledgees or secured parties may offer and sell the shares from time to
time pursuant to this prospectus.
To our knowledge, there currently are no plans, arrangements or understandings between any
selling stockholders and any underwriter, broker-dealer or agent regarding the sale of the shares
by the selling stockholders. The selling stockholders may determine not to sell any or all of the
shares offered by it pursuant to this prospectus. In addition, we cannot assure you that the
selling stockholders will not
72
transfer the shares by other means not described in this prospectus. In this regard, any
shares covered by this prospectus that qualify for sale pursuant to Rule 144 under the Securities
Act may be sold under Rule 144 rather than pursuant to this prospectus.
To the extent required, upon being notified by the selling stockholders that any material
arrangement has been entered into with any agent, underwriter or broker-dealer for the sale of
common stock through a block trade, special offering, exchange distribution or secondary
distribution or a purchase by any agent, underwriter or broker-dealer, the name of the selling
stockholders and of the participating agent, underwriter or broker-dealer, specific shares to be
sold, the respective purchase prices and public offering prices, any applicable commissions or
discounts, and other facts material to the transaction will be set forth in a supplement to this
prospectus or a post-effective amendment to the registration statement of which this prospectus is
a part, as appropriate.
EXPERTS
Our consolidated financial statements as of and for the years ended December 31, 2006 and 2005
included in this prospectus and in the registration statement of which this prospectus is a part
have been audited by Sherb & Co., LLP, independent registered public accountants, to the extent and
for the periods set forth in their report and are incorporated in this prospectus in reliance upon
the report given upon the authority of Sherb & Co., LLP as experts in auditing and accounting.
TRANSFER AGENT AND REGISTRAR
The transfer agent and registrar for our common stock is Pacific Stock Transfer Company, whose
address is 500 E. Warm Springs Road, Suite 240, Las Vegas, NV 89119, and whose phone number is
(702) 361-3033.
LEGAL MATTERS
The validity of the securities being offered by this prospectus have been passed upon for us
by Morgan, Lewis & Bockius LLP, Philadelphia, Pennsylvania.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the Commission a registration statement on Form SB-2, including exhibits,
schedules and amendments filed with this registration statement, under the Securities Act with
respect to offers and resales of shares of our common stock by the selling stockholders identified
in this prospectus. This prospectus, which constitutes part of the registration statement, does
not include all of the information contained in the registration statement and its exhibits and
schedules. You should refer to the registration statement and its exhibits and schedules for
additional information. Whenever we make reference in this prospectus to any of our contracts,
agreements or other documents, the references are not necessarily complete and you should refer to
the exhibits filed with the registration statement for copies of the actual contract, agreement or
other document. Statements contained in this prospectus as to the contents of any contract or other
document referred to in this prospectus are not necessarily complete and, where that contract is an
exhibit to the registration statement, each statement is qualified in all respects by reference to
the exhibit to which the reference relates.
You can read the registration statement and our other filings with the Commission, over the
Internet at the Commissions website at http://www.sec.gov. You also may read and copy any document
that we file with the Commission at its public reference room at Headquarters Office, 100 F Street,
N.E., Room 1580, Washington, D.C. 20549.
73
DISCLOSURE OF COMMISSION POSITION ON
INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to our directors, officers or persons controlling us, we have been advised that it is the
Commissions opinion that such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable.
74
FINANCIAL STATEMENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page Number
|
|
|
HEALTH BENEFITS DIRECT CORPORATION
|
|
|
|
|
|
|
|
|
|
Audited Financial Statements for the Years Ended December 31, 2006 and 2005
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
Interim Financial Statements for the Three Months ended September 30, 2007 and 2006 (Unaudited)
|
|
|
|
|
|
|
|
F-39
|
|
|
|
|
F-40
|
|
|
|
|
F-41
|
|
|
|
|
F-42
|
|
|
|
|
F-43
|
|
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Health Benefits Direct Corporation and Subsidiaries
Radnor, Pennsylvania
We have audited the accompanying consolidated balance sheet of Health Benefits Direct Corporation
and Subsidiaries as of December 31, 2006 and the related consolidated statements of operations,
changes in shareholders equity and cash flows for the years ended December 31, 2006 and December
31, 2005. These consolidated financial statements are the responsibility of the Companys
management. Our responsibility is to express an opinion on these consolidated financial statements
based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audit included consideration of internal control over financial
reporting as a basis for designing audit procedures that are appropriate in the circumstances, but
not for the purposes of expressing an opinion on the effectiveness of the Companys internal
control over financial reporting. Accordingly, we express no such opinion. An audit includes
examining on a test basis, evidence supporting the amount and disclosures in the consolidated
financial statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of Health Benefits Direct Corporation and Subsidiaries as
of December 31, 2006, and the results of their operations and their cash flows for the years ended
December 31, 2006 and December 31, 2005, in conformity with accounting principles generally
accepted in the United States of America.
|
|
|
|
|
|
|
|
|
/s/ Sherb & Co., LLP
|
|
|
Certified Public Accountants
|
|
|
|
|
|
Boca Raton, Florida
March 19, 2007
F-2
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
December 31, 2006
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
Cash
|
|
$
|
2,311,781
|
|
Accounts receivable, less allowance for doubtful accounts of $26,436
|
|
|
2,197,523
|
|
Deferred compensation advances
|
|
|
684,998
|
|
Prepaid expenses
|
|
|
107,995
|
|
Other current assets
|
|
|
11,011
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
5,313,308
|
|
|
|
|
|
|
Restricted cash
|
|
|
1,150,000
|
|
Property and equipment, net of accumulated depreciation of $511,985
|
|
|
1,483,411
|
|
Intangibles, net of accumulated amortization of $1,668,181
|
|
|
4,108,833
|
|
Other assets
|
|
|
181,900
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
12,237,452
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
Accounts payable
|
|
$
|
1,160,254
|
|
Accrued expenses
|
|
|
1,427,628
|
|
Due to related parties
|
|
|
63,672
|
|
Unearned commission advances
|
|
|
5,155,117
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
7,806,671
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
Preferred stock ($.001 par value; 10,000,000 shares authorized;
no shares issued and outstanding)
|
|
|
|
|
Common stock ($.001 par value; 90,000,000 shares authorized;
28,586,471 shares issued and outstanding
|
|
|
28,586
|
|
Additional paid-in capital
|
|
|
24,479,129
|
|
Accumulated deficit
|
|
|
(18,266,258
|
)
|
Deferred compensation
|
|
|
(1,810,676
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
4,430,781
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
12,237,452
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-3
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
12,240,101
|
|
|
$
|
2,660,491
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
Salaries, commission and related taxes
|
|
|
13,754,445
|
|
|
|
2,967,924
|
|
Lead, advertising and other marketing
|
|
|
5,174,260
|
|
|
|
901,036
|
|
Depreciation and amortization
|
|
|
2,146,703
|
|
|
|
102,350
|
|
Rent, utilities, telephone and communications
|
|
|
1,970,275
|
|
|
|
468,816
|
|
Professional fees
|
|
|
1,211,605
|
|
|
|
220,883
|
|
Management salaries related parties
|
|
|
|
|
|
|
487,800
|
|
Other general and administrative
|
|
|
2,294,188
|
|
|
|
579,959
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,551,476
|
|
|
|
5,728,768
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(14,311,375
|
)
|
|
|
(3,068,277
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
(339
|
)
|
|
|
(16,420
|
)
|
Registration rights penalty reversal
|
|
|
60,537
|
|
|
|
(60,537
|
)
|
Interest income
|
|
|
303,357
|
|
|
|
2,962
|
|
Interest expense
|
|
|
(20,004
|
)
|
|
|
(28,305
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expense)
|
|
|
343,551
|
|
|
|
(102,300
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(13,967,824
|
)
|
|
$
|
(3,170,577
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share:
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.51
|
)
|
|
$
|
(0.36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
basic and diluted
|
|
|
27,578,861
|
|
|
|
8,832,446
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-4
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2005 AND DECEMBER 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, $ .001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value
|
|
Additional
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
Number of
|
|
|
|
|
|
Paid-in
|
|
Accumulated
|
|
Deferred
|
|
Shareholders'
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Deficit
|
|
Compensation
|
|
Equity
|
|
Balance December 31, 2004
|
|
$
|
7,800,000
|
|
|
$
|
7,800
|
|
|
$
|
480,200
|
|
|
$
|
(1,127,857
|
)
|
|
|
|
|
|
$
|
(639,857
|
)
|
Recapitalization of Company
|
|
|
2,791,471
|
|
|
|
2,791
|
|
|
|
(2,791
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Contributions from prior member of LLC
|
|
|
|
|
|
|
|
|
|
|
206,999
|
|
|
|
|
|
|
|
|
|
|
|
206,999
|
|
Common stock issued for accrued management
salaries and related party debt
|
|
|
812,200
|
|
|
|
812
|
|
|
|
811,388
|
|
|
|
|
|
|
|
|
|
|
|
812,200
|
|
Common stock issued for accrued management
salaries
|
|
|
487,800
|
|
|
|
488
|
|
|
|
487,312
|
|
|
|
|
|
|
|
|
|
|
|
487,800
|
|
Common stock issued under consulting
agreement
|
|
|
100,000
|
|
|
|
100
|
|
|
|
99,900
|
|
|
|
|
|
|
|
(100,000
|
)
|
|
|
|
|
Common stock issued in private placement
|
|
|
8,250,000
|
|
|
|
8,250
|
|
|
|
7,232,252
|
|
|
|
|
|
|
|
|
|
|
|
7,240,502
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,333
|
|
|
|
8,333
|
|
Net loss for the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,170,577
|
)
|
|
|
|
|
|
|
(3,170,577
|
)
|
|
|
|
Balance December 31, 2005
|
|
|
20,241,471
|
|
|
$
|
20,241
|
|
|
$
|
9,315,260
|
|
|
$
|
(4,298,434
|
)
|
|
$
|
(91,667
|
)
|
|
$
|
4,945,400
|
|
|
|
|
Common stock issued in private placement
|
|
|
6,450,000
|
|
|
|
6,450
|
|
|
|
6,157,724
|
|
|
|
|
|
|
|
|
|
|
|
6,164,174
|
|
Common stock issued in ISG acquisition
|
|
|
1,000,000
|
|
|
|
1,000
|
|
|
|
3,733,993
|
|
|
|
|
|
|
|
|
|
|
|
3,734,993
|
|
Common stock issued in Healthplan Choice
asset purchase
|
|
|
80,000
|
|
|
|
80
|
|
|
|
270,160
|
|
|
|
|
|
|
|
|
|
|
|
270,240
|
|
Common stock issued under Real IT Group
consulting agreement
|
|
|
15,000
|
|
|
|
15
|
|
|
|
35,085
|
|
|
|
|
|
|
|
|
|
|
|
35,100
|
|
Common stock issued under Internet domain
name purchase and assignment agreement
|
|
|
50,000
|
|
|
|
50
|
|
|
|
111,150
|
|
|
|
|
|
|
|
|
|
|
|
111,200
|
|
Common stock issued upon exercise of options
|
|
|
300,000
|
|
|
|
300
|
|
|
|
299,700
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
Common stock issued upon exercise of warrants
|
|
|
450,000
|
|
|
|
450
|
|
|
|
674,550
|
|
|
|
|
|
|
|
|
|
|
|
675,000
|
|
Issuance of stock options
|
|
|
|
|
|
|
|
|
|
|
3,881,507
|
|
|
|
|
|
|
|
(3,231,711
|
)
|
|
|
649,796
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,512,702
|
|
|
|
1,512,702
|
|
Net loss for the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13,967,824
|
)
|
|
|
|
|
|
|
(13,967,824
|
)
|
|
|
|
Balance December 31, 2006
|
|
|
28,586,471
|
|
|
$
|
28,586
|
|
|
$
|
24,479,129
|
|
|
|
($18,266,258
|
)
|
|
|
($1,810,676
|
)
|
|
$
|
4,430,781
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-5
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(13,967,824
|
)
|
|
$
|
(3,170,577
|
)
|
Adjustments to reconcile net loss to net cash used in
operating activities:
|
|
|
|
|
|
|
|
|
operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
2,147,041
|
|
|
|
102,350
|
|
Stock-based compensation and consulting
|
|
|
2,162,498
|
|
|
|
496,133
|
|
Provision for bad debt
|
|
|
49,029
|
|
|
|
16,215
|
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(2,052,291
|
)
|
|
|
(176,920
|
)
|
Deferred compensation advances
|
|
|
(511,302
|
)
|
|
|
|
|
Prepaid expenses
|
|
|
(87,520
|
)
|
|
|
(173,696
|
)
|
Other current assets
|
|
|
(11,011
|
)
|
|
|
|
|
Other assets
|
|
|
(159,241
|
)
|
|
|
6
|
|
Accounts payable
|
|
|
778,942
|
|
|
|
368,436
|
|
Accrued expenses
|
|
|
1,015,564
|
|
|
|
326,283
|
|
Due to related parties
|
|
|
(144,082
|
)
|
|
|
169,534
|
|
Unearned commission advances
|
|
|
4,268,178
|
|
|
|
886,939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(6,512,019
|
)
|
|
|
(1,155,297
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(1,595,176
|
)
|
|
|
(184,669
|
)
|
Purchase of intangible assets and capitalization of software development
|
|
|
(1,603,994
|
)
|
|
|
(149,456
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(3,199,170
|
)
|
|
|
(334,125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
|
Gross proceeds from sales of common stock
|
|
|
6,450,000
|
|
|
|
8,250,000
|
|
Gross proceeds from exercise of warrants
|
|
|
675,000
|
|
|
|
|
|
Gross proceeds from exercise of stock options
|
|
|
300,000
|
|
|
|
|
|
Restricted cash in connection with letters of credit
|
|
|
(1,150,000
|
)
|
|
|
|
|
Placement and other fees paid in connection with offering
|
|
|
(285,826
|
)
|
|
|
(1,009,498
|
)
|
Proceeds from line of credit
|
|
|
|
|
|
|
199,630
|
|
Payment on notes payable related party
|
|
|
|
|
|
|
(25,000
|
)
|
Contributions from members
|
|
|
|
|
|
|
206,999
|
|
Repayment of related party advances
|
|
|
|
|
|
|
(286,200
|
)
|
Payment of line of credit
|
|
|
(399,630
|
)
|
|
|
|
|
Proceeds from related party advances
|
|
|
|
|
|
|
573,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
5,589,544
|
|
|
|
7,909,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease)/increase in cash
|
|
|
(4,121,645
|
)
|
|
|
6,419,909
|
|
|
|
|
|
|
|
|
|
|
Cash beginning of year
|
|
|
6,433,426
|
|
|
|
13,517
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash end of year
|
|
$
|
2,311,781
|
|
|
$
|
6,433,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information
|
|
|
|
|
|
|
|
|
Cash payments for interest
|
|
$
|
15,044
|
|
|
$
|
9,453
|
|
|
|
|
|
|
|
|
Cash payments for income taxes
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non cash investing and financing activities:
|
|
|
|
|
|
|
|
|
Common stock issued for accrued management fees and related party debt
|
|
$
|
|
|
|
$
|
812,200
|
|
|
|
|
|
|
|
|
Common stock issued for future services
|
|
$
|
35,100
|
|
|
$
|
91,667
|
|
|
|
|
|
|
|
|
Common stock and options issued for the purchase of ISG
|
|
$
|
3,736,187
|
|
|
$
|
|
|
|
|
|
|
|
|
|
Common stock issued for HealthPlan Choice asset purchase
|
|
$
|
270,240
|
|
|
$
|
|
|
|
|
|
|
|
|
|
Common stock issued for the purchase of domain name
|
|
$
|
111,200
|
|
|
$
|
|
|
|
|
|
|
|
|
|
See accompanying notes to consolidated financial statements.
F-6
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization
The Company was incorporated under the laws of the state of Nevada on October 21, 2004 as Darwin
Resources Corp., an exploration stage company engaged in mineral exploration (Darwin-NV). On
November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary, Darwin
Resources Corp., a Delaware corporation (Darwin-DE), solely for the purpose of changing the
Companys state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation (HBDC), and the name of the resulting entity
was changed from Health Benefits Direct Corporation to HBDC II, Inc. Following the merger,
Darwin-DE changed its name to Health Benefits Direct Corporation.
Concurrently with the closing of the merger, the Company completed a private placement of 40 units,
each unit consisting of 50,000 shares of the Companys common stock and a detachable, transferable
warrant to purchase 25,000 shares of the Companys common stock, which yielded gross proceeds of
$2,000,000 in 2005. In 2006 the Company completed the private placement of 129 additional units
for aggregate gross proceeds of an additional $6,450,000.
HBDC was formed in January 2004 for the purpose of acquiring, owning and operating businesses
engaged in direct marketing and distribution of health and life insurance products, primarily
utilizing the Internet. On September 9, 2005, HBDC acquired three affiliated Internet health
insurance marketing companies, namely Platinum Partners, LLC, a Florida limited liability company,
Health Benefits Direct II, LLC, a Florida limited liability company, and Health Benefits Direct
III, LLC, a Florida limited liability company. HBDC issued 7,500,000 shares of its common stock and
a warrant to purchase 50,000 shares of its common stock, in the aggregate, in exchange for 100% of
the limited liability company interests of these companies.
The acquisition of HBDC by the Company was accounted for as a reverse merger because, on a
post-merger basis, the former HBDC shareholders held a majority of the outstanding common stock of
the Company on a voting and fully diluted basis. As a result, HBDC was deemed to be the acquirer
for accounting purposes. Accordingly, the consolidated financial statements presented for the
period ended December 31, 2005, are those of HBDC for all periods prior to the acquisition, and the
financial statements of the consolidated companies from the acquisition date forward. The
historical shareholders deficit of HBDC prior to the acquisition has been retroactively restated
(a recapitalization) for the equivalent number of shares received in the acquisition after giving
effect to any differences in the par value of the Company and HBDCs common stock, with an offset
to additional paid-in capital. The restated consolidated retained earnings of the accounting
acquirer, HBDC, are carried forward after the acquisition.
The Company specializes in the direct marketing of health and life insurance and related products
to individuals, families and groups. The Company has developed proprietary technologies and
processes to connect prospective insurance customers with the Companys agents and service
personnel using an integrated on-line platform with call center follow up. The Company employs
licensed agents supported by verification, customer service and technology employees for the
purpose of providing immediate information to prospective customers and to sell insurance products.
The Company receives commissions and other fees from insurance carriers for the sale of insurance
products.
Basis of presentation
The consolidated financial statements are prepared in accordance with generally accepted accounting
principles in the United States of America (US GAAP). The consolidated financial statements of
the Company include the Company and its subsidiaries. All material inter-company balances and
transactions have been eliminated.
For purposes of comparability, certain prior period amounts have been reclassified to conform to
the 2006 presentation.
F-7
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to make
estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual
results could differ from those estimates. Significant estimates in 2006 and 2005 include the
allowance for doubtful accounts, stock-based compensation, the useful lives of property and
equipment and intangible assets and deferred compensation advances to employees.
Restricted cash
The Company considers all cash and cash equivalents held in restricted accounts pertaining to the
Companys letters of credit as restricted cash.
Accounts receivable
The Company has a policy of establishing an allowance for uncollectible accounts based on its best
estimate of the amount of probable credit losses in its existing accounts receivable. The Company
periodically reviews its accounts receivable to determine whether an allowance is necessary based
on an analysis of past due accounts and other factors that may indicate that the realization of an
account may be in doubt. Account balances deemed to be uncollectible are charged to the allowance
after all means of collection have been exhausted and the potential for recovery is considered
remote. At December 31, 2006, the Company has established, based on a review of its outstanding
balances, an allowance for doubtful accounts in the amount of $26,436.
Accounts receivable from the Companys four largest insurance carriers accounted for 63%, 18%, 5%
and 3% of the Companys accounts receivable balance at December 31, 2006. These balances were
collected subsequent to December 31, 2006.
Property and equipment
Property and equipment are carried at cost. The cost of repairs and maintenance is expensed as
incurred; major replacements and improvements are capitalized. When assets are retired or disposed
of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or
losses are included in income in the year of disposition. In accordance with Statement of
Financial Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets, the Company examines the possibility of decreases in the value of fixed assets
when events or changes in circumstances reflect the fact that their recorded value may not be
recoverable.
Intangible assets
Intangible assets consist of assets acquired in connection with the acquisition of ISG, costs
incurred in connection with the development of the Companys software and website costs and assets
acquired in connection with the HealthPlan Choice asset purchase agreement. See Note 2 ISG
Acquisition, Note 3 HealthPlan Choice Asset Purchase and Note 8 Intangible Assets. The
Company capitalized certain costs valued in connection with developing or obtaining internal use
software in accordance with American Institute of Certified Public Accountants Statement of
Position 98-1, Accounting for the Costs of Computer Software Developed or Obtained for Internal
Use. These costs, which consist of direct technology labor costs, are capitalized and amortized
using the straight-line method over expected useful lives. Costs that the Company has incurred in
connection with developing the Companys websites and purchasing domain names are capitalized and
amortized using the straight-line method over an expected useful life.
F-8
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Under the criteria set forth in SOP 98-1, Accounting for the Costs of Computer Software Developed
or Obtained for Internal Use capitalization of software development costs begins upon the
establishment of technological feasibility of the software. The establishment of technological
feasibility and the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but not limited to,
anticipated future gross product revenues, estimated economic life, and changes in software and
hardware technology. Capitalized software development costs are amortized utilizing the
straight-line method over the estimated economic life of the software not to exceed three years. We
regularly review the carrying value of software development assets and a loss is recognized when
the unamortized costs are deemed unrecoverable based on the estimated cash flows to be generated
from the applicable software.
Impairment of long-lived assets
In accordance with Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company periodically reviews its long-lived
assets for impairment whenever events or changes in circumstances indicate that the carrying amount
of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum
of expected undiscounted future cash flows is less than the carrying amount of the asset. The
amount of impairment is measured as the difference between the assets estimated fair value and its
book value.
As of September 30, 2006, the Company determined that intangible assets pertaining to the Companys
website, which was replaced during the fourth quarter of 2006, certain carrier integration costs,
which are not expected to be recoverable based on the future revenues, and lead system development,
which is no longer expected to be implemented, was impaired and the Company recorded $54,294 in
depreciation and amortization expense in the third quarter of 2006.
As of December 31, 2006, the Company determined that all furniture, equipment and intangible assets
acquired as a result of the Healthplan Choice Asset Purchase were impaired as a result of the
closure of the Companys Atlanta office in the fourth quarter of 2006 and the Companys decision to
concentrate its marketing on its
www.healthbenefitsdirect.com
web site and domain name acquired in
the third quarter of 2006. The Company recorded $66,175 in depreciation and amortization expense
in the fourth quarter of 2006 to write-off the value of these assets.
Income taxes
Through September 6, 2005, the Company was organized as a combination of limited liability
companies LLCs. In lieu of corporation income taxes, the members of the LLCs were eligible for
their proportional share of the
Companys net losses. Therefore, no provision or liability for Federal income taxes had been
included in the financial statements as of December 31, 2004.
The Company was taxed as a combination of LLCs until September 6, 2005, when the Company changed
its form of ownership to a C corporation. As a result of the change of ownership, the Company
accounts for income taxes under the liability method in accordance with Statement of Financial
Accounting Standards No. 109, Accounting for Income Taxes under this method, deferred income tax
assets and liabilities are determined based on differences between the financial reporting and tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be
in effect when the differences are expected to reverse.
Had income taxes been determined based on an effective tax rate of 38% consistent with the method
of SFAS 109, the Companys net losses for all periods presented would not have changed.
F-9
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Loss per common share
In accordance with SFAS No. 128 Earnings Per Share, basic earnings per share is computed by
dividing net income by the weighted average number of shares of common stock outstanding during the
period. Diluted earnings per share is computed by dividing net income by the weighted average
number of shares of common stock, common stock equivalents and potentially dilutive securities
outstanding during each period. Diluted loss per common share is not presented because it is
anti-dilutive. The Companys common stock equivalents at December 31, 2006 include the following:
|
|
|
|
|
Options
|
|
|
4,881,268
|
|
Warrants
|
|
|
8,200,000
|
|
|
|
|
|
|
|
|
13,081,268
|
|
|
|
|
|
Revenue recognition
The Company follows the guidance of the Commissions Staff Accounting Bulletin 104 for revenue
recognition. In general, the Company records revenue when persuasive evidence of an arrangement
exists, services have been rendered or product delivery has occurred, the sales price to the
customer is fixed or determinable, and collectibility is reasonably assured.
The Company generates revenue primarily from the receipt of commissions paid to the Company by
insurance companies based upon the insurance policies sold to consumers by the Company. These
revenues are in the form of first year, bonus and renewal commissions that vary by company and
product. We recognize commission revenue from the sale of primarily health insurance, after we
receive notice that the insurance company has received payment of the related premium. First year
commission revenues per policy can fluctuate due to changing premiums, commission rates, and types
or amount of insurance sold. Insurance premium commission revenues are recognized pro-rata over
the terms of the policies. Revenues for renewal commissions are recognized after we receive notice
that the insurance company has received payment for a renewal premium. Renewal commission rates are
significantly less than first year commission rates and may not be offered by every insurance
company or with respect to certain types of products. The unearned portion of premium commissions
has been included in the consolidated balance sheet as a liability for unearned commission
advances.
The length of time varies between when the Company submits a consumers application for insurance
to an insurance company and when the Company recognizes revenue. The type of insurance product and
the insurance companys backlog are the primary factors that impact the length of time between
submitted applications and revenue recognition. Any changes in the amount of time between submitted
application and revenue recognition, which will be influenced by many factors not under our
control, will create fluctuations in our operating results and could affect our business, operating
results and financial condition.
The Company receives bonuses based upon individual criteria set by insurance companies. We
recognize bonus revenues when we receive notification from the insurance company of the bonus due
to us. Bonus revenues have been higher in the fourth quarter of our fiscal year due to the bonus
system used by many health insurance companies, which pay greater amounts based upon the
achievement of certain levels of annual production.
The Company receives fees for the placement and issuance of insurance policies that are in addition
to, and separate from, any sales commissions paid by insurance companies. As these policy fees are
not refundable and the Company has no continuing obligation, all such revenues are recognized on
the effective date of the policies or, in certain cases, the billing date, whichever is later.
F-10
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The Company also generates revenue from the sale of leads to third parties. Such revenues are
recognized when we deliver the leads and bill the purchaser of the leads.
Deferred compensation advances
The Company has advanced commissions to employees, which are accounted for as deferred compensation
advances. In the event that the Company does not ultimately receive its revenue pertaining to the
underlying product sales for which the Company has advanced commissions to employees, the Company
deducts such advanced commissions from the employees current or future commissions. Deferred
compensation advances are charged to expense when earned by the employee, which approximates the
Companys recognition of earned revenue for the underlying product sales. The recoverability of
deferred compensation advances is periodically reviewed by management and is net of managements
estimate for uncollectability. Management believes deferred compensation advances as reported are
fully realizable.
Lead, advertising and other marketing expense
Lead expenses are costs incurred in acquiring potential client data. Advertising expense pertains
to direct response advertising. Other marketing consists of professional marketing services.
Lead, advertising and other marketing are expensed as incurred.
Concentrations of credit risk
The Company maintains its cash and restricted cash in bank deposit accounts, which, at times,
exceed the federally insured limits of $100,000 per account. At December 31, 2006, the Company had
approximately $3,200,000 in United States bank deposits, which exceeded federally insured limits.
The Company has not experienced any losses in such accounts through December 31, 2006.
Additionally, for the year ended December 31, 2006, approximately 33%, 31%, 9% and 8% of the
Companys revenue was earned from the Companys four largest insurance carriers. Management
believes that comparable carriers and products are available should the need arise. However, the
termination of the Companys agreement with these carriers could result in the loss or reduction of
future sales, and, in certain cases, future commissions for pre-termination sales.
Stock-based compensation
Effective January 1, 2006, the Company adopted the provisions of SFAS No. 123(R), Share-Based
Payment, under the modified prospective method. SFAS No. 123(R) eliminates accounting for
share-based compensation transactions using the intrinsic value method prescribed under APB Opinion
No. 25, Accounting for Stock Issued to Employees, and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective method, the Company
is required to recognize compensation cost for share-based payments to employees based on their
grant-date fair value from the beginning of the fiscal period in which the recognition provisions
are first applied. For periods prior to adoption, the financial statements are unchanged, and the
pro forma disclosures previously required by SFAS No. 123, as amended by SFAS No. 148, will
continue to be required under SFAS No. 123(R) to the extent those amounts differ from those in the
Statement of Operations.
F-11
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Through December 31, 2005, the Company accounts for stock options issued to employees in accordance
with the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock
Issued to Employees, and related interpretations. As such, compensation cost is measured on the
date of grant as the excess of the current market price of the underlying stock over the exercise
price. Such compensation amounts are amortized over the respective vesting periods of the option
grant. The Company adopted the disclosure provisions of SFAS No. 123, Accounting for Stock-Based
Compensation and SFAS 148, Accounting for Stock-Based Compensation -Transition and Disclosure,
which permits entities to provide pro forma net income (loss) and pro forma earnings (loss) per
share disclosures for employee stock option grants as if the fair-valued based method defined in
SFAS No. 123 had been applied. The Company accounts for stock options and stock issued to
non-employees for goods or services in accordance with the fair value method of SFAS 123.
Had compensation cost for the stock option plan been determined based on the fair value of the
options at the grant dates consistent with the method of SFAS 123(R), Accounting for Stock Based
Compensation, the Companys net loss and loss per share would have been changed to the pro forma
amounts indicated below for the year ended December 31, 2005:
|
|
|
|
|
Net loss, as reported
|
|
$
|
(3,170,577
|
)
|
Less: stock-based employee compensation expense
determined under fair value based method, net of related
tax effect
|
|
|
(6,941
|
)
|
|
|
|
|
Pro forma net loss
|
|
$
|
(3,177,518
|
)
|
|
|
|
|
Basic and diluted net loss per common share:
|
|
|
|
|
As reported
|
|
$
|
(0.36
|
)
|
|
|
|
|
Pro forma
|
|
$
|
(0.36
|
)
|
|
|
|
|
Non-employee stock based compensation
The cost of stock based compensation awards issued to non-employees for services are recorded at
either the fair value of the services rendered or the instruments issued in exchange for such
services, whichever is more readily determinable, using the measurement date guidelines enumerated
in Emerging Issues Task Force Issue (EITF) 96-18, Accounting for Equity Instruments That Are
Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services
(EITF 96-18).
F-12
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Registration rights agreements
The Company has adopted View C of EITF 05-4 Effect of a Liquidated Damages Clause on a
Freestanding Financial Instrument Subject to EITF 00-19 (EITF 05-4). Accordingly, the Company
classifies as liability instruments, the fair value of registration rights agreements when such
agreements (i) require it to file, and cause to be declared effective under the Securities Act, a
registration statement with the SEC within contractually fixed time periods, and (ii) provide for
the payment of liquidating damages in the event of its failure to comply with such agreements.
Under View C of EITF 05-4, (i) registration rights with these characteristics are accounted for as
derivative financial instruments at fair value and (ii) contracts that are (a) indexed to and
potentially settled in an issuers own stock and (b) permit gross physical or net share settlement
with no net cash settlement alternative are classified as equity instruments. At December 31, 2005,
the Company recorded a registration rights penalty expense of $60,537, which had been included in
accrued expenses as of December 31, 2005, and was reversed in the first quarter of 2006 concurrent
with the belief that the registration of the shares, including the private placement shares, would
be effective before the date after which a penalty would be incurred. On July 7, 2006, the
Securities and Exchange Commission (the Commission) declared effective the Companys Registration
Statement on Form SB-2 filed with the Commission on April 10, 2006 as amended.
Recent accounting pronouncements
In February 2006, the Financial Accounting Standards Board issued Statement No. 155 (SFAS No.
155), Accounting for Certain Hybrid Instruments: An Amendment of FASB Statements No. 133 and
140. Management does not believe that this statement will have a significant impact, as the
Company does not use such instruments.
In December 2006, the FASB issued the FASB Staff Position (FSP) No. EITF 00-19-2, (FSP EITF
00-19-2), Accounting for Registration Payment Arrangements. This FSP addresses an issuers
accounting for registration payment arrangements. This FSP specifies that the contingent obligation
to make future payments or otherwise transfer consideration under a registration payment
arrangement, whether issued as a separate agreement or included as a provision of a financial
instrument or other agreement, should be separately recognized and measured in accordance with FASB
Statement No. 5, Accounting for Contingencies. The guidance in this FSP amends FASB Statements No.
133, Accounting for Derivative Instruments and Hedging Activities, and No. 150, Accounting for
Certain Financial Instruments with Characteristics of both Liabilities and Equity, and FASB
Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others, to include scope exceptions for registration payment
arrangements. This FSP further clarifies that a financial instrument subject to a registration
payment arrangement should be accounted for in accordance with other applicable generally accepted
accounting principles (GAAP) without regard to the contingent obligation to transfer consideration
pursuant to the registration payment arrangement. This FSP shall be effective immediately for
registration payment arrangements and the financial instruments subject to those arrangements that
are entered into or modified subsequent to the date of issuance of this FSP, or for financial
statements issued for fiscal years beginning after December 15, 2006, and interim periods within
those fiscal years. The Company intends to adopt FSP EITF 00-19-2 beginning in 2007. The adoption
of this FSP will not have a material effect upon the Companys financial statements.
In July 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in
Income Taxes an interpretation of FASB Statement No. 109 (FIN 48), which prescribes a
recognition threshold and measurement attribute for a tax position taken or expected to be taken
in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal
years beginning after December 15, 2006. The Company believes that the adoption of FIN 48 will not
have a material effect on its financial statements.
F-13
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In March 2006, the FASB issued FASB Statement No. 156, which amends FASB Statement No. 140. This
Statement establishes, among other things, the accounting for all separately recognized servicing
assets and servicing liabilities. This Statement amends Statement 140 to require that all
separately recognized servicing assets and servicing liabilities be initially measured at fair
value, if practicable. This Statement permits, but does not require, the subsequent measurement of
separately recognized servicing assets and servicing liabilities at fair value. An entity that uses
derivative instruments to mitigate the risks inherent in servicing assets and servicing liabilities
is required to account for those derivative instruments at fair value. Under this Statement, an
entity can elect subsequent fair value measurement to account for its separately recognized
servicing assets and servicing liabilities. By electing that option, an entity may simplify its
accounting because this Statement permits income statement recognition of the potential offsetting
changes in fair value of those servicing assets and servicing liabilities and derivative
instruments in the same accounting period. This Statement is effective for financial statements for
fiscal years beginning after September 15, 2006. Earlier adoption of this Statement is permitted as
of the beginning of an entitys fiscal year, provided the entity has not yet issued any financial
statements for that fiscal year. Management believes that this Statement will have no impact on the
financial statements of the Company once adopted.
In September 2005, the FASB issued FASB Statement No. 157. This Statement defines fair value,
establishes a framework for measuring fair value in generally accepted accounting principles
(GAAP), and expands disclosures about fair value measurements. This Statement applies under other
accounting pronouncements that require or permit fair value measurements, the Board having
previously concluded in those accounting pronouncements that fair value is a relevant measurement
attribute. Accordingly, this Statement does not require any new fair value measurements. However,
for some entities, the application of this Statement will change current practices. This Statement
is effective for financial statements for fiscal years beginning after November 15, 2007. Earlier
application is permitted provided that the reporting entity has not yet issued financial statements
for that fiscal year. Management believes this Statement will have no impact on the financial
statements of the Company once adopted.
Other accounting standards that have been issued or proposed by the FASB or other standards-setting
bodies that do not require adoption until a future date are not expected to have a material impact
on the consolidated financial statements upon adoption.
NOTE 2
ISG ACQUISITION
On April 3, 2006, the Company entered into a merger agreement (the Merger Agreement) with ISG
Merger Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company
(Merger Sub), Insurance Specialist Group Inc., a Florida corporation (ISG), and Ivan M. Spinner
pursuant to which, among other things, Merger Sub merged with and into ISG (the Merger). As
consideration for the Merger, the Company made a cash payment of $920,000 and issued 1,000,000
shares of its common stock to Mr. Spinner, the sole stockholder of ISG, in exchange for all of the
outstanding stock of ISG. The merger was completed on April 4, 2006.
F-14
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 2
ISG ACQUISITION (continued)
On April 3, 2006, in connection with the Merger, HBDC II, Inc., a wholly-owned subsidiary of the
Company, entered into a two-year employment agreement with Mr. Spinner, which provides that Mr.
Spinner will be compensated at an annual base salary of $371,000 with bonus compensation at the
discretion of the Companys board of directors. The agreement may be terminated by the Company for
cause (as such term is defined in the agreement) and without cause upon 30 days notice. If Mr.
Spinner is terminated by the Company for cause or due to death or disability, or if Mr. Spinner
elects to terminate his employment at any time, he will be entitled to the amount, on a pro rata
basis, in excess of $250,000 per year for the balance of the term. If Mr. Spinner is terminated
without cause, he will be entitled to his base salary for the remainder of the term. Under the
agreement Mr. Spinner also would receive an initial sign-on bonus of $150,000, and an option to
purchase an aggregate of 150,000 shares of common stock at an exercise price of $3.50 per share, of
which 25% of the shares subject to the option will vest on April 3, 2007 and the remainder of which
will vest in equal monthly installments for 36 months thereafter.
On October 6, 2006, the Company and Mr. Spinner entered into a working capital settlement and
release agreement whereby the Company agreed to pay Mr. Spinner $65,000 as settlement of the
working capital provision of the Merger Agreement.
The Company accounted for the acquisition of ISG using the purchase method of accounting in
accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. The
results of ISGs operations have been included in the Companys statement of operations as of April
4, 2006. ISGs operations for the period April 1 through April 4, 2006 are considered immaterial.
The Companys purchase price for ISG in the aggregate was $5,154,329 and consisted of the
following:
|
|
|
|
|
Cash payment to seller
|
|
$
|
1,135,000
|
|
Fair value of common stock issued to seller
|
|
|
3,310,806
|
|
Discounted value of future fixed payments of employment agreement
|
|
|
225,212
|
|
Fair value of stock option issued to seller
|
|
|
425,381
|
|
Estimated direct transaction fees and expenses
|
|
|
57,930
|
|
|
|
|
|
|
Estimatedpurchase price
|
|
$
|
5,154,329
|
|
|
|
|
|
F-15
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 2
ISG ACQUISITION (continued)
The following table summarizes the preliminary estimated fair values of ISGs assets acquired and
liabilities assumed at the date of acquisition.
|
|
|
|
|
Cash
|
|
$
|
111,024
|
|
Accounts receivable
|
|
|
210,889
|
|
Deferred compensation advances
|
|
|
256,775
|
|
Prepaid expenses and other assets
|
|
|
957
|
|
Property and equipment, net
|
|
|
600
|
|
Intangible assets
|
|
|
4,964,330
|
|
Accrued expenses
|
|
|
(164,549
|
)
|
Unearned commission advances
|
|
|
(225,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,154,329
|
|
|
|
|
|
Intangible assets acquired from ISG were assigned the following values: value of purchased
commission override revenue with an assigned value of $1,411,594 amortized over five years in
proportion to expected future value; value of acquired carrier contracts and agent relationships
with an assigned value of $2,752,143 amortized straight line over the expected useful life of 5
years; and value of an employment and non-compete agreement acquired with an assigned value of
$800,593 amortized straight line over the contractual period, which is a weighted average expected
useful life of 3.1 years.
The following table summarizes the required disclosures of the pro forma combined entity, as if the
acquisition of ISG occurred at January 1, 2005.
|
|
|
|
|
|
|
|
|
|
|
For the Year
|
|
|
Ended December 31,
|
|
|
2006
|
|
2005
|
|
|
|
|
|
|
|
|
|
Revenues, net
|
|
$
|
12,674,814
|
|
|
$
|
4,058,276
|
|
Net loss
|
|
|
(14,145,739
|
)
|
|
|
(4,245,139
|
)
|
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.51
|
)
|
|
$
|
(0.43
|
)
|
The above unaudited pro forma results have been prepared for comparative purposes only and do not
purport to be indicative of the results of operations that actually would have resulted had the
acquisition occurred at January 1, 2005, nor is it necessarily indicative of future operating
results.
NOTE 3
HEALTHPLAN CHOICE ASSET PURCHASE
On April 10, 2006, the Company, through its wholly-owned subsidiary HBDC II, Inc. entered into an
asset purchase agreement with Healthplan Choice, Inc. (HealthPlan Choice) and Horace Richard
Priester III, pursuant to which, among other things, HBDC II, Inc. acquired all of the operating
assets of Healthplan Choice. As consideration for the asset purchase, the Company made a cash
payment of $100,000 and issued 80,000 shares of the Companys common stock to Mr. Priester. The
fair value of the Companys purchase price was estimated to be $370,240.
F-16
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 3
HEALTHPLAN CHOICE ASSET PURCHASE (continued)
Also on April 10, 2006, in connection with the acquisition of HealthPlan Choice, HBDC II, Inc.
entered into a two-year employment agreement with Mr. Priester (Employment Agreement), which
provides that Mr. Priester will be compensated at an annual base salary of $80,000 with bonus
compensation of 10% of the net profits of the Companys Atlanta office, as determined in good faith
by the Companys board of directors. The agreement specified that Mr. Priester would also receive
an option to purchase an aggregate of 50,000 shares of common stock at an exercise price of $3.10
per share, of which 25% of the shares subject to the option would vest on April 3, 2007 and the
remainder of which would vest in equal monthly installments for 36 months thereafter. Mr. Priester
resigned effective July 7, 2006. The $127,070 fair value of Mr. Priesters stock option was
expensed in the second quarter of 2006.
Also on April 10, 2006 in connection with the acquisition of HealthPlan Choice, HBDC II, Inc.
acquired an equitable interest in a sublease agreement between HealthPlan Choice, an unrelated
third party and the landlord of HealthPlan Choices Atlanta office (the Sublease). The Sublease
pertains to the lease of approximately 3,036 square feet of commercial office space in suites 2205
and 2206 of 245 Peachtree Center Avenue, NE Atlanta Georgia at a monthly sublease cost of $2,783.
The Sublease expired on December 31, 2006.
The Company accounted for the acquisition of HealthPlan Choice in accordance with Statement of
Financial Accounting Standards No. 142 Goodwill and Other Intangible Assets. Managements
estimates of the fair value of assets acquired, their useful life and amortization method were as
follows: $26,982 of property and equipment depreciated straight line over a weighted average of 19
months; $157,344 value of acquired employees, which was fully amortized in the second quarter of
2006; $11,132 value of the bargain sublease amortized straight line over the balance of the
Sublease; and $72,167 value of the 1-800-healthplan telephone number, www.1800healthplan.com,
www.1800healthplan.net, www.1-800-healthplan.com and www.1-800-healthplan.net domain names
amortized straight line over 36 months.
The Company also recorded $102,615 of other general administrative expense in the second quarter of
2006, which represent the cost of integrating HealthPlan Choices office as a satellite sales
office of the Company.
As of December 31, 2006, the Company determined that all assets acquired as a result of the
Healthplan Choice Asset Purchase were impaired as a result of the closure of the Companys Atlanta
office in the fourth quarter of 2006 and the Companys decision to concentrate its marketing on its www.healthbenefitsdirect.com
web site and domain name acquired in the third quarter of 2006. The Company recorded $66,145 in
depreciation and amortization expense in the fourth quarter of 2006.
NOTE 4 CONSULTING AGREEMENT WITH REAL IT GROUP LLC
On July 20, 2006, the Company entered into a consulting agreement with Real IT Group LLC (Real
IT) effective August 1, 2006 through July 17, 2007 whereby Real IT will provide software design,
development and implementation expertise to the Company for, among other things, assistance in the
Companys implementation of the STP software. The consulting agreement may be terminated by either
party with 30 days written prior notice and under certain specified conditions. The consulting
agreement provides that the Company will own the rights to all intellectual property developed as a
result of this consulting agreement.
F-17
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 4 CONSULTING AGREEMENT WITH REAL IT GROUP LLC (continued)
As consideration for the Consulting Agreement, the Company will pay Real IT $150,000 over the life
of the agreement in monthly installments and issued 15,000 shares of our common stock to Real ITs
sole stockholder and employee pursuant to the Companys 2006 Omnibus Equity Compensation Plan plus
the Company will pay Real ITs reasonable and customary out of pocket expenses. The 15,000 common
shares vest as follows: 2,000 common shares vest immediately, 1,000 common shares will vest in
equal monthly installments beginning on the first calendar month following the issuance of the
15,000 common shares; and the remaining 4,000 common shares will vest on the earlier of the
termination or expiration of the consulting agreement. The fair value of the Companys
consideration paid was estimated to be $185,100 and accounted for as either professional fee
expense as incurred or capitalized internally developed software in accordance with American
Institute of Certified Public Accountants Statement of Position 98-1, Accounting for the Costs of
Computer Software Developed or Obtained for Internal Use, depending upon the nature of the
consulting services provided. Capitalized costs will be amortized using the straight-line method
over expected useful lives of software developed.
Concurrent with the execution of the consulting agreement, the Company and Real ITs sole
stockholder and employee entered into a Registration Rights Agreement that provides for piggyback
registration rights for the 15,000 shares of our common stock issuable to Real ITs sole
stockholder and employee. Also concurrent with the execution of the consulting agreement, the
Company and Real ITs sole stockholder and employee entered into a non disclosure agreement.
NOTE 5 INTERNET DOMAIN NAME PURCHASE AND ASSIGNMENT AGREEMENT
On July 17, 2006, the Company entered into an Internet Domain Name Purchase and Assignment
Agreement with Dickerson Employee Benefits (Dickerson) to purchase the Internet domain name
www.healthbenefitsdirect.com
. As consideration for the Internet Domain Name Purchase and
Assignment Agreement, the Company made a cash payment of $50,000 and issued 50,000 shares of our
common stock to Dickerson. The fair value of the Companys purchase price was estimated to be
$161,200 and was accounted for as the purchase of an internet domain name, which is included in
intangible assets and amortized straight line over 36 months. The Internet Domain Name Purchase
and Assignment Agreement is subject to certain provisions pertaining to Dickersons transfer of
their ownership and their discontinuance of their use of
www.healthbenefitsdirect.com
. The
Internet Domain Name Purchase and Assignment Agreement will require the Company to pay Dickerson
10% of the net proceeds of the sale of the Internet domain name
www.healthbenefitsdirect.com
in the
event that the Company sells the Internet domain name
www.healthbenefitsdirect.com
to an
unaffiliated third party prior to July 16, 2009.
Concurrent with the execution of the Internet Domain Name Purchase and Assignment Agreement, the
Company and Dickerson entered into a Registration Rights Agreement that provides for piggyback
registration rights for the 50,000 shares of our common stock issued to Dickerson.
F-18
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 6
PROPERTY AND EQUIPMENT
At December 31, 2006, property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
|
|
|
Computer equipment and software
|
|
3
|
|
$
|
539,919
|
|
Phone equipment and software
|
|
3
|
|
|
728,891
|
|
Office equipment
|
|
5
|
|
|
64,760
|
|
Office furniture and fixtures
|
|
7
|
|
|
342,234
|
|
Leasehold improvements
|
|
10
|
|
|
319,592
|
|
|
|
|
|
|
|
|
|
|
|
|
1,995,396
|
|
|
|
|
|
|
|
|
Less accumulated depreciation
|
|
|
|
|
(511,985
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,483,411
|
|
|
|
|
|
|
|
For the years ended December 31, 2006 and 2005, depreciation expense was $417,005 and $86,350,
respectively.
NOTE 7
INTANGIBLE ASSETS
At December 31, 2006, intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
|
|
|
|
|
Weighted average
|
|
|
|
|
ISG intangible assets acquired
|
|
4.5
|
|
$
|
4,964,330
|
|
HealthPlan Choice intangible assets acquired
|
|
0.5
|
|
|
240,643
|
|
Software development costs
|
|
1.8
|
|
|
410,841
|
|
Internet domain (www.healthbenefits.com)
|
|
3
|
|
|
161,200
|
|
|
|
|
|
|
5,777,014
|
|
Less: accumulated amortization
|
|
|
|
|
(1,668,181
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,108,833
|
|
|
|
|
|
|
|
For the years ended December 31, 2006 and 2005, amortization expense was $1,729,698 and $16,000,
respectively.
Amortization expense subsequent to the period ended December 31, 2006 is as follows:
|
|
|
|
|
2007
|
|
$
|
1,463,555
|
|
2008
|
|
|
1,023,738
|
|
2009
|
|
|
845,656
|
|
2010
|
|
|
631,987
|
|
2011
|
|
|
143,897
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,108,833
|
|
|
|
|
|
NOTE 8
LINE OF CREDIT
The Company had a $400,000 line of credit with Regions Bank, which was dated August 2004 and was
repaid in full in the second quarter of 2006. The line of credit had an interest rate of prime
plus 1%. The Company has no further obligations regarding this line of credit and this line of
credit is not available for future borrowing.
F-19
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 9
UNEARNED COMMISSION ADVANCES
The Company has agreements with certain of its insurance carriers whereby the Companys insurance
carriers advance the Company first year premium commissions before the commissions are earned. The
unearned portion of premium commissions has been included in the consolidated balance sheet as a
liability for unearned commission advances. These advance agreements represent a material source
of cash to fund the Companys operations. The Companys advance agreement with its largest
insurance carrier cannot exceed $9,000,000, can be terminated by either party and in the event of
termination the Companys outstanding advance balance can be called by the insurance carrier with 7
days written notice. As of December 31, 2006, the Companys outstanding advance balance with this
carrier was $3,745,735. The Companys advance agreement with its second largest insurance carrier
allows the insurance carrier to terminate future advances and convert the outstanding advance
balance into a promissory note, which if not repaid within 30 days, would incur interest expense.
As of December 31, 2006, the Companys outstanding advance balance with this carrier was
$1,338,309.
NOTE 10
RELATED PARTY TRANSACTIONS
On March 1, 2004, the board of directors resolved that each member of management would receive
salaries in the amount of $17,500 per month. If in any calendar month the Company realized a profit
less than $52,500, the salaries for that month were to be accrued as salaries payable and
distributed at a later date as determined by the Board. For the period January 27, 2004 (inception)
through December 31, 2004, management salaries payable totaled $525,000. In 2005, the Company
accrued additional management salaries of $487,800. On November 28, 2005, total management salaries
payables of $1,012,800 were converted into 1,012,800 shares of common stock at $1.00 per share upon
the closing of the private placement.
During 2005, Scott Frohman, the Companys former Chief Executive Officer and a Director, had
advanced HBDC a total of $191,000, accruing interest at 5% per annum, payable upon the demand of
Scott Frohman. Of this amount, $95,000 was repaid out of the net proceeds of the private placement
and $96,000 was converted into 96,000 shares of common stock at $1.00 per share upon the closing of
the private placement.
During 2005, Charles Eissa, the Companys Chief Operating Officer, President and a Director, had
advanced HBDC a total of $73,000, accruing interest at 5% per annum, payable upon the demand of
Charles Eissa. Of this amount, $49,000 was repaid out of the net proceeds of the private placement
and $24,000 was converted into 24,000 shares of common stock at $1.00 per share upon the closing of
the private placement.
During 2005, Marlin Capital Partners I, LLC (Marlin) had advanced HBDC a total of $334,400,
accruing interest at 5% per annum, payable upon the demand of Marlin. Daniel Brauser, the Companys
Senior Vice President and Secretary, was an affiliate and control person of Marlin. Of this amount,
$167,200 was repaid out of the net proceeds of the private placement and $167,200 was converted
into 167,200 shares of common stock at $1.00 per share upon the closing of the private placement.
On September 16, 2005, Alvin H. Clemens, the Companys Executive Chairman, purchased 300,000 shares
of common stock and a five-year warrant to purchase an additional 75,000 shares of common stock at
an exercise price of $1.50 per share in a private offering, for an aggregate purchase price of
$225,000. In connection with the purchase of these securities, Mr. Clemens was granted piggy
back registration rights with regard to the shares and the shares underlying the warrants. These
securities were subsequently included in the Companys Registration Statement on Form SB-2 filed
with the Commission on April 10, 2006 as amended.
John Harrison, a Director, is associated with Keystone Equities Group, L.P. The Keystone Equities
Group, L.P. served as placement agent in connection with the Companys recent private placement.
The placement agent received (i) a total cash fee of $558,000, which was paid $300,000 in 2005 and $258,000 in 2006 and
represents 4% of the gross proceeds, and (ii) five-year warrants to purchase 735,000 shares (5% of
the shares sold in the private placement) of common stock at an exercise price of $1.50 per share.
The warrants were subsequently included in the Companys Registration Statement on Form SB-2 filed
with the Commission on April 10, 2006 as amended.
F-20
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 10
RELATED PARTY TRANSACTIONS (continued)
Pursuant to an Advisory Agreement, dated November 1, 2005, Warren V. Musser, the Vice-Chairman of
our board of directors, Mr. Musser introduced potential investors to the Company and provided
additional services. Under the Advisory Agreement, Mr. Musser did not (a) solicit investors to make
any investment, (b) make any recommendations to individuals regarding an investment, or (c) provide
any analysis or advice regarding an investment. As consideration for his services, Mr. Musser
received a cash fee of $352,000, which was paid $330,000 in 2005 and $22,000 in 2006, and a
five-year warrant to purchase 440,000 shares of the Companys common stock at an exercise price of
$1.50 per share. The warrants were subsequently included in the Companys Registration Statement
on Form SB-2 filed with the Commission on April 10, 2006 as amended.
As of December 31, 2006, the Company recorded $63,672 due to related parties, which consisted of
the following:
|
|
|
The Company from time to time uses a credit card in the name of ISG Partners, Inc.,
which is an entity owned by Mr. Ivan Spinner, who is an officer of the Company, for travel
expenses, purchases and operating purposes. This account is personally guaranteed by Mr.
Spinner. Mr. Spinner does not incur any interest or expense in connection with the
Companys use of his credit card account. The Company does not pay Mr. Spinner interest or
fees in connection with the Companys use of his credit card account. At December 31,
2006, the Company owed Mr. Spinner $42,130 for charges incurred on his credit card, which
was paid in January 2007.
|
|
|
|
|
In March 2006, the Company entered into Marketing Services Agreement with SendTec, Inc.
(SendTec). Paul Soltoff, a director of the Company, is the Chief Executive Officer of
SendTec. SendTec provided certain marketing and advertising services and received a flat
fee of $7,500 per month plus commissions on services rendered. For the year ended December
31, 2006, the Company paid SendTec $352,740 and has recorded other general and
administrative expense of $324,282, intangible assets pertaining to website development of
$50,000 and due to related parties of $21,542 in the accompanying financial statements.
|
NOTE 11
SHAREHOLDERS EQUITY
Common Stock
In September 2005, the Company received capital contributions of $206,999 from a LLC member prior
to the Companys recapitalization.
On September 16, 2005, Alvin H. Clemens, our Chairman and Chief Executive Officer, purchased
300,000 shares of our common stock and a five-year warrant to purchase an additional 75,000 shares
of our common stock at an exercise price of $1.50 per share in a private offering, for an aggregate
purchase price of $225,000. In connection with the purchase of these securities, Mr. Clemens was
granted piggy back registration rights with regard to the shares and the shares underlying the
warrants.
In November 2005, the Company issued 1,300,000 shares of common stock to officers of the Company
for debt and services amounting to $1,300,000. See Note 10 Related Party Transactions.
Through December 31, 2005, the Company completed the closing of a private placement of a total of
165 units, each unit (Unit) consisting of 50,000 shares of our common stock and a detachable,
transferable warrant to purchase shares of our common stock, at a purchase price of $50,000 per
Unit, to accredited investors pursuant to the terms of a Confidential Memorandum, dated November
21, 2005, as supplemented. Each warrant entitles the holder to purchase 25,000 shares of our common
stock at an exercise price of $1.50 per share and expires on the three-year anniversary of the date
of issuance, subject to certain redemption provisions. The Company received net proceeds from the
private placement of $7,240,502 (gross proceeds of $8,250,000 less placement fees of $660,000 and
legal and other costs of $349,498).
F-21
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
The private placement was made solely to accredited investors, as that term is defined in
Regulation D under the Securities Act of 1933, as amended (the Securities Act). None of the
Units, warrants or common stock, or shares of our common stock underlying such securities, were
registered under the Securities Act, or the securities laws of any state, and were offered and sold
in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506)
under the Securities Act and corresponding provisions of state securities laws, which exempts
transactions by an issuer not involving any public offering.
The Keystone Equities Group, Inc. served as placement agent in connection with the private
placement. See Note 10 Related Party Transactions.
Pursuant to an Advisory Agreement, Warren V. Musser introduced potential investors to the Company.
See Note 10 Related Party Transactions.
On December 1, 2005, the Company entered into a consulting agreement with Alliance Advisors, LLC
(Alliance) to provide certain financial and public relations consulting services (the Consulting
Agreement), ratified by our board of directors on January 12, 2006. Pursuant to the Consulting
Agreement, Alliance will develop, implement, and maintain an ongoing system with the general
objective of expanding awareness of our Company among stockholders, analysts, micro-cap fund
managers, market makers, and financial & trade publications for a twelve month term. In
consideration for the services provided by Alliance, we paid Alliance a monthly fee of $8,300 and
we issued 100,000 shares of our common stock, which the Company valued the 100,000 common shares
under the consulting agreement at $1.00 per share based on the recent selling price of the shares
under a private placement. Accordingly, the Company recorded deferred compensation of $100,000,
which was amortized into consulting expense over the term of the contract. For the years ended
December 31, 2006 and 2005, the Company amortized $91,667 and $8,333 into stock-based consulting
expense, respectively.
On January 11, 2006, the Company completed the fifth closing of the Companys private placement of
units (the Units), which began in 2005, and terminated the offering. Each Unit sold in the
private placement consisted of 50,000 shares of the Companys common stock and a detachable,
transferable warrant to purchase 25,000 shares of the Companys common stock, at a purchase price
of $50,000 per Unit. Each warrant entitles the holder to purchase shares of the Companys common
stock at an exercise price of $1.50 per share and expires on the three-year anniversary of the date
of issuance, subject to certain redemption provisions. The Company received gross proceeds of
$6,450,000 and net proceeds of $6,164,174 from this closing.
The private placement was made solely to accredited investors, as that term is defined in
Regulation D under the Securities Act of 1933, as amended (the Securities Act). None of the
Units, warrants or common stock, or shares of our common stock underlying such securities, were
registered under the Securities Act, or the securities laws of any state, and were offered and sold
in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506)
under the Securities Act and corresponding provisions of state securities laws, which exempts
transactions by an issuer not involving any public offering.
On July 7, 2006, the Commission declared effective the Companys Registration Statement on Form
SB-2 filed with the Commission on April 10, 2006 as amended.
On April 3, 2006, the Company issued 1,000,000 shares of the Companys common stock to Ivan M.
Spinner. See Note 2 ISG Acquisition.
On April 10, 2006, the Company issued 80,000 unregistered shares of the Companys common stock to
Mr. Horace Richard Priester III. See Note 3 HealthPlan Choice Asset Purchase.
F-22
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
On May 31, 2006, the Company entered into a License Agreement with Realtime Solutions Group, L.L.C.
As consideration for the grant of the rights and licenses under the License Agreement, the Company
upon delivery of the STP software and other materials will pay to Realtime a license fee in the
form of 216,612 unregistered shares of our common stock. See Note 13 Restricted Cash,
commitments and contingencies
On July 17, 2006, the Company issued 50,000 unregistered shares of common stock to Dickerson
Employee Benefits. See Note 5 Internet Domain Name Purchase and Assignment Agreement.
On July 20, 2006, the Company issued 15,000 unregistered shares of common stock to Pete Gries. See
Note 4 Consulting Agreement With Real IT Group.
Stock Options
On November 10, 2005, Anthony Verdi, as Chief Financial Officer, received a ten-year option grant
of 350,000 shares, which vests as follows: 100,000 shares on the six month anniversary of the
grant, 125,000 shares on the first year anniversary of the grant and the remaining 125,000 shares
in eleven equal increments of 10,416 and a final increment of 10,424 at the end of each calendar
month thereafter. These options have an exercise price of $1.00
On November 10, 2005, the Company granted 2,335,000 options to its existing management and
employees, of which 600,000, 500,000 and 500,000 were granted to Scott Frohman, Charles Eissa and
Daniel Brauser, respectively. All of these options have an exercise price of $2.50 and vest over
four years, with 25% vesting on November 10, 2006 and the remainder vesting in 36 approximately
equal increments at the end of each calendar month thereafter. These options expire on November
10, 2015.
On November 23, 2005, each non-employee member of the board of directors received a ten-year stock
option to purchase 250,000 shares of common stock with an exercise price equal to $1.00 per share,
for an aggregate of 1,000,000 options, which vests as follows: 100,000 shares on the six month
anniversary of the grant; 75,000 shares on the first year anniversary of the grant and the
remaining 75,000 shares in twelve equal increments at the end of each calendar month thereafter.
Alvin Clemens, as Chairman, received an additional ten-year option grant equal to 250,000 shares
with an exercise price equal to $1.00 per share, which vests as set forth above.
In connection with the appointment of Warren V. Musser to the board of directors, on January 11,
2006, the Company granted him a ten-year option to purchase 250,000 shares of the Companys common
stock at an exercise price of $1.00 per share. The fair market value of this option grant was
estimated on the date of grant using the Black-Scholes option-pricing model with the following
weighted-average assumptions: dividend yield of 0%; expected volatility of 103%; risk-free
interest rate of 4.5%; and, a term of five years. The Company valued these options at a fair market
value of $193,264 and recorded stock-based compensation expense of $20,132 and deferred
compensation of $173,132, the latter of which will be amortized over the vesting period of one
year.
On March 14, 2006, the board of directors of the Company adopted the Companys Compensation Plan
for Directors (the Plan), which was approved by the Companys shareholders at the Companys
annual shareholders meeting held on November 2, 2006. An aggregate of 1,000,000 shares of the
Companys common stock have been reserved for issuance under the Plan in addition to any authorized
and unissued shares of common stock available for issuance under the Companys 2005 Non-Employee
Directors Stock Option Plan (2005 Directors Plan). The purpose of the Plan is to provide a
comprehensive compensation program to attract and retain qualified individuals to serve as
directors. The Company is authorized to award cash fees and issue non-qualified stock options
under the Plan. The Plan is administered by the Companys board of directors or the compensation
committee established by the board.
F-23
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
The Plan provides for the (i) one-time (a) payment of $250,000 to each non-employee director
who serves as Vice Chairman of the board of directors (who is not also Chairman or Executive
Chairman), $125,000 of which is payable upon the adoption of the Plan and $125,000 of which is
payable in 12 equal monthly installments commencing on March 31, 2006 so long as such person
remains a director and is serving in such capacity on the date of each such installment, and (b)
grant of an additional option to purchase 425,000 shares of common stock to each non-employee
director who is or has been appointed or elected as Vice Chairman of the board of directors (who
is not also Chairman or Executive Chairman) on the later of the date of (x) such appointment or
election, or (y) adoption of the Plan, which option shall vest and become exercisable as to
one-half of the shares subject to the option six months from the date of grant, and one-half of the
shares six months thereafter; (ii) the payment of $1,000 to each director for each special or
committee meeting of the board of directors attended, in person or by telephone, as reimbursement
of fees and expenses of attendance and participation by such director at such meeting; and (iii) an
annual retainer of $1,000 payable to each director upon appointment as chairperson of a committee
of the board of directors.
On March 14, 2006, the Company granted to Warren V. Musser, as Vice Chairman of the board of
directors, an option to purchase 425,000 shares of the Companys common stock at an exercise price
of $2.70 per share. The fair market value of this option was estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted-average assumptions: dividend
yield of 0%; expected volatility of 105%; risk-free interest rate of 4.5%; and, a term of five
years. The Company valued these options at a fair market value of $896,542 and recorded stock-based
compensation expense of $37,356 and deferred compensation of $859,186, the latter of which will be
amortized over the vesting period of one year.
The Plan also provides for (i) the automatic initial grant of an option to purchase 100,000 shares
of common stock to each director who joins the Companys board of directors, at an exercise price
equal to the fair market value, as defined in the Plan, on the date of such election to the board,
and (ii) the grant of an option to purchase 10,000 shares of common stock to each director
reelected to the board, at an exercise price equal to the fair market value, as defined in the
Plan, on the date of such reelection to the board, subject to vesting as follows: one-third of
the shares issuable pursuant to the option shall be exercisable on the first anniversary of the
date of grant, an additional one-third of the shares shall be exercisable on the second year
anniversary of the date of grant, and the remaining one-third of the shares shall be
exercisable on the third anniversary of the date of grant. Upon removal without cause, or upon a
change of control (as defined in the 2005 Directors Plan), all options shall vest and become
immediately exercisable. The term of each option under the Plan is five years.
On April 3, 2006, in connection with the Merger, HBDC II, Inc., a wholly-owned subsidiary of the
Company, entered into a two-year employment agreement with Mr. Spinner, which provided that Mr.
Spinner receive an option to purchase an aggregate of 150,000 shares of common stock at an exercise
price of $3.50 per share. See Note 2 ISG Acquisition.
On April 10, 2006, in connection with the acquisition of HealthPlan Choice, HBDC II, Inc. entered
into a two-year employment agreement with Mr. Priester, which provided that Mr. Priester receive an
option to purchase an aggregate of 50,000 shares of common stock at an exercise price of $3.10 per
share. See Note 3 HealthPlan Choice Asset Purchase.
F-24
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
On April 27, 2006, the board of directors approved the grant of stock options to each of L.J.
Rowell, C. James Jensen and Sanford Rich, who are all non-employee members of the board of
directors (the Director Options). Messrs Rowell, Jensen and Rich each received nonqualified
options to purchase 200,000 shares of common stock with a term of ten years at an exercise price of
$3.60 per share. Forty percent (40%) of the Director Options will be exercisable on the date of
grant; thirty percent (30%) on the first anniversary of the date of grant; and the remaining thirty
percent (30%) in 12 equal increments at the end of each calendar month thereafter. These Director
Options were approved by the Companys shareholders at the Companys annual shareholders meeting
held on November 2, 2006. The fair market value of these option grants was estimated on the date
of grant using the Black-Scholes option-pricing model with the following weighted-average
assumptions: dividend yield of 0%; expected volatility of 113%; risk-free interest rate of 4.66%;
and, a term of five years. The Company valued these options at a fair market value of $1,761,973
and recorded stock-based compensation expense of $117,465 and deferred compensation of $1,644,509,
the latter of which will be amortized over the vesting period of 2.75 years.
On April 27, 2006, the Companys board of directors adopted the Health Benefits Direct Corporation
2006 Omnibus Equity Compensation Plan, (Omnibus Plan) subject to stockholder approval at the
Companys next annual meeting of shareholders. The purpose of the Omnibus Plan is to attract,
retain and motivate the employees, non-employee members of the board of directors and consultants
of the Company and its subsidiaries and to focus their efforts on the long-term enhancement of
stockholder value.
The Health Benefits Direct Corporation 2005 Incentive Stock Plan (2005 Stock Plan), the 2005
Directors Plan and the Health Benefits Direct Corporation Compensation Plan for Directors (the
Directors Compensation Plan) (the 2005 Stock Plan, 2005 Directors Plan and Directors Compensation
Plan, collectively, the Prior Plans) will be merged with and into the Omnibus Plan as of the
effective date of the Omnibus Plan, and no additional grants will be made thereafter under the
Prior Plans. Outstanding grants under the Prior Plans will continue in effect according to their
terms as in effect before the Omnibus Plan merger (subject to such amendments as the board of
directors determines, consistent with the Prior Plans, as applicable), and the shares with respect
to outstanding grants under the Prior Plans will be issued or transferred under the Omnibus Plan.
The effective date of the Omnibus Plan is April 27, 2006.
Key terms of the Omnibus Plan are as follows:
Administration
. The Omnibus Plan is administered and interpreted by the board of directors.
The board of directors has the authority to: (i) determine the individuals to whom grants
will be made; (ii) determine the type, size and terms of the grants; (iii) determine the
time when grants will be made and the duration of any applicable exercise or restriction
period, including the criteria for exercisability and the acceleration of exercisability;
(iv) amend the terms of any previously issued grant, subject to the limitations described
below; and (v) deal with any other matters arising under the Omnibus Plan. The
determinations of the board of directors are made in its sole discretion and are final,
binding and conclusive.
Eligibility
. All of the employees of the Company and its subsidiaries, and advisors and
consultants of the Company and its subsidiaries, are eligible for grants. Non-employee
directors of the Company are also eligible to receive grants.
Types of Awards.
The Omnibus Plan provides that grants may be in any of the following forms:
(i) incentive stock options; (ii) nonqualified stock options (incentive stock options and
nonqualified stock options collectively are referred to as options); (iii) stock
appreciation rights (SARs); (iv) stock units; (v) stock awards; (vi) dividend equivalents;
and (vii) other stock-based awards.
F-25
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
Shares Subject to the Plan.
The Omnibus Plan authorizes up to 7,050,000 shares of the
Companys common stock for issuance, subject to adjustment in certain circumstances. The
maximum number of authorized shares includes shares to be issued or transferred pursuant to
outstanding grants under the Prior Plans that are to be merged into the Omnibus Plan as of
the effective date of the Omnibus Plan. The Omnibus Plan provides that the maximum aggregate
number of shares of common stock that may be made with respect to grants, other than
dividend equivalents, to any individual during any calendar year is 1,000,000 shares,
subject to adjustment as described below. Grantees may not accrue dividend equivalents
during any calendar year in excess of $1,000,000.
These limits may be adjusted by reason of a stock dividend, spin-off, recapitalization,
stock split, or combination or exchange of shares, by reason of a merger, reorganization or
consolidation, by reason of a recapitalization or change in par value or by reason of any
other extraordinary or unusual event affecting the outstanding shares of common stock as a
class without the Companys receipt of consideration, or if the value of outstanding shares
of common stock is substantially reduced as a result of a spin-off or the Companys payment
of an extraordinary dividend or distribution.
Change of Control.
If a change of control of the Company occurs, unless the board of
directors determines otherwise, all outstanding options and SARs will automatically
accelerate and become fully exercisable, the restrictions and conditions on all outstanding
stock awards will immediately lapse, all outstanding stock units will become payable in cash
or shares of common stock in an amount not less than their target amount (as determined by
the board of directors), and dividend equivalents and other-stock based awards will become
fully payable in cash or shares of common stock (in amounts determined by the board of
directors).
Upon a change of control, the board of directors may also take any of the following actions
with respect to outstanding grants, without the consent of the grantee: (i) require that
grantees surrender their outstanding options and SARs in exchange for payment by the
Company, in cash or shares of common stock as determined by the board of directors, in an
amount equal to the amount by which the then fair market value subject to the grantees
unexercised options and SARs exceeds the exercise price of the option or the base amount of
the SAR, as applicable; (ii) after giving grantees the opportunity to exercise their
outstanding options and SARs, the board of directors may terminate any or all unexercised
options and SARs at such time as the board of directors determines appropriate; and (iii)
determine that outstanding options and SARs that are not exercised shall be assumed by, or
replaced with comparable options or rights by, the surviving corporation (or a parent or
subsidiary of the surviving corporation), and other outstanding grants that remain in effect
after the change of control will be converted to similar grants of the surviving corporation
(or a parent or subsidiary of the surviving corporation).
Amendment and Termination of the Plan
. The board may amend or terminate the Omnibus Plan at
any time, subject to stockholder approval if such approval is required under any applicable
laws or stock exchange requirements. No grants may be issued under the Plan after April 27,
2016.
During 2006, the Company issued options to purchase 197,500 shares of the Companys common stock to
various employees at prices ranging from $2.55 to $3.60. These options will vest 25% on the first
anniversary and an additional 25% on each anniversary thereafter.
During 2006, Alvin Clemens exercised an option to purchase 200,000 shares of the Companys common
stock and Paul Soltoff exercised an option to purchase 100,000 shares of the Companys common stock
each at an exercise price of $1 per share and the Company received $300,000 in aggregate.
F-26
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
During 2006, 426,232 options were forfeited, which included 225,000 options granted to Mr. Frohman
and forfeited as a result of a separation agreement and 50,000 options to Mr. Priester, which were
forfeited as a result of his resignation. See Note 13 Restricted Cash, Commitments and
Contingencies and Note 3 HealthPlan Choice Asset Purchase. The remaining 151,232 options were
forfeited as a result of the termination of the employment of various employees in accordance with
the terms of the stock options.
A summary of the Companys outstanding stock options as of and for the years ended December 31,
2006 and 2005 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
Weighted
|
|
|
|
|
|
|
Of Shares
|
|
|
Average
|
|
|
Weighted
|
|
|
|
Underlying
|
|
|
Exercise
|
|
|
Average
|
|
|
|
Options
|
|
|
Price
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2004
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
For the year ended December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
3,935,000
|
|
|
|
1.89
|
|
|
|
0.14
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2005
|
|
|
3,935,000
|
|
|
|
1.89
|
|
|
|
0.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,672,500
|
|
|
|
2.91
|
|
|
|
2.35
|
|
Exercised
|
|
|
300,000
|
|
|
|
0.67
|
|
|
|
0.20
|
|
Forfeited
|
|
|
426,232
|
|
|
|
2.73
|
|
|
|
0.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2006
|
|
|
4,881,268
|
|
|
$
|
2.24
|
|
|
$
|
0.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable at December 31, 2006
|
|
|
2,074,352
|
|
|
$
|
1.90
|
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted average fair value of option grants are estimated as of the date of grant using the
Black-Scholes option-pricing model based on the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
Stock Options Granted During the Period
|
|
|
For the Year Ended
|
|
For the Year Ended
|
|
|
December 31, 2006
|
|
December 31, 2005
|
|
|
|
|
|
|
|
|
|
Expected volatility
|
|
|
111
|
%
|
|
|
25
|
%
|
Risk-free interest rate
|
|
|
4.61
|
%
|
|
|
3.75
|
%
|
Expected life in years
|
|
|
5.0
|
|
|
|
4.5
|
|
Assumed dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
F-27
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
The following information applies to options outstanding at December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Options Exercisable
|
|
|
Number of Shares
|
|
Average
|
|
Weighted
|
|
Number
|
|
Weighted
|
|
|
Underlying
|
|
Remaining
|
|
Average
|
|
Exercisable at
|
|
Average
|
Exercise
|
|
Options at
|
|
Contractual
|
|
Exercise
|
|
December 31,
|
|
Exercise
|
Price
|
|
December 31, 2006
|
|
Life
|
|
Price
|
|
2006
|
|
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$1.00
|
|
|
1,550,000
|
|
|
|
8.9
|
|
|
$
|
1.00
|
|
|
|
1,008,332
|
|
|
$
|
1.00
|
|
2.50
|
|
|
2,018,768
|
|
|
|
8.9
|
|
|
|
2.50
|
|
|
|
826,020
|
|
|
|
2.50
|
|
2.55
|
|
|
25,000
|
|
|
|
4.5
|
|
|
|
2.55
|
|
|
|
|
|
|
|
2.62
|
|
|
20,000
|
|
|
|
5.0
|
|
|
|
2.62
|
|
|
|
|
|
|
|
2.70
|
|
|
425,000
|
|
|
|
4.2
|
|
|
|
2.70
|
|
|
|
|
|
|
|
2.95
|
|
|
45,000
|
|
|
|
4.3
|
|
|
|
2.95
|
|
|
|
|
|
|
|
3.50
|
|
|
150,000
|
|
|
|
9.3
|
|
|
|
3.50
|
|
|
|
|
|
|
|
$3.60
|
|
|
647,500
|
|
|
|
4.3
|
|
|
$
|
3.60
|
|
|
|
240,000
|
|
|
$
|
3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,881,268
|
|
|
|
|
|
|
|
|
|
|
|
2,074,352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2006 there were 7,050,000 shares of our common stock authorized to be issued
under our Omnibus Plan of which 803,732 shares of our common stock remain available for future
stock option grants.
Common Stock warrants
On September 16, 2005, Alvin H. Clemens, the Companys Executive Chairman purchased 300,000 shares
of common stock and a five-year warrant to purchase an additional 75,000 shares of common stock at
an exercise price of $1.50 per share in a private offering, for an aggregate purchase price of
$225,000.
In November and December 2005, in connection with a private placement, the Company granted
4,125,000 warrants to purchase 4,125,000 shares of common stock at $1.50 per share to investors and
852,500 placement warrants at an exercise price of $1.50. The warrants expire on the three-year
anniversary of the date of issuance through December 2008.
In January 2006, in connection with a private placement, the Company granted warrants to purchase
an aggregate of 3,225,000 shares of common stock at an exercise price of $1.50 per share to
investors and warrants to purchase an aggregate of 322,500 shares of common stock at an exercise
price of $1.50 to the placement agent as compensation for services provided in connection with the
private placement. All warrants issued in the private placement expire on the three-year
anniversary of the date of issuance through January 2009.
F-28
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
In January 2006, in connection with a private placement and a Securities Contribution Agreement,
dated September 9, 2005, by and among the Company, Marlin Capital Partners I, LLC, Scott Frohman,
Charles Eissa, Platinum Partners II, LLC, and Dana Boskoff, the Company was obligated to issue to
Dana Boskoff a warrant to purchase 50,000 shares of the Companys common stock, par value $0.001
per share (
Common Stock
), at an exercise price of $1.50 per share, which shall vest
immediately. The warrants expire on the three-year anniversary of the date of issuance.
During 2006, certain holders of the Companys warrants exercised their warrants to purchase an
aggregate of 450,000 shares of the Companys common stock at an exercise price of $1.50 per share
for an aggregate exercise price of $675,000.
A summary of the status of the Companys outstanding stock warrants granted as of December 31, 2006
and changes during the period is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Common
|
|
|
Average
|
|
|
|
Stock
|
|
|
Exercise
|
|
|
|
Warrants
|
|
|
Price
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2004
|
|
|
|
|
|
$
|
|
|
For the year ended December 31, 2005
|
|
|
|
|
|
|
|
|
Granted
|
|
|
5,052,500
|
|
|
$
|
1.50
|
|
Exercised
|
|
|
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2005
|
|
|
5,052,500
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2006
Granted
|
|
|
3,597,500
|
|
|
$
|
1.50
|
|
Exercised
|
|
|
450,000
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2006
|
|
|
8,200,000
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2006
|
|
|
8,200,000
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
Outstanding warrants at December 31, 2006 have a weighted average remaining contractual life of 2
years.
Registration Rights
On May 31, 2006, the Company entered into a License Agreement with Realtime Solutions Group, L.L.C.
As consideration for the grant of the rights and licenses under the License Agreement, the Company
upon delivery of the STP software and other materials will pay to Realtime a license fee in the
form of 216,612 unregistered shares of our common stock. Concurrent with entering into the License
Agreement the Company and Realtime Solutions Group, L.L.C entered into a Registration Rights
Agreement that provides for piggyback registration rights for the Shares. See Note 4 Realtime
License Agreement.
On July 17, 2006, the Company issued 50,000 unregistered shares of common stock to Dickerson
Employee Benefits and entered into a Registration Rights Agreement that provides for piggyback
registration rights for the shares. See Note 6 Internet Domain Name Purchase and Assignment
Agreement.
F-29
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 11
SHAREHOLDERS EQUITY (continued)
On July 20, 2006, the Company issued 15,000 unregistered shares of common stock to Pete Gries, who
is the principal of Real IT Group, entered into a Registration Rights Agreement that provides for
piggyback registration rights for the shares. See Note 5 Consulting Agreement With Real IT
Group.
NOTE 12
INCOME TAXES
The Company has net operating losses for federal income tax purposes of approximately
$6,700,000 at December 31, 2006 which will expire in 2026. The Company accounts for income taxes
under Statement of Financial Accounting Standards No. 109, Accounting for Income Taxes SFAS
109. SFAS 109 requires the recognition of deferred tax assets and liabilities for both the
expected impact of differences between the financial statements and the tax basis of assets and
liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit
carry forwards. SFAS 109 additionally requires the establishment of a valuation allowance to
reflect the likelihood of realization of deferred tax assets. Internal Revenue Code Section 382
places a limitation on the amount of taxable income that can be offset by carry forwards after a
change in control (generally greater than a 50% change in ownership).
The table below summarizes the differences between the Companys effective tax rate and the
statutory federal rate as follows for the periods ended December 31, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
2005
|
Computed expected benefit
|
|
$
|
(4,888,738
|
)
|
|
$
|
(1,110,000
|
)
|
State tax benefit, net of federal effect
|
|
|
(419,035
|
)
|
|
|
(95,000
|
)
|
Losses incurred during LLC operations
|
|
|
|
|
|
|
513,000
|
|
Amortization of ISG assets
|
|
|
488,933
|
|
|
|
|
|
Other permanent differences
|
|
|
13,207
|
|
|
|
60,000
|
|
Increase in valuation allowance
|
|
|
4,805,633
|
|
|
|
632,000
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
F-30
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 12
INCOME TAXES (continued)
Deferred tax assets and liabilities are provided for significant income and expense items
recognized in different years for tax and financial reporting purposes. The components of the net
deferred tax assets for the years ended December 31, 2006 and 2005 were as follows:
|
|
|
|
|
|
|
|
|
Deferred tax assets:
|
|
2006
|
|
2005
|
Deferred tax assets:
|
|
|
|
|
Net operating loss carryforward
|
|
$
|
2,558,804
|
|
|
$
|
645,000
|
|
Unearned commission advances
|
|
|
1,958,944
|
|
|
|
|
|
Stock option and other compensation expense
|
|
|
962,192
|
|
|
|
|
|
All Other
|
|
|
126,209
|
|
|
|
6,000
|
|
|
|
|
Total deferred tax asset
|
|
|
5,606,149
|
|
|
|
651,000
|
|
Deferred Tax liabilities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
(55,722
|
)
|
|
|
10,000
|
|
Software development costs
|
|
|
(112,794
|
)
|
|
|
(29,000
|
)
|
|
|
|
Net deferred tax asset
|
|
|
5,437,633
|
|
|
|
632,000
|
|
|
|
|
Less: Valuation allowance
|
|
|
(5,437,633
|
)
|
|
|
(632,000
|
)
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
The Company fully reserved the net deferred tax asset due to the fact that it is still
operating within its initial period as a C Corporation and substantial uncertainty exists as to the
utilization of any of its deferred tax assets in future periods. The valuation allowance was
increased by $4,805,633 from the prior year.
NOTE 13
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES
Employment and Separation Agreements
Effective November 10, 2005, the Company entered into an employment agreement with Daniel Brauser,
its Senior Vice President, for a 24-month period ending November 10, 2007, which automatically
renews for successive 12-month terms unless earlier terminated by the Company or the employee. In
addition to an annual salary of $157,500, the agreement entitled the officer to bonus compensation
(in cash, capital stock or other property) as a majority of the members of the board of directors
may determine from time to time in their sole discretion, and shall be entitled to participate in
such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans
and all other benefits and plans as the Corporation provides to its senior executives.
In the event of Mr. Brausers termination without cause or for good reason, he would receive his
then current base annual salary, plus unpaid accrued employee benefits, which is primarily accrued
vacation, plus the continuation of his employee benefits for a period of 1 year, less all
applicable taxes. In the event of his voluntary termination, death or disability, he or his estate
would receive unpaid accrued employee benefits, plus the continuation of his employee benefits for
a period of 1 month, less all applicable taxes.
F-31
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 13
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Effective November 10, 2005, the Company entered into an employment agreement with Anthony
Verdi, its Chief Financial Officer, for a 24-month period ending November 10, 2007, which
automatically renews for successive 12-month terms unless earlier terminated by the Company or the
employee. In addition to an annual salary of $225,000, the agreement entitled the officer to bonus
compensation (in cash, capital stock or other property) as a majority of the members of the board
of directors may determine from time to time in their sole discretion, and shall be entitled to
participate in such pension, profit sharing, group insurance, hospitalization, and group health and
benefit plans and all other benefits and plans as the Corporation provides to its senior
executives.
In the event of Mr. Verdis termination without cause or for good reason, he would receive his
then current base annual salary, plus unpaid accrued employee benefits, which is primarily accrued
vacation, plus the continuation of his employee benefits for a period of 1 year, less all
applicable taxes. In the event of his voluntary termination, death or disability, he or his estate
would receive unpaid accrued employee benefits, plus the continuation of his employee benefits for
a period of 1 month, less all applicable taxes.
Effective November 18, 2005, the Company entered into an employment agreement with Charles Eissa,
its President and Chief Operating Officer, for a 24-month period ending November 18, 2007, which
automatically renews for successive 12-month terms unless earlier terminated by the Company or the
employee. In addition to an annual salary of $214,200, the agreement entitled the officer to bonus
compensation (in cash, capital stock or other property) as a majority of the members of the board
of directors may determine from time to time in their sole discretion, and shall be entitled to
participate in such pension, profit sharing, group insurance, hospitalization, and group health and
benefit plans and all other benefits and plans as the Corporation provides to its senior
executives.
On January 12, 2006, the Company agreed to terms of employment with Alvin Clemens, under which Mr.
Clemens was named Executive Chairman of the Company, an executive officer position. Under the two
year agreement, Mr. Clemens is to be paid a base salary of $275,000 per year and is entitled to
receive such bonus compensation as a majority of the board of directors may determine from time to
time. On December 7, 2006 Mr. Clemens was appointed as our Chief Executive Officer.
In the event of Mr. Clemens termination without cause or for good reason, he would receive his
then current base annual salary, plus unpaid accrued employee benefits, which is primarily accrued
vacation, plus the continuation of his employee benefits for a period of 1 year, less all
applicable taxes. In the event of his voluntary termination, death or disability, he or his estate
would receive unpaid accrued employee benefits, plus the continuation of his employee benefits for
a period of 1 month, less all applicable taxes.
On April 3, 2006, in connection with the Merger, HBDC II, Inc., a wholly-owned subsidiary of the
Company, entered into a two-year employment agreement with Ivan M. Spinner. See Note 2 ISG
Acquisition.
On April 10, 2006 in connection with the Asset Purchase, HBDC II, Inc., a wholly-owned subsidiary
of HBDC, entered into a two-year employment agreement with Mr. Horace Richard Priester III. Mr.
Priester resigned effective July 7, 2006. See Note 3 HealthPlan Choice Asset Purchase.
On December 7, 2006, Scott Frohman resigned as our Chief Executive Officer and as one of our
directors and Alvin H. Clemens, our Executive Chairman, was appointed as our Chief Executive
Officer. In connection with Mr. Frohmans resignation, we and Mr. Frohman entered into a separation
agreement dated December 7, 2006.
Under the separation agreement, Mr. Frohmans employment with us ceased to be effective on December
7, 2006. The separation agreement provides for the resolution of all matters with respect to Mr.
Frohmans employment, including all obligations to Mr. Frohman under his employment agreement with
us dated as of October 10, 2005, with respect to his outstanding options to purchase shares of our
common stock and with respect to any other similar amounts or benefits payable to Mr. Frohman
pursuant to the employment agreement or otherwise.
F-32
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 13
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
The separation agreement provides for the payment to Mr. Frohman of his current monthly salary for
a period of 18 months, less taxes, in satisfaction of all obligations under the employment
agreement, and in recognition that a material portion is in consideration of Mr. Frohmans
confidentiality, non-competition and non-solicitation obligations. In addition, Mr. Frohman will
receive (i) a lump sum payment equal to $21,525 for four weeks of accrued but unused vacation, less
$8,075 for certain business expenses and (ii) payment of, or reimbursement for, monthly COBRA
premiums for a period of 18 months following the separation date. The separation agreement further
provides that upon his termination of employment, Mr. Frohmans option to purchase 600,000 shares
of our common stock, exercisable at $2.50 per share and originally granted on November 10, 2005,
will become vested as to 375,000 shares (150,000 of which were already vested and 225,000 of which
became vested on December 7, 2006). These 375,000 shares shall remain exercisable by Mr. Frohman
for one year following the separation date. The option will terminate with respect to the remaining
225,000 shares that will not become vested under the separation agreement.
Certain of Mr. Frohmans shares of our common stock (1,566,007 shares) remain locked up until
November 23, 2007 under the terms of a lock-up agreement with us, dated as of November 23, 2005. A
portion of Mr. Frohmans shares (1,191,006 shares) and his option to acquire 375,000 shares of our
common stock have since been released from the lock-up agreement. Under the separation agreement,
Mr. Frohman has agreed that the released securities will remain subject to general lock-up terms
for a period of 18 months following the separation date, subject to certain exceptions as set forth
in the separation agreement.
The separation agreement also provides for mutual non-disparagement by Mr. Frohman and us. Mr.
Frohman also is subject to confidentiality provisions and an 18 month non-competition,
non-solicitation and no-hire period under the separation agreement.
The Company estimated the future value of the payments under the separation agreement to be
$389,119 and recorded an expense charge and liability for that amount as of December 31, 2006. The
Company also recorded in the fourth quarter salaries, commissions and related tax expense of
$21,500 for severance payments and $12,075 for the unamortized portion of the fair value of Mr.
Frohmans stock options.
Restricted Cash and Operating Leases
The Company leases office space in Pompano Beach, Florida under an operating lease which expires in
February 2007. This office lease agreement has certain escalation clauses and renewal options. In
March 2006, the Company vacated this lease to relocate to its new facilities in Deerfield Beach,
Florida. In connection with the vacated lease, as of December 31, 2006 the Company has accrued
$16,054 in lease termination fees and utilities that management estimated as due under the
remaining lease term.
On February 17, 2006, the Company entered into a lease agreement with FG2200, LLC, a Florida
limited liability company, for approximately 50,000 square feet of office space at 2200 S.W. 10th
Street, Deerfield Beach, Florida (the Lease). The initial term of the Lease commences on March
15, 2006 and terminates on March 31, 2016. The Company has the option to extend the term for two
additional 36-month periods, as well as the right to terminate the Lease within the first five
years. The monthly rent increases every 12 months, starting at $62,500 plus certain building
expenses incurred by the landlord and ending at approximately $81,550 plus certain building
expenses incurred by the landlord. This space replaced the Companys 10,312 square feet of office
space at 2900 Gateway Drive, Pompano Beach, Florida 33069. In connection with the Lease, the
Company provided a $1 million letter of credit to the landlord as a security deposit for the
Companys obligations under the Lease.
F-33
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 13
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
On March 7, 2006, the Company entered into a sublease for approximately 13,773 square feet of
office space located on the 7th floor at 1120 Avenue of the Americas, New York, New York (Sublease
Agreement). The initial term of the Sublease Agreement commences in March 2006, and terminates on
December 31, 2010. The monthly rent increases every 12 months, starting at approximately $303,000
per annum plus a proportionate share of landlords building expenses and ending at approximately
$341,000 per annum plus a proportionate share of landlords building expenses. In connection with
the Sublease Agreement, the Company provided a $151,503 letter of credit to the landlord as a
security deposit for the Companys obligations under the sublease. On May 15, 2006 the Company
received the landlords consent, dated April 18, 2006, to the Sublease Agreement.
Effective during the second quarter of 2006 the letters of credit pertaining to the lease for our
Deerfield Beach Florida office and our Avenue of the Americas, New York office were collateralized
in the form of a certificate of deposit, which as of December 31, 2006 had a balance of $1,150,000.
This certificate of deposit is on deposit with the issuer of the letters of credit and is
classified as restricted cash on the Companys balance sheet. The terms of the certificate of
deposit and letters of credit allow the Company to receive interest on the principal but prohibits
the Company from withdrawing the principal for the life of the letters of credit.
On July 7, 2006, the Company entered into a lease agreement with Radnor Properties-SDC, L.P. (the
Landlord) for the lease of 7,414 square feet of office space located in Radnor Financial Center,
Building B, 150 Radnor-Chester Road, Radnor, Pennsylvania. The term of the lease commenced on
November 1, 2006, which was the date the Company, with the Landlords prior consent, assumed
possession of the premises and the date the Landlord tendered possession of the premises to the
Company following the substantial completion of the improvements required to be made by the
Landlord under the lease agreement, and will expire on the last day of the 125
th
month
following the commencement of the lease term. The annual rent increases every 12 months, starting
at approximately $161,592 plus a proportionate share of landlords building expenses after the
second month and ending at approximately $258,378 plus a proportionate share of landlords building
expenses. Under the terms of the lease agreement, rent is waived for the first five months of the
lease term with respect to 5,238 square feet and for the first twelve months for the remaining
2,176 square feet. The Company recorded an expense charge and liability for deferred rent in the
amount of $38,578 as of December 31, 2006.
The Company paid to the Landlord a security deposit of $100,000 under the lease (the Security
Deposit) during the third quarter of 2006, which is accounted for as a deposit in other assets.
The Company will not earn interest on the Security Deposit. The Security Deposit will decrease and
the Landlord will return to the Company $10,000 on the third anniversary of the commencement date
of the lease and on each anniversary thereafter until the required Security Deposit has been
reduced to $20,000. The Security Deposit will be returned to the Company 30 days after the end of
the lease provided the Company has complied with all provisions of the lease.
The Company leases 3 automobiles for the personal and business use of 3 of the Companys employees,
which are leased in the name of ISG and personally guarenteed by Mr. Ivan Spinner. None of the 3
automobiles are used by Mr. Spinner and Mr. Spinner receives no compensation pertaining to these
leases or his personal guarentee. The aggregate payments for these leases are $2,826 per month.
The aggregate future lease payments for these 3 leases are; $33,912 in 2007, $21,172 in 2008,
$13,968 in 2009, for a total of $69,051.
The Company has executed letters of authorization to a direct marketing agency to spend $184,601 in
advertising during 2007.
F-34
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 13
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Future minimum payments required under operating leases, severance and employment agreements and
service agreements are as follows:
|
|
|
|
|
2007
|
|
$
|
2,160,790
|
|
2008
|
|
|
1,857,921
|
|
2009
|
|
|
1,428,419
|
|
2010
|
|
|
1,416,990
|
|
2011
|
|
|
1,306,795
|
|
thereafter
|
|
|
5,225,751
|
|
|
|
|
|
Total
|
|
$
|
13,396,666
|
|
|
|
|
|
REALTIME LICENSE AGREEMENT
On May 31, 2006, the Company entered into a Software and Services Agreement (the License
Agreement) with Realtime Solutions Group, L.L.C. (Realtime), under which Realtime granted the
Company a worldwide, transferable, non-exclusive, perpetual and irrevocable license to use,
display, copy, modify, enhance, create derivate works within, and access Realtime Solutions Groups
Straight Through Processing software (STP) and all associated documentation, source code and
object code, for use in the marketing, promotion and sale of health benefits or insurance products.
As consideration for the grant of the rights and licenses under the License Agreement, the Company
paid to Realtime a $10,000 nonrefundable cash deposit and upon delivery of the STP software and
other materials the Company will pay a license fee in the form of 216,612 unregistered shares of
our common stock. Concurrent with the entering into the License Agreement, HBDC and Realtime
entered into a Registration Rights Agreement that provides for piggyback registration rights for
the Shares.
The Company may unilaterally terminate the License Agreement, with or without cause, at any time on
30 calendar day prior written notice to Realtime. The license rights in the software granted under
the License Agreement survive any termination of the License Agreement in perpetuity.
As of December 31, 2006 the Company has not taken delivery of the software or issued common stock.
NOTE 14
BOARD OF DIRECTORS
On April 27, 2006, Leon Brauser, a member of the Companys board of directors, resigned from his
position as a director of the Company. The Company accepted Mr. Brausers resignation, which was
effective as of April 27, 2006. Mr. Brausers decision to resign was not the result of any
disagreement with the Company. The Companys board of directors approved the acceleration of the
vesting of Mr. Brausers stock option and the Company recorded an expense of $49,192 in the second
quarter of 2006 in connection with the unamortized portion of the fair value of Mr. Brausers stock
options.
On April 27, 2006, the board of directors voted to increase its size from seven to nine members and
appointed C. James Jensen, Sanford Rich and L.J. Rowell to serve as directors, effective as of
April 27, 2006, to fill the vacancies created by such increase and by Mr. Brausers departure.
On December 7, 2007 Mr. Frohman resigned from the board of directors. See NOTE 13 Restricted
Cash, Commitments and Contingencies.
F-35
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 15
SUBSEQUENT EVENTS
Issuance of Common Stock and Warrants
On March 30, 2007, Health Benefits Direct Corporation, a Delaware corporation (the Company),
entered into a Securities Purchase Agreement (the Purchase Agreement) with certain institutional
and individual accredited investors (collectively, the Investors), whereby the Company has agreed
to complete a private placement (the Private Placement) of an aggregate of 5,000,000 shares
(each, a Share) of its Common Stock, par value $0.001 per share (Common Stock), and warrants
(Warrants) to purchase 2,500,000 shares of its Common Stock (each, a Warrant Share).
Pursuant to the Purchase Agreement, the Company has agreed to sell investment units (each, a
Unit) in the Private Placement at a per Unit purchase price equal to $2.25. Each Unit sold in
the Private Placement will consist of one share of Common Stock and a Warrant to purchase one-half
(1/2) of one share of Common Stock at an initial exercise price of $3.00 per share, subject to
adjustment (the Warrant). The closing of the Private Placement is subject to customary closing
conditions. The gross proceeds from the Private Placement are expected to be $11.25 million and
the Company intends to use the net proceeds of the Private Placement for working capital purposes.
The Companys Chief Executive Officer and Chairman, Alvin H. Clemens, has agreed to purchase 1.0
million Units in the Private Placement.
The Warrants provide that the holder thereof shall have the right, at any time after March 30, 2007
but prior to the earlier of (i) ten business days after the Company has properly provided written
notice to all such holders of a Call Event (as defined below) or (ii) the fifth anniversary of the
date of issuance of the Warrant, to acquire shares of Common Stock upon the payment of $3.00 per
Warrant Share (the Exercise Price). The Company also has the right, at any point after which the
volume weighted average trading price per share of the Common Stock for a minimum of 20 consecutive
trading days is equal to at least two times the Exercise Price per share, provided that certain
other conditions have been satisfied to call the outstanding Warrants (a Call Event), in which
case such Warrants will expire if not exercised within ten business days thereafter. The Warrants
also include weighted average anti-dilution adjustment provisions for issuances of securities below
$3.00 during the first two years following the date of issuance of the Warrants, subject to
customary exceptions.
In connection with the signing of the Purchase Agreement, the Company and the Investors also
entered into a Registration Rights Agreement (the Registration Rights Agreement). Under the
terms of the Registration Rights Agreement, the Company agreed to prepare and file with the
Securities and Exchange Commission (the SEC), as soon as possible but in any event within 30 days
following the later of (i) the date the Company is required to file with the SEC its Annual Report
on Form 10-KSB for the fiscal year ended December 31, 2006, or (ii) the date of the Registration
Rights Agreement, a registration statement on Form SB-2 (the Registration Statement) covering the
resale of the Shares and the Warrant Shares collectively, the Registrable Securities). Subject
to limited exceptions, the Company also agreed to use its reasonable best efforts to cause the
Registration Statement to be declared effective under the Securities Act of 1933 as amended (the
Securities Act) as soon as practicable but, in any event, no later than 90 days following the
date of the Registration Rights Agreement (or 150 days following the date of the Registration
Rights Agreement in the event the Registration Statement is subject to review by the SEC), and
agreed to use its reasonable best efforts to keep the Registration Statement effective under the
Securities Act until the date that is two years after the date that the Registration Statement is
declared effective by the SEC or such earlier date when all of the Registrable Securities covered
by the Registration Statement have been sold or may be sold without volume restrictions pursuant to
Rule 144(k) promulgated under the Securities Act. The Registration Rights Agreement also provides
for payment of partial damages to the Investors under certain circumstances relating to failure to
file or obtain or maintain effectiveness of the Registration Statement, subject to adjustment.
F-36
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 15
SUBSEQUENT EVENTS
(continued)
Oppenheimer & Co., Inc. (Oppenheimer or Representative) is acting as lead-placement agent on a
best efforts basis along with Sanders Morris Harris Inc. (Sanders) and Roth Capital Partners
(Roth and, together with Oppenheimer and Sanders, the Placement Agreements) in the Private
Placement. In connection with the Private Placement, the Company will pay the Placement Agents an
aggregate placement fee equal to approximately $788,000 plus the reimbursement of certain expenses.
The Company will also issue to the Placement Agents Warrants (the Placement Agent Warrants) to
purchase in the aggregate 350,000 shares of the Companys Common Stock, each Placement Agent
Warrant having an exercise price equal to the greater of $2.70 and the closing bid price of the
Companys common stock as of the date of closing of the Private Placement and a term of three
years. The Placement Agent Warrants are exercisable at any time after six months following their
date of issuance. Under the terms of the Registration Rights Agreement, the holders of the
Placement Agent Warrants have registration rights for the shares of Common Stock underlying the
Placement Agent Warrants (the Placement Agent Warrant Shares) as described above.
In order to induce the Representative to act as lead Placement Agent in the Private Placement, each
of the Companys directors and certain executive officers entered into Lock-Up Agreements with the
Representative (the Lock-Up Agreements). Under the terms of the Lock-Up Agreements, the
Companys directors and executive officers agreed, among other things, not to sell or transfer any
shares of Common Stock during the period from March 28, 2007 until and through the later of (i)
three months from the closing of the Private Placement or (ii) 45 days following the effective date
of any Registration Statement.
The Company also agreed, pursuant to the terms of the Purchase Agreement, that for a period of 90
days after the effective date of the initial Registration Statement required to be filed by the
Company under the Registration Rights Agreement, the Company shall not, subject to certain
exceptions, offer, sell, grant any option to purchase, or otherwise dispose of any equity
securities or equity equivalent securities, including without limitation, any debt, preferred
stock, rights, options, warrants or other instrument that is at any time convertible into or
exchangeable for, or otherwise entitles the holder thereof to receive, capital stock and other
securities of the Company.
The Purchase Agreement also provides a customary participation right, subject to exceptions and
limitations, which provides for a designated investor to be able to participate in future
financings for capital raising purposes occurring within two years of March 30, 2007 at a level
based on such investors ownership percentage of the Company on a fully-diluted basis prior to such
financing.
Restricted Stock Grants to Officers
On February 15, 2007, the Company granted 125,000 restricted shares of Common Stock to each of
Charles A. Eissa, the Companys President and Chief Operating Officer, and Ivan M. Spinner, the
Companys Senior Vice President, in accordance with the terms of the Companys 2006 Omnibus Equity
Compensation Plan (the Plan). The shares granted to Messrs. Eissa and Spinner will vest as
follows: 50,000 shares on February 15, 2008; 50,000 additional shares on February 15, 2009; 2,083
shares per month on the 15th day of each month thereafter beginning on March 15, 2009 through
January 15, 2010; and 2,087 shares on February 15, 2010.
Amendment No. 1 to Option Daniel Brauser
On February 15, 2007, Health Benefits Direct Corporation (the Company) and Daniel Brauser, the
Companys Senior Vice President, entered into Amendment No. 1 (the Amendment) to Mr. Brausers
Option dated November 10, 2005 (the Option). The Amendment was approved by the Companys board
of directors (the Board) on February 15, 2007. Under the Option, Mr. Brauser has the right to
purchase, at an exercise price of $2.50 per share, 500,000 fully-paid and non-assessable shares
(the Option Shares) of the Companys common stock, par value $0.001 per share (Common Stock).
F-37
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2006
NOTE 15
SUBSEQUENT EVENTS
(continued)
Under the terms of the Option, the vesting schedule of the Option Shares was as follows: (a) 25% of
the Option Shares on or after the first anniversary of the Options grant date; (b) 10,416 Option
Shares on or after the last day of each month thereafter; and (c) 10,440 Option Shares on or after
November 30, 2009. As of February 15, 2007, the Option was vested with respect to 145,832 Option
Shares and remained unvested with respect to the remaining 354,168 Option Shares. The Amendment
accelerates the vesting schedule of the Option Shares as follows: (v) 25% of the Option Shares
subject to the Option on the first anniversary of the Options date of grant; (w) an additional
10,416 Option Shares on December 31, 2006; (x) an additional 10,416 Option Shares on January 31,
2007; (y) an additional 19,966 Option Shares on February 15, 2007; and (z) an additional 30,382
Option Shares on the last day of each month thereafter beginning on February 28, 2007 through
December 31, 2007.
The Amendment also provides that, in the event Mr. Brauser is removed as an officer or employee of
the Company at any time on or before December 31, 2007, 100% of the Option Shares that are
unexercisable as of the removal date will become fully vested upon such removal. Alternatively, in
the event Mr. Brauser resigns as an employee of the Company at any time after March 31, 2007 but
before December 31, 2007, 50% of the Option Shares that are unexercisable as of the resignation
date will become exercisable upon such resignation.
Finally, the Amendment provides that, upon the termination of Mr. Brausers employment with the
Company for any reason, the vested portion of Mr. Brausers Option Shares as of the date of such
termination will remain exercisable by Mr. Brauser for one year following such termination.
Exercise of Warrants
Subsequent to December 31, 2006, certain holders of the Companys warrants exercised their warrants
to purchase an aggregate of 220,000 shares of the Companys common stock at an exercise price of
$1.50 per share for an aggregate exercise price of $330,000.
Consent and Lock-Up Agreement
(unaudited)
On April 5, 2007, we entered into a new Consent and Lock-Up Agreement, or new lock-up arrangement,
with Mr. Frohman. Under the new lock-up arrangement, we consented to the release from lock-up of
1,300,000 shares out of 1,566,007 shares of our common stock held by Mr. Frohman that were locked
up in our favor until June 7, 2008 pursuant to Mr. Frohmans Separation Agreement. We consented to
this release in consideration for a lock-up until May 23, 2008 by Mr. Frohman in favor of us of 50%
of Mr. Frohmans remaining 1,566,007 shares of Common Stock (or securities exercisable for or
convertible into shares of Common Stock) that were otherwise locked up until November 23, 2007
under Mr. Frohmans prior Lock-Up Agreement with us. Prior to this new lock-up arrangement, the
lock-up restrictions in the Separation Agreement allowed Mr. Frohman to sell or otherwise transfer
up to 50,000 shares of the 1,300,000 shares in any given month. Under the new lock-up arrangement,
Frohman was not entitled to transfer any 50,000 monthly tranches of shares until on or after July
5, 2007 as these transfers relate to the 259,007 shares of that were not released from lock-up
under the new lock-up arrangement.
On May 1, 2007, the new lock-up arrangement was further amended. Under this most recent
amendment, we consented to the release from lock-up of 200,000 of Mr. Frohmans shares of Common
Stock that were locked up until July 5, 2007 under the new lock-up arrangement. We consented to
this release in consideration for a lock-up until February 21, 2008 by Mr. Frohman of 200,000 of
his shares of Common Stock that, under the new lock-up arrangement, were previously locked-up until
November 23, 2007.
F-38
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
September 30, 2007
(Unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
Cash
|
|
$
|
8,868,990
|
|
Accounts receivable, less allowance for doubtful
accounts of $34,962
|
|
|
1,978,874
|
|
Deferred compensation advances
|
|
|
775,120
|
|
Prepaid expenses
|
|
|
218,948
|
|
Other current assets
|
|
|
22,409
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
11,864,341
|
|
|
|
|
|
|
Restricted cash
|
|
|
1,150,000
|
|
Property and
equipment, net of accumulated depreciation of $948,453
|
|
|
1,496,130
|
|
Intangibles, net of accumulated amortization of $2,620,293
|
|
|
3,509,953
|
|
Other assets
|
|
|
210,922
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
18,231,346
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
Accounts payable
|
|
$
|
1,277,087
|
|
Accrued expenses
|
|
|
1,344,404
|
|
Unearned commission advances
|
|
|
8,774,910
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
11,396,401
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
Preferred stock ($.001 par value; 10,000,000 shares authorized;
no shares issued and outstanding)
|
|
|
|
|
Common stock ($.001 par value; 90,000,000 shares authorized;
34,098,971 shares issued and outstanding
|
|
|
34,099
|
|
Additional paid-in capital
|
|
|
34,535,820
|
|
Accumulated deficit
|
|
|
(27,734,974
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
6,834,945
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
18,231,346
|
|
|
|
|
|
See accompanying notes to unaudited consolidated financial statements.
F-39
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
5,048,139
|
|
|
$
|
3,222,434
|
|
|
$
|
14,704,547
|
|
|
$
|
7,082,413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, commission and related taxes
|
|
|
4,413,794
|
|
|
|
3,917,483
|
|
|
|
12,329,418
|
|
|
|
9,455,841
|
|
Lead, advertising and other marketing
|
|
|
2,177,789
|
|
|
|
1,511,262
|
|
|
|
5,973,442
|
|
|
|
3,082,819
|
|
Depreciation and amortization
|
|
|
518,098
|
|
|
|
645,802
|
|
|
|
1,631,182
|
|
|
|
1,485,115
|
|
Rent, utilities, telephone and communications
|
|
|
669,847
|
|
|
|
536,267
|
|
|
|
1,934,299
|
|
|
|
1,323,462
|
|
Professional fees
|
|
|
383,617
|
|
|
|
206,273
|
|
|
|
1,277,345
|
|
|
|
994,535
|
|
Other general and administrative
|
|
|
476,990
|
|
|
|
517,491
|
|
|
|
1,283,126
|
|
|
|
1,379,912
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,640,135
|
|
|
|
7,334,578
|
|
|
|
24,428,812
|
|
|
|
17,721,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(3,591,996
|
)
|
|
|
(4,112,144
|
)
|
|
|
(9,724,265
|
)
|
|
|
(10,639,271
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
(2,592
|
)
|
|
|
(339
|
)
|
|
|
(2,592
|
)
|
|
|
(339
|
)
|
Registration rights penalty reversal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,537
|
|
Interest income
|
|
|
107,317
|
|
|
|
54,638
|
|
|
|
279,964
|
|
|
|
258,220
|
|
Interest expense
|
|
|
(5,810
|
)
|
|
|
(3,630
|
)
|
|
|
(21,825
|
)
|
|
|
(17,467
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expense)
|
|
|
98,915
|
|
|
|
50,669
|
|
|
|
255,547
|
|
|
|
300,951
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(3,493,081
|
)
|
|
$
|
(4,061,475
|
)
|
|
$
|
(9,468,718
|
)
|
|
$
|
(10,338,320
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.10
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.29
|
)
|
|
$
|
(0.38
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
basic and diluted
|
|
|
34,098,971
|
|
|
|
28,254,578
|
|
|
|
32,378,934
|
|
|
|
27,351,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited consolidated financial statements.
F-40
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY
FOR NINE MONTHS ENDED SEPTEMBER 30, 2007
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, $.001
|
|
|
|
|
|
|
|
|
|
|
Par Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Total
|
|
|
Number of
|
|
|
|
|
|
Paid-in
|
|
Accumulated
|
|
Shareholders
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Deficit
|
|
Equity
|
|
Balance December 31, 2006
|
|
|
28,586,471
|
|
|
$
|
28,586
|
|
|
$
|
22,668,452
|
|
|
|
($18,266,256
|
)
|
|
$
|
4,430,782
|
|
Common stock issued in private placement
|
|
|
5,000,000
|
|
|
|
5,000
|
|
|
|
10,349,760
|
|
|
|
|
|
|
|
10,354,760
|
|
Issuance of restricted stock to employees
|
|
|
250,000
|
|
|
|
250
|
|
|
|
(250
|
)
|
|
|
|
|
|
|
|
|
Common stock issued upon exercise of warrants
|
|
|
262,500
|
|
|
|
263
|
|
|
|
393,487
|
|
|
|
|
|
|
|
393,750
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
1,124,371
|
|
|
|
|
|
|
|
1,124,371
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9,468,718
|
)
|
|
|
(9,468,718
|
)
|
|
|
|
Balance September 30, 2007
|
|
|
34,098,971
|
|
|
$
|
34,099
|
|
|
$
|
34,535,820
|
|
|
|
($27,734,974
|
)
|
|
$
|
6,834,945
|
|
|
|
|
See accompanying notes to unaudited consolidated financial statements.
F-41
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(9,468,718
|
)
|
|
$
|
(10,338,320
|
)
|
Adjustments to reconcile net loss to net cash used in
operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
1,631,182
|
|
|
|
1,485,453
|
|
Stock-based compensation and consulting
|
|
|
1,144,845
|
|
|
|
1,620,357
|
|
Provision for bad debt
|
|
|
(9,026
|
)
|
|
|
(9,886
|
)
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
227,675
|
|
|
|
(1,282,767
|
)
|
Deferred compensation advances
|
|
|
(90,122
|
)
|
|
|
(512,497
|
)
|
Prepaid expenses
|
|
|
(131,428
|
)
|
|
|
(374,130
|
)
|
Other current assets
|
|
|
(11,398
|
)
|
|
|
(17,611
|
)
|
Other assets
|
|
|
(29,019
|
)
|
|
|
(147,192
|
)
|
Accounts payable
|
|
|
116,833
|
|
|
|
390,584
|
|
Accrued expenses
|
|
|
(83,224
|
)
|
|
|
414,392
|
|
Due to related parties
|
|
|
(63,672
|
)
|
|
|
68,926
|
|
Unearned commission advances
|
|
|
3,619,793
|
|
|
|
2,904,041
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(3,146,279
|
)
|
|
|
(5,798,650
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(451,147
|
)
|
|
|
(1,481,530
|
)
|
Purchase of intangible assets and capitalization of
software development
|
|
|
(593,875
|
)
|
|
|
(1,415,186
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(1,045,022
|
)
|
|
|
(2,896,716
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
|
Gross proceeds from sales of common stock
|
|
|
11,250,000
|
|
|
|
6,450,000
|
|
Gross proceeds from exercise of warrants
|
|
|
393,750
|
|
|
|
525,000
|
|
Gross proceeds from exercise of stock options
|
|
|
|
|
|
|
200,000
|
|
Restricted cash in connection with letters of credit
|
|
|
|
|
|
|
(1,154,504
|
)
|
Placement and other fees paid in connection with offering
|
|
|
(895,240
|
)
|
|
|
(285,826
|
)
|
Payment on notes payable
|
|
|
|
|
|
|
(399,630
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
10,748,510
|
|
|
|
5,335,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
6,557,209
|
|
|
|
(3,360,326
|
)
|
|
|
|
|
|
|
|
|
|
Cash beginning of period
|
|
|
2,311,781
|
|
|
|
6,433,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash end of period
|
|
$
|
8,868,990
|
|
|
$
|
3,073,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information
|
|
|
|
|
|
|
|
|
Cash payments for interest
|
|
$
|
|
|
|
$
|
15,044
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited consolidated financial statements.
F-42
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with
generally accepted accounting principles in the United States of America for interim financial
information and with the instructions to Form 10-QSB and Item 310(b) of Regulation S-B.
Accordingly, the consolidated financial statements do not include all of the information and
footnotes required by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments considered necessary for a fair presentation have
been included and such adjustments are of a normal recurring nature. These consolidated financial
statements should be read in conjunction with the consolidated financial statements for the year
ended December 31, 2006 and notes thereto and other pertinent information contained in Form 10-KSB
of Health Benefits Direct Corporation (the Company, we, us or our) as filed with the
Securities and Exchange Commission (the Commission).
The consolidated financial statements of the Company include the Company and its subsidiaries. All
material inter-company balances and transactions have been eliminated.
For purposes of comparability, certain prior period amounts have been reclassified to conform to
the 2007 presentation.
The results of operations for the nine months ended September 30, 2007 are not necessarily
indicative of the results for the full fiscal year ending December 31, 2007.
Organization
The Company was incorporated under the laws of the state of Nevada on October 21, 2004 as Darwin
Resources Corp., an exploration stage company engaged in mineral exploration (Darwin-NV). On
November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary, Darwin
Resources Corp., a Delaware corporation (Darwin-DE), solely for the purpose of changing the
Companys state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation (HBDC), and the name of the resulting entity
was changed from Health Benefits Direct Corporation to HBDC II, Inc. Following the merger,
Darwin-DE changed its name to Health Benefits Direct Corporation.
Concurrently with the closing of the merger, the Company completed a private placement of 40 units,
each unit consisting of 50,000 shares of the Companys common stock and a detachable, transferable
warrant to purchase 25,000 shares of the Companys common stock, which yielded gross proceeds of
$2,000,000 in 2005. In 2006 the Company completed the private placement of 129 additional units
for aggregate gross proceeds of an additional $6,450,000.
HBDC was formed in January 2004 for the purpose of acquiring, owning and operating businesses
engaged in direct marketing and distribution of health and life insurance products, primarily
utilizing the Internet. On September 9, 2005, HBDC acquired three affiliated Internet health
insurance marketing companies, namely Platinum Partners, LLC, a Florida limited liability company,
Health Benefits Direct II, LLC, a Florida limited liability company, and Health Benefits Direct
III, LLC, a Florida limited liability company. HBDC issued 7,500,000 shares of its common stock and
a warrant to purchase 50,000 shares of its common stock, in the aggregate, in exchange for 100% of
the limited liability company interests of these companies.
F-43
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The acquisition of HBDC by the Company was accounted for as a reverse merger because, on a
post-merger basis, the former HBDC shareholders held a majority of the outstanding common stock of
the Company on a voting and fully diluted basis. As a result, HBDC was deemed to be the acquirer
for accounting purposes. Accordingly, the consolidated financial statements presented for the
period ended December 31, 2005, are those of HBDC for all periods prior to the acquisition, and the
financial statements of the consolidated companies from the acquisition date forward. The
historical shareholders deficit of HBDC prior to the acquisition has been retroactively restated
(a recapitalization) for the equivalent number of shares received in the acquisition after giving
effect to any differences in the par value of the Company and HBDCs common stock, with an offset
to additional paid-in capital. The restated consolidated retained earnings of the accounting
acquirer, HBDC, are carried forward after the acquisition.
The Company specializes in the direct marketing of health and life insurance and related products
to individuals and families. The Company has developed proprietary technologies and processes to
connect prospective insurance customers with the Companys agents and service personnel using an
integrated on-line platform with call center follow up. The Company employs licensed agents
supported by tele-application, customer service and technology employees for the purpose of
providing immediate information to prospective customers and to sell insurance products. The
Company receives commissions and other fees from insurance carriers for the sale of insurance
products.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to make
estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual
results could differ from those estimates. Significant estimates in 2007 and 2006 include the
allowance for doubtful accounts, stock-based compensation, the useful lives of property and
equipment and intangible assets, revenue recognition and deferred compensation advances to
employees.
Restricted cash
The Company considers all cash and cash equivalents held in restricted accounts pertaining to the
Companys letters of credit as restricted cash.
Accounts receivable
The Company has a policy of establishing an allowance for uncollectible accounts based on its best
estimate of the amount of probable credit losses in its existing accounts receivable. The Company
periodically reviews its accounts receivable to determine whether an allowance is necessary based
on an analysis of past due accounts and other factors that may indicate that the realization of an
account may be in doubt. Account balances deemed to be uncollectible are charged to the allowance
after all means of collection have been exhausted and the potential for recovery is considered
remote. At September 30, 2007, the Company has established, based on a review of its outstanding
balances, an allowance for doubtful accounts in the amount of $34,962.
Accounts receivable from the Companys largest insurance carrier accounted for 70% of the Companys
total accounts receivable balance at September 30, 2007, which was collected subsequent to
September 30, 2007.
F-44
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Property and equipment
Property and equipment are carried at cost. The cost of repairs and maintenance is expensed as
incurred; major replacements and improvements are capitalized. When assets are retired or disposed
of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or
losses are included in income in the year of disposition. In accordance with Statement of
Financial Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets the Company examines the possibility of decreases in the value of fixed assets
when events or changes in circumstances reflect the fact that their recorded value may not be
recoverable.
Intangible assets
Intangible assets consist of assets acquired in connection with the acquisition of ISG, costs
incurred in connection with the development of the Companys software and website, the purchase of
internet domain names and assets acquired in connection with the HealthPlan Choice asset purchase
agreement. See Note 2 ISG Acquisition, Note 3 HealthPlan Choice Asset Purchase, Note 5
Internet Domain Name Purchase and Assignment Agreement and Note 7 Intangible Assets. The
Company capitalized certain costs valued in connection with developing or obtaining internal use
software in accordance with American Institute of Certified Public Accountants Statement of
Position 98-1, Accounting for the Costs of Computer Software Developed or Obtained for Internal
Use. These costs, which consist of direct technology labor costs, are capitalized and amortized
using the straight-line method over expected useful lives. Costs that the Company has incurred in
connection with developing the Companys websites and purchasing domain names are capitalized and
amortized using the straight-line method over an expected useful life.
Under the criteria set forth in SOP 98-1, Accounting for the Costs of Computer Software Developed
or Obtained for Internal Use capitalization of software development costs begins upon the
establishment of technological feasibility of the software. The establishment of technological
feasibility and the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but not limited to,
anticipated future gross product revenues, estimated economic life, and changes in software and
hardware technology. Capitalized software development costs are amortized utilizing the
straight-line method over the estimated economic life of the software not to exceed three years. We
regularly review the carrying value of software development assets and a loss is recognized when
the unamortized costs are deemed unrecoverable based on the estimated cash flows to be generated
from the applicable software.
Impairment of long-lived assets
In accordance with Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company periodically reviews its long-lived
assets for impairment whenever events or changes in circumstances indicate that the carrying amount
of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum
of expected undiscounted future cash flows is less than the carrying amount of the asset. The
amount of impairment is measured as the difference between the assets estimated fair value and its
book value.
Income taxes
Through September 6, 2005, the Company was organized as a combination of limited liability
companies LLCs. In lieu of corporation income taxes, the members of the LLCs were eligible for
their proportional share of the Companys net losses. Therefore, no provision or liability for
Federal income taxes had been included in the financial statements as of December 31, 2004.
F-45
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The Company was taxed as a combination of LLCs until September 6, 2005, when the Company changed
its form of ownership to a C corporation. As a result of the change of ownership, the Company
accounts for income taxes under the liability method in accordance with Statement of Financial
Accounting Standards No. 109, Accounting for Income Taxes under this method, deferred income tax
assets and liabilities are determined based on differences between the financial reporting and tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be
in effect when the differences are expected to reverse.
Had income taxes been determined based on an effective tax rate of 38% consistent with the method
of SFAS 109, the Companys net losses for all periods presented would not have changed.
Loss per common share
In accordance with SFAS No. 128 Earnings Per Share, basic earnings per share is computed by
dividing net income by the weighted average number of shares of common stock outstanding during the
period. Diluted earnings per share is computed by dividing net income by the weighted average
number of shares of common stock, common stock equivalents and potentially dilutive securities
outstanding during each period. Diluted loss per common share is not presented because it is
anti-dilutive. The Companys common stock equivalents at September 30, 2007 include the following:
|
|
|
|
|
Options
|
|
|
4,856,985
|
|
Warrants
|
|
|
10,787,500
|
|
|
|
|
|
|
|
|
15,644,485
|
|
|
|
|
|
Revenue recognition
The Company follows the guidance of the Commissions Staff Accounting Bulletin 104 for revenue
recognition. In general, the Company records revenue when persuasive evidence of an arrangement
exists, services have been rendered or product delivery has occurred, the sales price to the
customer is fixed or determinable, and collectibility is reasonably assured.
The Company generates revenue primarily from the receipt of commissions paid to the Company by
insurance companies based upon the insurance policies sold to consumers by the Company. These
revenues are in the form of first year, bonus and renewal commissions that vary by company and
product. We recognize commission revenue primarily from the sale of health insurance, after we
receive notice that the insurance company has received payment of the related premium. First year
commission revenues per policy can fluctuate due to changing premiums, commission rates, and types
or amount of insurance sold. Insurance premium commission revenues are recognized pro-rata over
the terms of the policies. Revenues for renewal commissions are recognized after we receive notice
that the insurance company has received payment for a renewal premium. Renewal commission rates are
significantly less than first year commission rates and may not be offered by every insurance
company or with respect to certain types of products. The unearned portion of premium commissions
has been included in the consolidated balance sheet as a liability for unearned commission
advances.
F-46
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The length of time varies between when the Company submits a consumers application for insurance
to an insurance company and when the Company recognizes revenue. The type of insurance product and
the insurance companys backlog are the primary factors that impact the length of time between
submitted applications and revenue recognition. Any changes in the amount of time between submitted
application and revenue recognition, which are influenced by many factors not under our control,
create fluctuations in our operating results and could affect our business, operating results and
financial condition.
The Company receives bonuses based upon individual criteria set by insurance companies, which
varies over time and generally do not extend beyond the current calendar year. We recognize bonus
revenues when we receive notification from the insurance company of the bonus due to us.
The Company receives fees for the placement and issuance of insurance policies that are in addition
to, and separate from, any sales commissions paid by insurance companies. As these policy fees are
not refundable and the Company has no continuing obligation, all such revenues are recognized on
the effective date of the policies or, in certain cases, the billing date, whichever is later.
The Company also generates revenue from the sale of leads to third parties. Such revenues are
recognized when we deliver the leads and bill the purchaser of the leads.
Deferred compensation advances
The Company has advanced commissions to employees, which are accounted for as deferred compensation
advances. In the event that the Company does not ultimately receive its revenue pertaining to the
underlying product sales for which the Company has advanced commissions to employees, the Company
deducts such advanced commissions from the employees current or future commissions. Deferred
compensation advances are charged to expense when earned by the employee, which approximates the
Companys recognition of earned revenue for the underlying product sales. The recoverability of
deferred compensation advances is periodically reviewed by management and is net of managements
estimate for uncollectability. Management believes deferred compensation advances as reported are
fully realizable.
Lead, advertising and other marketing expense
Lead expenses are costs incurred in acquiring potential client data. Advertising expense pertains
to direct response advertising. Other marketing consists of professional marketing services.
Lead, advertising and other marketing are expensed as incurred.
Concentrations of credit risk
The Company maintains its cash and restricted cash in bank deposit accounts, which, at times,
exceed the federally insured limits of $100,000 per account. At September 30, 2007, the Company
had approximately $9,791,000 in United States bank deposits, which exceeded federally insured
limits. The Company has not experienced any losses in such accounts through September 30, 2007.
F-47
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
During the nine months ended September 30, 2007, approximately 53%, 17%, 8% and 8% of the Companys
revenue was earned from each of the Companys four largest insurance carriers. Management believes
that comparable carriers and products are available should the need arise. However, a termination
of any of the Companys agreements with any of these carriers could result in the loss or reduction
of future sales, and, in certain cases, future commissions for pre-termination sales.
Stock-based compensation
Effective January 1, 2006, the Company adopted the provisions of SFAS No. 123(R), Share-Based
Payment, under the modified prospective method. SFAS No. 123(R) eliminates accounting for
share-based compensation transactions using the intrinsic value method prescribed under APB Opinion
No. 25, Accounting for Stock Issued to Employees, and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective method, the Company
is required to recognize compensation cost for share-based payments to employees based on their
grant-date fair value from the beginning of the fiscal period in which the recognition provisions
are first applied. For periods prior to adoption, the financial statements are unchanged, and the
pro forma disclosures previously required by SFAS No. 123, as amended by SFAS No. 148, will
continue to be required under SFAS No. 123(R) to the extent those amounts differ from those in the
Statement of Operations.
Non-employee stock based compensation
The cost of stock based compensation awards issued to non-employees for services are recorded at
either the fair value of the services rendered or the instruments issued in exchange for such
services, whichever is more readily determinable, using the measurement date guidelines enumerated
in Emerging Issues Task Force Issue (EITF) Issue No. 96-18, Accounting for Equity Instruments
That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or
Services (EITF 96-18).
Registration rights agreements
The Company has adopted View C of EITF 05-4 The Effect of a Liquidated Damages Clause on a
Freestanding Financial Instrument Subject to EITF Issue No. 00-19 Accounting for Derivative
Financial Instruments Indexed to, and Potentially Settled In, a Companys Own Stock (EITF 05-4).
Accordingly, the Company classifies as liability instruments the fair value of registration rights
agreements when such agreements (i) require it to file, and cause to be declared effective under
the Securities Act, a registration statement with the Commission within contractually fixed time
periods, and (ii) provide for the payment of liquidating damages in the event of its failure to
comply with such agreements. Under View C of EITF 05-4, (i) registration rights with these
characteristics are accounted for as derivative financial instruments at fair value and (ii)
contracts that are (a) indexed to and potentially settled in an issuers own stock and (b) permit
gross physical or net share settlement with no net cash settlement alternative are classified as
equity instruments.
At December 31, 2005, the Company recorded a registration rights penalty expense of $60,537, which
had been included in accrued expenses as of December 31, 2005, and was reversed in the first
quarter of 2006 concurrent with the belief that the registration of the shares, including the
private placement shares, would be effective before the date after which a penalty would be
incurred. On July 7, 2006, the Commission declared effective the Companys Registration Statement
on Form SB-2 filed with the Commission on April 10, 2006 as amended.
F-48
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Recent accounting pronouncements
In February 2006, the Financial Accounting Standards Board (the FASB) issued Statement No. 155
(SFAS No. 155), Accounting for Certain Hybrid Instruments: An Amendment of FASB Statements No.
133 and 140. Management does not believe that this SFAS No. 155 will have a significant impact, as
the Company does not use such instruments.
In December 2006, the FASB issued the FASB Staff Position (FSP) No. EITF 00-19-2, (FSP EITF
00-19-2), Accounting for Registration Payment Arrangements. This FSP addresses an issuers
accounting for registration payment arrangements. This FSP specifies that the contingent obligation
to make future payments or otherwise transfer consideration under a registration payment
arrangement, whether issued as a separate agreement or included as a provision of a financial
instrument or other agreement, should be separately recognized and measured in accordance with FASB
Statement No. 5, Accounting for Contingencies. The guidance in this FSP amends FASB Statements No.
133, Accounting for Derivative Instruments and Hedging Activities, and No. 150, Accounting for
Certain Financial Instruments with Characteristics of both Liabilities and Equity, and FASB
Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others, to include scope exceptions for registration payment
arrangements. This FSP further clarifies that a financial instrument subject to a registration
payment arrangement should be accounted for in accordance with other applicable generally accepted
accounting principles (GAAP) without regard to the contingent obligation to transfer consideration
pursuant to the registration payment arrangement. This FSP shall be effective immediately for
registration payment arrangements and the financial instruments subject to those arrangements that
are entered into or modified subsequent to the date of issuance of this FSP, or for financial
statements issued for fiscal years beginning after December 15, 2006, and interim periods within
those fiscal years. The Company intends to adopt FSP EITF 00-19-2 beginning in 2007. The adoption
of this FSP will not have a material effect upon the Companys financial statements.
In July 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in
Income Taxes an interpretation of FASB Statement No. 109 (FIN 48), which prescribes a
recognition threshold and measurement attribute for a tax position taken or expected to be taken
in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal
years beginning after December 15, 2006. The Company believes that the adoption of FIN 48 will not
have a material effect on the Companys financial statements.
F-49
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In March 2006, the FASB issued FASB Statement No. 156 Accounting for Servicing of Financial Assets
an amendment of FASB Statement No. 140 (SFAS No. 156), which establishes, among other things,
the accounting for all separately recognized servicing assets and servicing liabilities. SFAS No.
156 amends Statement 140 to require that all separately recognized servicing assets and servicing
liabilities be initially measured at fair value, if practicable. SFAS No. 156 permits, but does not
require, the subsequent measurement of separately recognized servicing assets and servicing
liabilities at fair value. An entity that uses derivative instruments to mitigate the risks
inherent in servicing assets and servicing liabilities is required to account for those derivative
instruments at fair value. Under SFAS No. 156, an entity can elect subsequent fair value
measurement to account for its separately recognized servicing assets and servicing liabilities. By
electing that option, an entity may simplify its accounting because this Statement permits income
statement recognition of the potential offsetting changes in fair value of those servicing assets
and servicing liabilities and derivative instruments in the same accounting period. SFAS No. 156 is
effective for financial statements for fiscal years beginning after September 15, 2006. Earlier
adoption of SFAS No. 156 is permitted as of the beginning of an entitys fiscal year, provided the
entity has not yet issued any financial statements for that fiscal year. Management believes that
SFAS No. 156 will have no impact on the financial statements of the Company once adopted.
In September 2005, the FASB issued FASB Statement No. 157 Fair Value Measurements (SFAS 157),
which defines fair value, establishes a framework for measuring fair value in US GAAP, and expands
disclosures about fair value measurements. SFAS 157 applies under other accounting pronouncements
that require or permit fair value measurements, the Board having previously concluded in those
accounting pronouncements that fair value is a relevant measurement attribute. Accordingly, SFAS
157 does not require any new fair value measurements. However, for some entities, the application
of SFAS 157 will change current practices. SFAS 157 is effective for financial statements for
fiscal years beginning after November 15, 2007. Earlier application is permitted provided that the
reporting entity has not yet issued financial statements for that fiscal year. Management believes
SFAS 157 will have no impact on the financial statements of the Company once adopted.
In September 2006, FASB issued SFAS No. 158,
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans, an amendment of FASB Statements No 87, 88, 106 and 132(R)
(SFAS 158)
.
SFAS No. 158 requires the recognition of the over-funded or under-funded status of a defined
benefit postretirement plan as an asset or liability in the statement of financial position and the
recognition of changes in that funded status in the year in which the changes occur through
comprehensive income. SFAS No. 158 also requires the measurement of the funded status of a plan as
of the date of the year-end statement of financial position. Management believes that the adoption
of SFAS No. 158 will not have a material effect on the Companys financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities, which provides companies with an option to report selected financial assets
and liabilities at fair value. SFAS No. 159 also establishes presentation and disclosure
requirements designed to facilitate comparisons between companies that choose different measurement
attributes for similar types of assets and liabilities. SFAS No. 159 is effective as of the
beginning of an entitys first fiscal year beginning after November 15, 2007. Management is
currently assessing the impact of the adoption of this standard on its financial statements.
Other accounting standards that have been issued or proposed by the FASB or other standards-setting
bodies that do not require adoption until a future date are not expected to have a material impact
on the consolidated financial statements upon adoption.
F-50
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 2
ISG ACQUISITION
On April 3, 2006, the Company entered into a merger agreement (the ISG Merger Agreement) with ISG
Merger Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company
(Merger Sub), Insurance Specialist Group Inc., a Florida corporation (ISG), and Ivan M. Spinner
pursuant to which, among other things, Merger Sub merged with and into ISG (the ISG Merger). As
consideration for the ISG Merger, the Company made a cash payment of $920,000 and issued 1,000,000
shares of its common stock to Mr. Spinner, the sole stockholder of ISG, in exchange for all of the
outstanding stock of ISG. The ISG merger was completed on April 4, 2006.
On April 3, 2006, in connection with the ISG Merger, HBDC II, Inc., a wholly-owned subsidiary of
the Company, entered into a two-year employment agreement with Mr. Spinner, which provides that Mr.
Spinner will be compensated at an annual base salary of $371,000 with bonus compensation at the
discretion of the Companys board of directors. The agreement may be terminated by the Company for
cause (as such term is defined in the agreement) and without cause upon 30 days notice. If Mr.
Spinner is terminated by the Company for cause or due to death or disability, or if Mr. Spinner
elects to terminate his employment at any time, he will be entitled to the amount, on a pro rata
basis, in excess of $250,000 per year for the balance of the term. If Mr. Spinner is terminated
without cause he will be entitled to his base salary for the remainder of the term. Under the
agreement, Mr. Spinner also received an initial sign-on bonus of $150,000, and an option to
purchase an aggregate of 150,000 shares of common stock at an exercise price of $3.50 per share, of
which 25% of the shares subject to the option vested on April 3, 2007 and the remainder of which
will vest in equal monthly installments for 36 months thereafter.
On October 6, 2006, the Company and Mr. Spinner entered into a working capital settlement and
release agreement whereby the Company agreed to pay Mr. Spinner $65,000 as settlement of the
working capital provision of the ISG Merger Agreement.
The Company accounted for the acquisition of ISG using the purchase method of accounting in
accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. The
results of ISGs operations have been included in the Companys statement of operations as of April
4, 2006. ISGs operations for the period April 1 through April 4, 2006 are considered immaterial.
The Companys purchase price for ISG in the aggregate was $5,154,329 and consisted of the
following:
|
|
|
|
|
Cash payment to seller
|
|
$
|
1,135,000
|
|
Fair value of common stock issued to seller
|
|
|
3,310,806
|
|
Discounted value of future fixed payments of employment agreement
|
|
|
225,212
|
|
Fair value of stock option issued to seller
|
|
|
425,381
|
|
Estimated direct transaction fees and expenses
|
|
|
57,930
|
|
|
|
|
|
|
|
|
|
|
Estimated purchase price
|
|
$
|
5,154,329
|
|
|
|
|
|
F-51
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 2
ISG ACQUISITION (continued)
The following table summarizes the estimated fair values of ISGs assets acquired and liabilities
assumed at the date of acquisition.
|
|
|
|
|
Cash
|
|
$
|
111,024
|
|
Accounts receivable
|
|
|
210,889
|
|
Deferred compensation advances
|
|
|
256,775
|
|
Prepaid expenses and other assets
|
|
|
957
|
|
Property and equipment, net
|
|
|
600
|
|
Intangible assets
|
|
|
4,964,330
|
|
Accrued expenses
|
|
|
(164,549
|
)
|
Unearned commission advances
|
|
|
(225,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,154,329
|
|
|
|
|
|
Intangible assets acquired from ISG were assigned the following values: value of purchased
commission override revenue with an assigned value of $1,411,594 amortized over five years in
proportion to expected future value; value of acquired carrier contracts and agent relationships
with an assigned value of $2,752,143 amortized straight line over the expected useful life of 5
years; and value of an employment and non-compete agreement acquired with an assigned value of
$800,593 amortized straight line over the contractual period, which is a weighted average expected
useful life of 3.1 years. Intangible assets acquired from ISG had the following unamortized values
as of September 30. 2007: value of purchased commission override revenue with an assigned value of
$425,088; value of acquired carrier contracts and agent relationships of $1,926,504; and value of
an employment and non-compete agreement acquired of $359,666.
The following table summarizes the required disclosures of the pro forma combined entity, as if the
acquisition of ISG occurred at January 1, 2006.
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months
|
|
|
Ended September 30,
|
|
|
2007
|
|
2006
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
14,704,547
|
|
|
$
|
7,517,126
|
|
Net loss
|
|
|
(9,468,718
|
)
|
|
|
(10,294,962
|
)
|
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.29
|
)
|
|
$
|
(0.38
|
)
|
NOTE 3
HEALTHPLAN CHOICE ASSET PURCHASE
On April 10, 2006, the Company, through its wholly-owned subsidiary HBDC II, Inc. entered into an
asset purchase agreement with Healthplan Choice, Inc. (HealthPlan Choice) and Horace Richard
Priester III, pursuant to which, among other things, HBDC II, Inc. acquired all of the operating
assets of Healthplan Choice. As consideration for the asset purchase, the Company made a cash
payment of $100,000 and issued 80,000 shares of the Companys common stock to Mr. Priester.
Also on April 10, 2006, in connection with the acquisition of HealthPlan Choice, HBDC II, Inc.
entered into a two-year employment agreement with Mr. Priester, which provided that Mr. Priester
would receive an option to purchase an aggregate of 50,000 shares of common stock at an exercise
price of $3.10 per share. Mr. Priester resigned effective July 7, 2006. The $127,070 fair value
of Mr. Priesters stock option was expensed in 2006.
F-52
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 3
HEALTHPLAN CHOICE ASSET PURCHASE (continued)
The Company accounted for the acquisition of HealthPlan Choice in accordance with Statement of
Financial Accounting Standards No. 142 Goodwill and Other Intangible Assets. As of December 31,
2006, the Company determined that all assets acquired as a result of the Healthplan Choice Asset
Purchase were impaired as a result of the closure of the Companys Atlanta office in the fourth
quarter of 2006 and the Companys decision to concentrate its marketing on its
www.healthbenefitsdirect.com
web site and domain name acquired in the third quarter of 2006. The
fair value of the Companys purchase price was estimated to be $370,240, which was expensed in
2006.
NOTE 4
CONSULTING AGREEMENT WITH REAL IT GROUP LLC
On July 20, 2006, the Company entered into a consulting agreement with Real IT Group LLC (Real
IT) effective August 1, 2006 through July 17, 2007 whereby Real IT provided software design,
development and implementation expertise to the Company. Effective May 7, 2007, Real ITs sole
stockholder and employee became an employee of the Company and the consulting agreement between the
Company and Real IT was terminated.
As part of the consideration for the consulting agreement, the Company issued 15,000 shares of our
common stock to Real ITs sole stockholder and employee pursuant to the Companys 2006 Omnibus
Equity Compensation Plan (the Plan). The fair value of the 15,000 shares of the Companys common
stock was $35,100 and accounted for as professional fee expense as incurred.
NOTE 5
INTERNET DOMAIN NAME PURCHASE AND ASSIGNMENT AGREEMENT
On July 17, 2006, the Company entered into an Internet Domain Name Purchase and Assignment
Agreement with Dickerson Employee Benefits (Dickerson) to purchase the Internet domain name
www.healthbenefitsdirect.com
. As consideration for the Internet Domain Name Purchase and
Assignment Agreement, the Company made a cash payment of $50,000 and issued 50,000 shares of our
common stock to Dickerson. The fair value of the Companys purchase price was estimated to be
$161,200 and was accounted for as the purchase of an internet domain name, which is included in
intangible assets and amortized straight line over 36 months. The Internet Domain Name Purchase
and Assignment Agreement is subject to certain provisions pertaining to Dickersons transfer of
their ownership and their discontinuance of their use of
www.healthbenefitsdirect.com
. The
Internet Domain Name Purchase and Assignment Agreement will require the Company to pay Dickerson
10% of the net proceeds of the sale of the Internet domain name
www.healthbenefitsdirect.com
in the
event that the Company sells the Internet domain name
www.healthbenefitsdirect.com
to an
unaffiliated third party prior to July 16, 2009.
F-53
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 6
PROPERTY AND EQUIPMENT
At September 30, 2007, property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
|
|
|
|
Computer equipment and software
|
|
|
3
|
|
|
$
|
769,003
|
|
Phone equipment and software
|
|
|
3
|
|
|
|
726,535
|
|
Office equipment
|
|
|
3
|
|
|
|
89,485
|
|
Office furniture and fixtures
|
|
|
7
|
|
|
|
511,229
|
|
Leasehold improvements
|
|
|
7
|
|
|
|
348,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,444,583
|
|
|
|
|
|
|
|
|
|
|
Less accumulated depreciation
|
|
|
|
|
|
|
(948,453
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,496,130
|
|
|
|
|
|
|
|
|
|
For the three months ended September 30, 2007 and 2006, depreciation expense was $152,598 and
$131,278, respectively. For the nine months ended September 30, 2007 and 2006, depreciation
expense was $438,417 and $289,444, respectively.
NOTE 7
INTANGIBLE ASSETS
At September 30, 2007, intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
|
|
|
|
|
|
Weighted average
|
|
|
|
|
|
ISG intangible assets acquired
|
|
|
4.5
|
|
|
$
|
4,964,338
|
|
Software development costs
|
|
|
1.8
|
|
|
|
1,004,708
|
|
Internet domain (www.healthbenefits.com)
|
|
|
3.0
|
|
|
|
161,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,130,246
|
|
Less: accumulated amortization
|
|
|
|
|
|
|
(2,620,293
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,509,953
|
|
|
|
|
|
|
|
|
|
For the three months ended September 30, 2007 and 2006, amortization expense was $365,490 and
$514,524, respectively. For the nine months ended September 30, 2007 and 2006, amortization expense
was $1,192,755 and $1,195,671, respectively.
Amortization expense subsequent to the period ended September 30, 2007 is as follows:
|
|
|
|
|
2007
|
|
$
|
338,384
|
|
2008
|
|
|
1,202,526
|
|
2009
|
|
|
1,043,614
|
|
2010
|
|
|
762,361
|
|
2011
|
|
|
163,068
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,509,953
|
|
|
|
|
|
F-54
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 8
LINE OF CREDIT
The Company had a $400,000 line of credit with Regions Bank, which was dated August 2004 and was
repaid in full in the second quarter of 2006. The line of credit had an interest rate of prime
plus 1%. The Company has no further obligations regarding this line of credit and this line of
credit is not available for future borrowing.
NOTE 9
UNEARNED COMMISSION ADVANCES
The Company has agreements with certain of its insurance carriers whereby the Companys insurance
carriers advance the Company first year premium commissions before the commissions are earned. The
unearned portion of premium commissions has been included in the consolidated balance sheet as a
liability for unearned commission advances. These advance agreements represent a material source
of cash to fund the Companys operations. The Companys advance agreement with its largest
insurance carrier is contractually limited to a maximum of $9,000,000, can be terminated by either
party, and in the event of termination the Companys outstanding advance balance can be called by
the insurance carrier with 7 days written notice. As of September 30, 2007, the Companys
outstanding advance balance with this carrier was $6,379,064. The Companys advance agreement with
its second largest insurance carrier allows the insurance carrier to terminate future advances and
convert the outstanding advance balance into a promissory note, which if not repaid within 30 days,
would incur interest expense. As of September 30, 2007, the Companys outstanding advance balance
with this carrier was $1,554,234. During the third quarter of 2007, the Company began receiving
advances of first year premium commissions before the commissions are earned from its third largest
insurance carrier. The Companys understanding pertaining to the advance from this carrier is that
the carrier may terminate future advances and demand repayment of the outstanding unearned
commission advance balance if certain performance standards are not met. The Company and this
insurance carrier are working together on reaching an agreement pertaining to these advances. As
of September 30, 2007, the Companys outstanding advance balance with this carrier was $634,915.
NOTE 10
RELATED PARTY TRANSACTIONS
John Harrison, a member of our board of directors, is associated with Keystone Equities Group, L.P.
Keystone Equities Group, L.P. served as placement agent in connection with the Companys private
placement, which was completed in 2006. The placement agent received (i) a total cash fee of
$558,000, which was paid $300,000 in 2005 and $258,000 in 2006 and represents 4% of the gross
proceeds, and (ii) a five-year warrant to purchase 735,000 shares (5% of the shares sold in the
private placement) of common stock at an exercise price of $1.50 per share. This warrant was
subsequently included in the Companys Registration Statement on Form SB-2 filed with the
Commission on April 10, 2006, as amended.
Pursuant to an Advisory Agreement, dated November 1, 2005, Warren V. Musser, the Vice-Chairman of
our board of directors, introduced potential investors to the Company and provided additional
services. Under the Advisory Agreement, Mr. Musser did not (a) solicit investors to make any
investment, (b) make any recommendations to individuals regarding an investment, or (c) provide any
analysis or advice regarding an investment. As consideration for his services, Mr. Musser received
a cash fee of $352,000, which was paid $330,000 in 2005 and $22,000 in 2006, and a five-year
warrant to purchase 440,000 shares of the Companys Common Stock at an exercise price of $1.50 per
share. The warrant was subsequently included in the Companys Registration Statement on Form SB-2
filed with the Commission on April 10, 2006, as amended.
On March 30, 2007, the Companys Chairman and CEO, Alvin H. Clemens, participated in a private
placement along with other accredited and institutional investors wherein he purchased 1,000,000
shares of the Companys Common Stock and a warrant to purchase 500,000 shares of the Companys
Common Stock for a total purchase price of $2,225,000. See Note 11 Shareholders Equity.
F-55
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY
Common Stock
On February 15, 2007, the Company granted 125,000 restricted shares of Common Stock to each of
Charles A. Eissa, the Companys President and Chief Operating Officer, and Ivan M. Spinner, the
Companys Senior Vice President, in accordance with the terms of the Plan. The shares granted to
Messrs. Eissa and Spinner were valued at $3.00 per share and vest as follows: 50,000 shares on
February 15, 2008; 50,000 additional shares on February 15, 2009; 2,083 shares per month on the
15th day of each month thereafter beginning on March 15, 2009 through January 15, 2010; and 2,087
shares on February 15, 2010.
On March 30, 2007, the Company entered into Securities Purchase Agreements (Purchase Agreements)
and completed a private placement with certain institutional and individual accredited investors
and issued 5,000,000 shares of its Common Stock, par value $0.001 per share and warrants to
purchase 2,500,000 shares of its Common Stock. Pursuant to the Purchase Agreements, the Company
sold investment units (each, a Unit) in the 2007 Private Placement at a per Unit purchase price
equal to $2.25. Each Unit sold in the 2007 Private Placement consisted of one share of Common
Stock and a Warrant to purchase one-half (1/2) of one share of Common Stock at an initial exercise
price of $3.00 per share, subject to adjustment (Warrant). The gross proceeds from the 2007
Private Placement were $11,250,000 and the Company intends to use the net proceeds of the 2007
Private Placement for working capital purposes. The Companys Chairman and CEO Alvin H. Clemens
purchased 1,000,000 Units in the 2007 Private Placement.
In connection with the 2007 Private Placement, the Company paid the placement agents an aggregate
placement fee equal of $787,500 plus the reimbursement of certain expenses in the amount of
$42,500. The Company also issued to the placement agents Warrants (the Placement Agent Warrants)
to purchase in the aggregate 350,000 shares of the Companys Common Stock with an exercise price of
$2.80 and exercisable from September 30, 2007 through March 30, 2010. The Company also incurred
legal and other expenses in the amount of $65,240 in connection with the 2007 private placement.
In order to induce one of the placement agents to act as the lead placement agent in the 2007
private placement, each of the Companys directors and certain executive officers entered into
Lock-Up Agreements with lead placement agent (the Lock-Up Agreements). Under the terms of the
Lock-Up Agreements, the Companys directors and executive officers agreed, among other things, not
to sell or transfer any shares of Common Stock during the period from March 28, 2007 until and
through the later of (i) three months from the closing of the 2007 private placement or (ii) 45
days following the effective date of any Registration Statement. On June 1, 2007, the Commission
declared effective the Companys Registration Statement on Form SB-2 filed with the Commission on
May 2, 2007 as amended.
The Company also agreed, pursuant to the terms of the Purchase Agreement, that for a period of 90
days after the effective date of the initial registration statement required to be filed by the
Company under the Registration Rights Agreement entered into and between the Company and the 2007
Private Placement participants (the Registration Rights Agreement), the Company shall not,
subject to certain exceptions, offer, sell, grant any option to purchase, or otherwise dispose of
any equity securities or equity equivalent securities, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any time convertible into
or exchangeable for, or otherwise entitles the holder thereof to receive, capital stock and other
securities of the Company.
The Purchase Agreement also provides a customary participation right, subject to exceptions and
limitations, which provides for a designated investor to be able to participate in future
financings for capital raising purposes occurring within two years of March 30, 2007 at a level
based on such investors ownership percentage of the Company on a fully-diluted basis prior to such
financing.
F-56
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY (continued)
On March 30, 2007 in connection with the 2007 Private Placement, the Company received $6,817,500,
which represented a portion of the gross proceeds of $6,255,000 together with an overpayment of
$562,500 from one investor. Also on March 30, 2007 the Company recorded the issuance of the Units,
amounts receivable from private placement escrow agent of $4,165,000, which represents $4,995,000
gross proceeds net of placement agents fees and expenses of $830,000 held by the escrow agent for
the 2007 private placement transaction, and amounts payable to private placement investor of
$562,500. On April 2, 2007, the Company received the amounts receivable from the 2007 Private
Placement escrow agent and the Company returned the overpayment amount to private placement
investor.
Stock Options
On February 15, 2007, the Company and Daniel Brauser, the Companys Senior Vice President,
entered into Amendment No. 1 (the Brauser Amendment) to Mr. Brausers Option dated November 10,
2005 (the Brauser Option). The Brauser Amendment was approved by the Companys board of
directors on February 15, 2007. Under the Option, Mr. Brauser has the right to purchase, at an
exercise price of $2.50 per share, 500,000 fully-paid and non-assessable shares (the Option
Shares) of the Companys Common Stock.
Under the terms of the Brauser Option, the vesting schedule of the Brauser Option Shares was as
follows: (a) 25% of the Brauser Option Shares on or after the first anniversary of the Brauser
Options grant date; (b) 10,416 Brauser Option Shares on or after the last day of each month
thereafter; and (c) 10,440 Brauser Option Shares on or after November 30, 2009. As of February 15,
2007, the Brauser Option was vested with respect to 145,832 Option Shares and remained unvested
with respect to the remaining 354,168 Brauser Option Shares. The Amendment accelerates the vesting
schedule of the Brauser Option Shares as follows: 25% of the Brauser Option Shares subject to the
Brauser Option on the first anniversary of the Brauser Options date of grant; an additional 10,416
Brauser Option Shares on December 31, 2006; an additional 10,416 Brauser Option Shares on January
31, 2007; an additional 19,966 Brauser Option Shares on February 15, 2007; and an additional
30,382 Brauser Option Shares on the last day of each month thereafter beginning on February 28,
2007 through December 31, 2007.
The Amendment also provides that, in the event Mr. Brauser is removed as an officer or employee of
the Company at any time on or before December 31, 2007, 100% of the Brauser Option Shares that are
unexercisable as of the removal date will become fully vested upon such removal. Alternatively, in
the event Mr. Brauser resigns as an employee of the Company at any time after June 30, 2007 but
before December 31, 2007, 50% of the Brauser Option Shares that are unexercisable as of the
resignation date will become exercisable upon such resignation.
Finally, the Amendment provides that, upon the termination of Mr. Brausers employment with the
Company for any reason, the vested portion of the Brauser Option Shares as of the date of such
termination will remain exercisable by Mr. Brauser for one year following such termination. Mr.
Brausers employment terminated during the third quarter of 2007 and all unexercisable Brauser
Option Shares became fully vested.
During the nine months ended September 30, 2007 the Company issued options to purchase 175,550
shares of Common Stock to various employees at prices ranging from $2.30 to $3.00. These options
will vest one third on the first anniversary and an additional one third on each anniversary
thereafter.
During the nine months ended September 30, 2007, options to purchase an aggregate of 199,833 shares
were forfeited as a result of the termination of the employment of various employees in accordance
with the terms of the stock options.
F-57
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY (continued)
A summary of the Companys outstanding stock options as of and for the nine months ended September
30, 2007 and for the year ended December 31, 2006 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
Weighted
|
|
|
|
|
Of Shares
|
|
Average
|
|
Weighted
|
|
|
Underlying
|
|
Exercise
|
|
Average
|
|
|
Options
|
|
Price
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,672,500
|
|
|
|
2.91
|
|
|
|
2.35
|
|
Exercised
|
|
|
300,000
|
|
|
|
1.00
|
|
|
|
0.30
|
|
Forfeited
|
|
|
426,232
|
|
|
|
2.73
|
|
|
|
0.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2006
|
|
|
4,881,268
|
|
|
$
|
2.22
|
|
|
$
|
0.83
|
|
Outstanding and exercisable at December 31, 2006
|
|
|
2,074,352
|
|
|
|
1.90
|
|
|
|
0.49
|
|
For the nine month period ended September 30, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
175,550
|
|
|
|
2.89
|
|
|
|
2.31
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
199,833
|
|
|
|
2.50
|
|
|
|
0.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2007
|
|
|
4,856,985
|
|
|
|
2.24
|
|
|
|
0.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable at September 30, 2007
|
|
|
3,427,225
|
|
|
$
|
2.06
|
|
|
$
|
0.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-58
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY (continued)
The following information applies to options outstanding at September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
|
|
|
|
Number of Shares
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
Average
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
Options at
|
|
Remaining
|
|
Average
|
|
Exercisable at
|
|
Average
|
Exercise
|
|
September 30,
|
|
Contractual
|
|
Exercise
|
|
September 30,
|
|
Exercise
|
Price
|
|
2007
|
|
Life
|
|
Price
|
|
2007
|
|
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.00
|
|
|
|
1,550,000
|
|
|
|
8.2
|
|
|
$
|
1.00
|
|
|
|
1,433,320
|
|
|
$
|
1.00
|
|
|
2.30
|
|
|
|
5,000
|
|
|
|
4.8
|
|
|
|
2.30
|
|
|
|
|
|
|
|
|
|
|
2.50
|
|
|
|
1,825,935
|
|
|
|
8.1
|
|
|
|
2.50
|
|
|
|
1,045,155
|
|
|
|
2.50
|
|
|
2.55
|
|
|
|
25,000
|
|
|
|
3.8
|
|
|
|
2.55
|
|
|
|
|
|
|
|
|
|
|
2.62
|
|
|
|
20,000
|
|
|
|
4.2
|
|
|
|
2.62
|
|
|
|
5,000
|
|
|
|
2.62
|
|
|
2.70
|
|
|
|
475,000
|
|
|
|
3.6
|
|
|
|
2.70
|
|
|
|
425,000
|
|
|
|
2.70
|
|
|
2.95
|
|
|
|
45,000
|
|
|
|
3.6
|
|
|
|
2.95
|
|
|
|
11,250
|
|
|
|
2.95
|
|
|
3.00
|
|
|
|
113,550
|
|
|
|
4.6
|
|
|
|
3.00
|
|
|
|
|
|
|
|
|
|
|
3.50
|
|
|
|
150,000
|
|
|
|
8.5
|
|
|
|
3.50
|
|
|
|
53,125
|
|
|
|
|
|
$
|
3.60
|
|
|
|
647,500
|
|
|
|
3.6
|
|
|
$
|
3.60
|
|
|
|
454,375
|
|
|
$
|
3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,856,985
|
|
|
|
|
|
|
|
|
|
|
|
3,427,225
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2007, there were 6,000,000 shares of our common stock authorized to be issued
under the Plan of which 578,015 shares of our common stock remain available for future stock option
grants.
Common Stock warrants
In March 2007, in connection with the 2007 Private Placement, the Company issued warrants to
purchase an aggregate of 2,500,000 shares of common stock at an exercise price of $3.00 per share
to the participating investors in the 2007 Private Placement, which provides that the holder
thereof shall have the right, at any time after March 30, 2007, but prior to the earlier of (i) ten
business days after the Company has properly provided written notice to all such holders of a Call
Event (as defined below) or (ii) the fifth anniversary of the date of issuance of the warrant, to
acquire shares of Common Stock upon the payment of the exercise price. The Company also has the
right, at any point after which the volume weighted average trading price per share of the Common
Stock for a minimum of 20 consecutive trading days is equal to at least two times the Exercise
Price per share, provided that certain other conditions have been satisfied to call the outstanding
Warrants (a Call Event), in which case such Warrants will expire if not exercised within ten
business days thereafter. The Warrants also include a cashless exercise and weighted average
anti-dilution adjustment provisions for issuances of securities below the exercise price during the
first two years following the date of issuance of the warrants, subject to customary exceptions.
F-59
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY (continued)
Also in March 2007, in connection with the 2007 Private Placement, the Company issued to the
placement agents warrants to purchase in the aggregate 350,000 shares of the Companys Common
Stock, which have an exercise price of $2.80 and are exercisable from September 30, 2007 through
March 30, 2010.
During the nine months ended September 30, 2007, certain holders of the Companys outstanding
warrants exercised their warrants to purchase an aggregate of 262,500 shares of the Companys
common stock at an exercise price of $1.50 per share for an aggregate exercise price of $393,750.
A summary of the Companys outstanding warrants as of and for the nine months ended September 30,
2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Common
|
|
Average
|
|
|
Stock
|
|
Exercise
|
|
|
Warrants
|
|
Price
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2006
|
|
|
8,200,000
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
For the nine month period ended September 30, 2007
|
|
|
|
|
|
|
|
|
Granted
|
|
|
2,850,000
|
|
|
$
|
2.98
|
|
Exercised
|
|
|
262,500
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2007
|
|
|
10,787,500
|
|
|
$
|
1.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at September 30, 2007
|
|
|
10,787,500
|
|
|
$
|
1.87
|
|
|
|
|
|
|
|
|
|
|
Outstanding warrants at September 30, 2007 have a weighted average remaining contractual life of 2
years.
Registration Rights
On March 30, 2007 and in connection with 2007 Private Placement, the Company and the participating
investors entered into a Registration Rights Agreement (the Registration Rights Agreement).
Under the terms of the Registration Rights Agreement, the Company agreed to prepare and file with
the Commission, as soon as possible but in any event within 30 days following the later of (i) the
date the Company is required to file with the Commission its Annual Report on Form 10-KSB for the
fiscal year ended December 31, 2006, or (ii) the date of the Registration Rights Agreement, a
registration statement on Form SB-2 covering the resale of the shares and the warrant shares
collectively, the Registrable Securities). The Company subsequently filed its Form 10-KSB on
April 2, 2007. Subject to limited exceptions, the Company also agreed to use its reasonable best
efforts to cause the registration statement to be declared effective under the Securities Act of
1933 as amended (the Securities Act) as soon as practicable but, in any event, no later than 90
days following the date of the Registration Rights Agreement (or 150 days following the date of the
Registration Rights Agreement in the event the Registration Statement is subject to review by the
Commission), and agreed to use its reasonable best efforts to keep the registration statement
effective under the Securities Act until the date that is two years after the date that the
registration statement is declared effective by the Commission or such earlier date when all of the
Registrable Securities covered by the Registration Statement have been sold or may be sold without
volume restrictions pursuant to Rule 144(k) promulgated under the Securities Act. The Registration
Rights Agreement also provides for payment of partial damages to the 2007 Private Placement
investors under certain circumstances relating to failure to file or obtain or maintain
effectiveness of the registration statement, subject to adjustment.
F-60
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 11
SHAREHOLDERS EQUITY (continued)
In connection with the 2007 Private Placement, the Company issued to the placement agents the
Placement Agent Warrants to purchase in the aggregate 350,000 shares of the Companys Common Stock
with an exercise price of $2.80 and exercisable from September 30, 2007 through March 30, 2010.
Under the terms of the Registration Rights Agreement, the holders of the Placement Agent Warrants
have certain piggyback registration rights for the shares of Common Stock underlying the
Placement Agent Warrants (the Placement Agent Warrant Shares).
On May 2, 2007, the Company and Alvin H. Clemens entered into a Waiver of Registration Rights
Agreement whereby Mr. Clemens agreed to waive his registration rights for the 500,000 warrants that
he purchased in the 2007 Private Placement until the later of 60 days following the sale of
substantially all of the shares he purchased in the 2007 Private Placement or six months following
the effectiveness of the registration statement filed in connection with the 2007 Private
Placement. On May 10, 2007, the Company and Mr. Clemens entered into a Consent and Waiver of
Registration Rights Agreement whereby Mr. Clemens and the Company consented to the filing of an
amendment to the registration statement filed in connection with the 2007 Private Placement to
remove the 1,000,000 shares of Common Stock that Mr. Clemens purchased in the 2007 private
placement from the registration statement until the six months following the effectiveness of such
registration statement.
On June 1, 2007, the Commission declared effective the Companys Registration Statement on Form
SB-2 filed with the Commission on May 2, 2007 as amended.
NOTE 12
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES
Employment and Separation Agreements
On December 7, 2006, Scott Frohman resigned as our Chief Executive Officer and as one of our
directors and Alvin H. Clemens, our Executive Chairman, was appointed as our Chief Executive
Officer. In connection with Mr. Frohmans resignation, we and Mr. Frohman entered into a separation
agreement dated December 7, 2006 (the Separation Agreement).
Under the Separation Agreement, Mr. Frohmans employment with us ceased to be effective on December
7, 2006. The Separation Agreement provides for the resolution of all matters with respect to Mr.
Frohmans employment, including all obligations to Mr. Frohman under his employment agreement with
us dated as of October 10, 2005, with respect to his outstanding options to purchase shares of our
common stock and with respect to any other similar amounts or benefits payable to Mr. Frohman
pursuant to the employment agreement or otherwise.
The Separation Agreement provides for the payment to Mr. Frohman of his current monthly salary for
a period of 18 months, less taxes, in satisfaction of all obligations under the employment
agreement, and in recognition that a material portion is in consideration of Mr. Frohmans
confidentiality, non-competition and non-solicitation obligations. In addition, Mr. Frohman will
receive (i) a lump sum payment equal to $21,525 for four weeks of accrued but unused vacation, less
$8,075 for certain business expenses and (ii) payment of, or reimbursement for, monthly COBRA
premiums for a period of 18 months following the separation date. The Separation Agreement further
provides that upon his termination of employment, Mr. Frohmans option to purchase 600,000 shares
of our common stock, exercisable at $2.50 per share and originally granted on November 10, 2005,
will become vested as to 375,000 shares (150,000 of which were already vested and 225,000 of which
became vested on December 7, 2006). These 375,000 shares shall remain exercisable by Mr. Frohman
for one year following the separation date. The option will terminate with respect to the remaining
225,000 shares that will not become vested under the separation agreement.
F-61
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 12
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Certain of Mr. Frohmans shares of our common stock (1,566,007 shares) were locked up until
November 23, 2007 under the terms of a lock-up agreement with us, dated as of November 23, 2005. A
portion of Mr. Frohmans shares (1,191,006 shares) and his option to acquire 375,000 shares of our
common stock have since been released from the lock-up agreement. Under the separation agreement,
Mr. Frohman has agreed that the released securities will remain subject to general lock-up terms
for a period of 18 months following the separation date, subject to certain exceptions as set forth
in the separation agreement.
On April 5, 2007, we entered into a new Consent and Lock-Up Agreement with Mr. Frohman, which
superseded a lock-up agreement with us, dated as of November 23, 2005. Under the new lock-up
arrangement, we consented to the release from lock-up of 1,300,000 shares out of 1,566,007 shares
of our common stock held by Mr. Frohman that were locked up in our favor until June 7, 2008
pursuant to Mr. Frohmans Separation Agreement. We consented to this release in consideration for
a lock-up until May 23, 2008 by Mr. Frohman in favor of us of 50% of Mr. Frohmans remaining
1,566,007 shares of Common Stock (or securities exercisable for or convertible into shares of
Common Stock) that were otherwise locked up until November 23, 2007 under Mr. Frohmans prior
Lock-Up Agreement with us. Prior to this Consent and Lock-up Agreement, the lock-up restrictions
in the Separation Agreement allowed Mr. Frohman to sell or otherwise transfer up to 50,000 shares
of the 1,300,000 shares in any given month. Under the new lock-up arrangement, Frohman will not be
entitled to transfer any 50,000 monthly tranches of shares until on or after July 5, 2007 as these
transfers relate to the 259,007 shares of that were not released from lock-up under the new lock-up
arrangement.
The separation agreement also provides for mutual non-disparagement by Mr. Frohman and us. Mr.
Frohman also is subject to confidentiality, non-competition, non-solicitation and no-hire
provisions under the Separation Agreement.
The Company estimated the future value of the payments under the Separation Agreement to be
$389,119 and recorded an expense charge and liability for that amount as of December 31, 2006.
On September 10, 2007, the Company and Mr. Brauser entered into a separation agreement dated
September 10, 2007 (the Brauser Separation Agreement). Under the Brauser Separation Agreement,
Mr. Brausers employment with us ceased to be effective on September 10, 2007 and provides for the
resolution of all matters with respect to Mr. Brausers employment, including all obligations to
Mr. Brauser under his employment agreement with us dated as of November 10, 2005, with respect to
his outstanding options to purchase shares of our common stock and with respect to any other
similar amounts or benefits payable to Mr. Brauser pursuant to the employment agreement or
otherwise.
The Separation Agreement provides for the payment to Mr. Brauser of his current monthly salary for
a period of 12 months, less taxes, in satisfaction of all obligations under the employment
agreement. In addition, Mr. Brauser will receive payment of, or reimbursement for, monthly COBRA
premiums for a period of 12 months following the separation date. The Separation Agreement further
provides that upon his termination of employment, Mr. Brausers
option to purchase 500,000 shares of our common stock, exercisable at $2.50 per share and
originally granted on November 10, 2005, will become fully vested and shall remain exercisable by
Mr. Brauser for two years following the separation date.
Restricted Cash and Operating Leases
Effective during the first quarter of 2007, the letters of credit pertaining to the lease for our
Deerfield Beach, Florida office and our New York office were collateralized in the form of a money
market account, which as of September 30, 2007 had a balance of $1,150,000. This money market
account is on deposit with the issuer of the letters of credit and is classified as restricted cash
on the Companys balance sheet. The terms of the money market account allow the Company to receive
interest on the principal but prohibits the Company from withdrawing the principal for the life of
the letters of credit.
F-62
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 12
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
The Company leases 3 automobiles for the personal and business use by the Companys employees,
which are leased in the name of ISG and personally guaranteed by Mr. Ivan Spinner. None of the 3
automobiles are used by Mr. Spinner and Mr. Spinner receives no compensation pertaining to these
leases or his personal guarentee. The aggregate payments for these leases are $2,826 per month.
License Agreement With Realtime Solutions Group
On May 31, 2006, the Company entered into a Software and Services Agreement (the License
Agreement) with Realtime Solutions Group, L.L.C. (Realtime), under which Realtime granted the
Company a worldwide, transferable, non-exclusive, perpetual and irrevocable license to use,
display, copy, modify, enhance, create derivate works within, and access Realtime Solutions Groups
Straight Through Processing software (STP) and all associated documentation, source code and
object code, for use in the marketing, promotion and sale of health benefits or insurance products.
As consideration for the grant of the rights and licenses under the License Agreement, the Company
paid to Realtime a $10,000 nonrefundable cash deposit and upon delivery of the STP software and
other materials the Company will pay a license fee in the form of 216,612 unregistered shares of
our common stock. Concurrent with the entering into the License Agreement, HBDC and Realtime
entered into a Registration Rights Agreement that provides for piggyback registration rights for
the Shares.
The Company may unilaterally terminate the License Agreement, with or without cause, at any time on
30 calendar day prior written notice to Realtime. The license rights in the software granted under
the License Agreement survive any termination of the License Agreement in perpetuity.
As of September 30, 2007 the Company has not taken delivery of the STP software or issued Common
Stock in connection with the License Agreement.
Software License Agreement and Professional Services Agreement With Atiam Technologies L.P.
Effective June 30, 2007, the Company executed a Software License Agreement (the Atiam License
Agreement) with Atiam Technologies L.P. (Atiam), under which Atiam granted the Company a
worldwide, transferable, non-exclusive, perpetual and irrevocable license to use, display, copy,
modify, enhance, create derivate works within, and access certain modules of Atiams policy
insurance software (Atiams software) and all associated documentation, source code and object
code, for use in the marketing, promotion and sale of health benefits or insurance products.
Additionally the Company has the option to license certain other policy insurance software modules
from Atiam at specified license fees, which range from $75,000 to an aggregate maximum of $400,000,
through June 30, 2008 in accordance with the Atiam License Agreement.
As consideration for Atiam License Agreement, the Company agreed to pay to Atiam $175,000 due upon
execution of the Atiam License Agreement and $175,000 due and payable upon the delivery and testing
of the software by Atiam and the Companys acceptance of Atiams software in accordance with the
Atiam License Agreement. If in the future the Company exercises its option to license certain
other policy insurance software modules from Atiam such license fees will be payable 50% upon the
exercise of the option and the remainder upon the delivery and testing of the software by Atiam and
the Companys acceptance of the software in accordance with the Atiam License Agreement.
F-63
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 12
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
The Company may unilaterally terminate the Atiam License Agreement, with or without cause, at any
time on 30 calendar day prior written notice to Atiam. In the event that the Company terminates
the Atiam License Agreement and the Company has paid to Atiam all amounts owed under the Atiam
License Agreement including amounts owed upon the delivery and testing of the software by Atiam and
the Companys acceptance of Atiams software then the license rights in the software granted under
the Atiam License Agreement survive any termination in perpetuity. In the event the Company
terminates the Atiam License Agreement and the Company has not paid all amounts owed under the
Atiam License Agreement including amounts owed upon the delivery and testing of the software by
Atiam and the Companys acceptance of Atiams software then all rights granted the Company under
the Atiam License Agreement terminate and the Company must return all software and materials to
Atiam.
As of September 30, 2007 the Company has not taken delivery of Atiams Software. The Company has
recorded $175,000 in intangible assets.
Simultaneously with the Atiam License Agreement the Company executed a Professional Services
Agreement (the Atiam Services Agreement) with Atiam, under which Atiam agreed to provide the
Company development, installation and testing services in connection with the Atiam License
Agreement. The Company agreed to pay Atiam for services provided at specified hourly rates in
accordance with the Atiam Services Agreement. The Company has exclusive intellectual property
rights in connection with work performed under the Atiam Services Agreement and modifications made
to Atiams Software for use by the Company. Upon the Companys acceptance of modifications to
Atiams Software such modifications will be incorporated into the Atiam License Agreement.
On October 1, 2007 the Company acquired Atiam. See Note 13 Subsequent Events.
NOTE 13
SUBSEQUENT EVENTS
Acquisition of ATIAM
On October 1, 2007, HBDC Acquisition, LLC (HBDC Sub), a Delaware limited liability company and
wholly-owned subsidiary of Health Benefits Direct Corporation, a Delaware corporation (the
Company), entered into an Agreement to Transfer Partnership Interests (the Bilenia Agreement)
with the former partners (the Bilenia Partners) of BileniaTech, L.P., a Delaware limited
partnership (Bilenia), whereby HBDC Sub purchased all of the outstanding general and limited
partnership interests of Atiam Technologies, L.P., a Delaware limited partnership (Atiam), owned
by the Bilenia Partners. The execution of the Bilenia Agreement and the transfer of the Atiam
partnership interests to HBDC Sub there under were conditions precedent to the closing of the
Merger Agreement (as defined below) on October 1, 2007 (the Closing Date).
The aggregate amount paid by HBDC Sub to the Bilenia Partners for the Atiam partnership interests
under the Bilenia Agreement was $1,000,000, consisting of $500,000 in cash and 224,216 shares of
Common Stock, which shares had an aggregate value of $500,000 based on the average closing price
per share ($2.23) of Company Common Stock on The Over the Counter Bulletin Board on the five
consecutive trading days preceding the Closing Date.
In connection with the Bilenia Agreement, the Company and Computer Command and Control Company, a
Pennsylvania corporation (CCCC), also entered into a Registration Rights Agreement (the Bilenia
Registration Rights Agreement). Under the terms of the Bilenia Registration Rights Agreement, the
Company has agreed to give prompt written notice to CCCC of the registration of any of the
Companys securities under the Securities Act, and CCCC shall have the opportunity, upon 20 days
written notice to the Company, to request that the shares of Company Common Stock issued to CCCC
under the Bilenia Agreement be included in such registration statement. The Company agreed that its
current intention is to begin to prepare and file a registration statement with the Commission
within 60 days of the Closing Date.
F-64
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2007
NOTE 13
SUBSEQUENT EVENTS (continued)
On September 21, 2007, the Company entered into an Agreement and Plan of Merger (the Atiam Merger
Agreement) by and among the Company, HBDC, System Consulting Associates, Inc., a Pennsylvania
corporation (SCA), and the shareholders of SCA party thereto (the Shareholders). The Company
and SCA closed on the Merger on October 1, 2007.
The Atiam Merger Agreement provided for a business combination whereby SCA would be merged with and
into HBDC Sub, with HBDC Sub continuing as the surviving corporation and as a wholly-owned
subsidiary of the Company (the Merger). The aggregate amount paid by the Company with respect to
all outstanding shares of capital stock of SCA (such amount, the Atiam Merger Consideration) was
$2,000,000, consisting of (a) $850,000 in cash and (b) 515,697 unregistered shares of Common Stock,
which number of shares had a value of $1,150,000 based on the average closing price per share
($2.23) of Common Stock on The Over the Counter Bulletin Board on the five consecutive trading days
preceding the closing date. Upon the effectiveness of the Merger, each share of SCA Common Stock
issued and outstanding immediately prior to the closing date was converted into the right to
receive a pro rata portion of the Merger Consideration. The Company placed certificates
representing 134,529 shares, or an amount equal to $300,000, of the Company Common Stock that
otherwise would be payable to the Shareholders as Merger Consideration into an escrow account,
which shares will be held in escrow for a period of one year to satisfy any indemnification claims
by the Company or HBDC Sub under the Atiam Merger Agreement.
In connection with the Atiam Merger Agreement, the Company and Shareholders also entered into a
Registration Rights Agreement (the Shareholder Registration Rights Agreement). Under the terms of
the Shareholder Registration Rights Agreement, the Company has agreed to give prompt written notice
to each Shareholder of the registration of any of the Companys securities under the Securities Act
and the Shareholders shall have the opportunity, upon 20 days written notice to the Company, to
request that the shares of Company Common Stock issued to the Shareholders under the Atiam Merger
Agreement be included in such registration statement. The Company agreed that its current intention
is to begin to prepare and file a registration statement with the Commission within 60 days of the
Closing Date.
SCA, which operates through Atiam, is a provider of comprehensive, web-based insurance
administration software applications that support individual insurance products.
The Company estimates the fair value of SCA, which accounted for Atiam as a majority owned
subsidiary, and the remaining minority interest in Atiam not owned by SCA based on the fair value
of the aggregate consideration paid by the Company in connection with the Bilenia Agreement and
Atiam Merger Agreement, which is estimated at $3,000,000 and will be accounted for using the
purchase method of accounting in accordance with SFAS No. 141. We will assign fair values to the
individual tangible and intangible assets purchased based on managements estimates. As a result
of the Bilenia Agreement and Atiam Merger Agreement, the Company acquired tangible assets valued at
$1,400,000, short-term liabilities valued at $380,000 and long term liabilities consisting of
deferred tax liabilities of $197,000. The excess of $3,000,000 over the tangible assets acquired
net of liabilities assumed will be allocated to intangible assets with useful lives not anticipated
to exceed 5 years. The estimated purchase price, estimated purchase price allocation and estimated
useful lives of intangible assets acquired are preliminary and the final purchase accounting
adjustments may differ from aforementioned.
In connection with the ATIAM acquisition, ATIAM entered into three-year employment agreements with
four key employees of ATIAM effective October 1, 2007. These employment agreements provide that
these four key employees will be compensated at an aggregate annual base salary of $700,000 with
bonus compensation at the discretion of the Companys board. These agreements may be terminated by
the Company for cause (as such term is defined in the agreements) and without cause upon 30
days notice. These agreements may be terminated by the Company without cause, in which case the
terminated employee will be entitled to their base salary for a period ranging from 6 to 12 months.
These agreements also contain non-competition and non-solicitation provisions for the duration of
the agreements plus a period ranging from 6 to 12 months after termination of employment.
F-65
Part II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 24. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law provides, in general, that a corporation
incorporated under the laws of the State of Delaware, such as us, may indemnify any person who was
or is a party or is threatened to be made a party to any threatened, pending or completed action,
suit or proceeding (other than a derivative action by or in the right of the corporation) by reason
of the fact that such person is or was a director, officer, employee or agent of the corporation,
or is or was serving at the request of the corporation as a director, officer, employee or agent of
another enterprise, against expenses (including attorneys fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by such person in connection with such action, suit
or proceeding if such person acted in good faith and in a manner such person reasonably believed to
be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe such persons conduct was unlawful. In
the case of a derivative action, a Delaware corporation may indemnify any such person against
expenses (including attorneys fees) actually and reasonably incurred by such person in connection
with the defense or settlement of such action or suit if such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed to the best interests of the
corporation, except that no indemnification will be made in respect of any claim, issue or matter
as to which such person will have been adjudged to be liable to the corporation unless and only to
the extent that the Court of Chancery of the State of Delaware or any other court in which such
action was brought determines such person is fairly and reasonably entitled to indemnity for such
expenses.
Our certificate of incorporation and bylaws provide that we will indemnify our directors,
officers, employees and agents to the extent and in the manner permitted by the provisions of the
Delaware General Corporation Law, as amended from time to time, subject to any permissible
expansion or limitation of such indemnification, as may be set forth in any shareholders or
directors resolution or by contract. We also have director and officer indemnification agreements
with each of our executive officers and directors which provide, among other things, for the
indemnification to the fullest extent permitted or required by Delaware law, provided that such
indemnitee shall not be entitled to indemnification in connection with any claim (as such term is
defined in the agreement) initiated by the indemnitee against us or our directors or officers
unless we join or consent to the initiation of such claim, or the purchase and sale of securities
by the indemnitee in violation of Section 16(b) of the Exchange Act.
Pursuant to Director and Officer Indemnification Agreements entered into with each of our
directors and officers, we have agreed to indemnify each of our directors and officers to the
fullest extent of the law permitted or required by the State of Delaware.
Item 25. Other Expenses of Issuance and Distribution
The expenses payable by us in connection with this registration statement are estimated as follows:
|
|
|
|
|
SEC Registration Fee
|
|
$
|
112
|
|
Accounting Fees and Expenses
|
|
|
5,000
|
|
Legal Fees and Expenses
|
|
|
35,000
|
|
Printing Fees and Expenses
|
|
|
10,000
|
|
Miscellaneous
|
|
|
0
|
|
|
|
|
|
Total
|
|
$
|
50,112
|
|
105
Item 26. Recent Sales of Unregistered Securities
During the last three years, we have issued the following securities that were not registered
under the Securities Act:
|
|
|
During 2005 and prior to the merger that resulted in our current public company
structure:
|
|
|
|
Scott Frohman, our former Chief Executive Officer and director,
advanced to us a total of $191,000, accruing interest at 5% annually, payable upon
the demand of Mr. Frohman. Of this amount, $95,000 was repaid out of the net
proceeds of our private placement and $96,000 was converted into shares of our
common stock at a price of $1.00 per share upon the closing of the private
placement.
|
|
|
|
|
Charles A. Eissa, our President, Chief Operating Officer and director,
advanced to us a total of $73,000, accruing interest at 5% annually, payable upon
the demand of Mr. Eissa. Of this amount, $49,000 was repaid out of the net proceeds
of our private placement and $24,000 was converted into shares of our common stock
at a price of $1.00 per share upon the closing of the private placement.
|
|
|
|
|
Marlin Capital Partners I, LLC advanced to us a total of $334,400,
accruing interest at 5% annually, payable upon the demand of Marlin Capital
Partners I, LLC. Of this amount, $167,200 was repaid out of the net proceeds of our
private placement and $167,200 was converted into shares of our common stock at a
price of $1.00 per share upon the closing of the private placement.
|
|
|
|
In September 2005, Alvin H. Clemens, our Chairman and CEO, purchased 300,000 shares
of our common stock and a five-year warrant to purchase an additional 75,000 shares of
our common stock at an exercise price of $1.50 per share in a private offering, for an
aggregate purchase price of $225,000. In connection with the purchase of these
securities, Mr. Clemens was granted piggy back registration rights with regard to the
shares and the shares underlying the warrants.
|
|
|
|
|
In December 2005, we entered into a consulting agreement with Alliance Advisors, LLC
to provide certain financial and public relations consulting services, approved by our
board of directors on January 12, 2006. Pursuant to the consulting agreement, Alliance
Advisors, LLC would develop, implement, and maintain an ongoing system with the general
objective of expanding awareness of us among stockholders, analysts, micro-cap fund
managers, market makers, and financial and trade publications for a 12 month term. In
consideration for the services to be provided by Alliance Advisors, LLC, we agreed to
pay Alliance Advisors, LLC a monthly fee of $8,300 and issued 100,000 shares of common
stock to Alliance Advisors, LLC.
|
|
|
|
|
In January 2006, we completed a private placement under which we issued 14,700,000
shares of our common stock and warrants to purchase 7,350,000 shares of our common
Stock. We sold an aggregate of 295 units to accredited investors in the private
placement. Each unit sold in the private placement consisted of 50,000 shares of our
common stock and a detachable transferable warrant to purchase 25,000 shares of our
common stock. Keystone Equities Group, L.P. acted as the placement agent in connection
with this private placement and received, as compensation, a total cash fee of $558,000
(4% of the gross proceeds), and warrants to purchase an aggregate of 735,000 shares
(5% of the shares sold in the private
placement) of our common stock at an exercise price of $1.50 per share. Warren V.
Musser
|
|
|
|
acted as an advisor to the Company in connection with the private placement. In
his role as an advisor, Mr. Musser did not solicit investors to make an investment in
the Company, make any recommendations to individuals regarding an investment in the
Company or provide any analysis or advice regarding an investment in the Company. Mr.
Musser received as compensation for his services a total cash fee of $325,000 and
warrants to purchase 440,000 shares of our common stock at an exercise price of $1.50 a
share. We realized gross proceeds of $14,700,000 from the private placement.
|
|
|
|
|
In April 2006, we and our wholly-owned subsidiary, ISG Merger Acquisition Corp., a
Delaware corporation, or the Merger Sub, entered into a merger agreement with Insurance
Specialist Group Inc., or ISG, and Ivan M. Spinner, pursuant to which, among other
things, the Merger Sub merged with and into ISG. As consideration for the merger, we
made a cash payment of $920,000 and issued 1,000,000 shares of our common stock to Mr.
Spinner, the sole stockholder of ISG, in exchange for all of the outstanding stock of
ISG. In connection with this merger, we entered into an employment agreement with Mr.
Spinner, under which he was appointed as senior vice president of HBDC II, LLC. Mr.
Spinner currently serves as our Executive Vice President.
|
|
|
|
|
In April 2006, our wholly-owned subsidiary, HBDC II, Inc., entered into an Asset
Purchase Agreement with Healthplan Choice, Inc. and Horace Richard Priester III,
pursuant to which among other things, HBDC II, Inc. acquired all of the operating
assets of Healthplan Choice, Inc. As consideration for the asset purchase, we made a
cash payment of $100,000 and issued 80,000 shares of our common stock to Mr. Priester.
|
|
|
|
|
In May 2006, we and Insurint Corporation, our wholly-owned subsidiary, entered into
a software and services agreement with Realtime, under which Realtime granted to
Insurint Corporation a worldwide, transferable, non-exclusive, perpetual and
irrevocable license to use, display, copy, modify, enhance, create derivate works
within, and access Realtimes Straight Through Processing software and all associated
documentation, source code and object code, for use in the marketing, promotion and
sale of health benefits or insurance products. As consideration for the grant of the
rights and licenses to Insurint Corporation under the agreement, we agreed to pay
Realtime a license fee in the form of 216,612 unregistered shares of our common stock
upon the later delivery of the licensed software and related materials.
|
|
|
|
|
On July 17, 2006, we entered into an Internet Domain Name Purchase and Assignment
Agreement with Dickerson Employee Benefits, or Dickerson, to purchase the Internet
domain name www.healthbenefitsdirect.com. As consideration for the Internet Domain Name
Purchase and Assignment Agreement, we made a cash payment of $50,000 and issued 50,000
shares of our unregistered common stock to Dickerson.
|
|
|
|
|
On March 30, 2007, we completed a private placement of an aggregate of 5,000,000
shares of our common stock and warrants to purchase 2,500,000 shares of our common
stock to certain institutional and individual accredited investors. We sold 5,000,000
investment units in the private placement at a per unit purchase price equal to $2.25
for gross proceeds to us of $11.25 million. These sales were made pursuant to a
Securities Purchase Agreement that we entered into with certain institutional and
individual accredited investors, effective as of March 30, 2007. Mr. Clemens, our
Chairman and CEO, purchased 1.0 million units in the private placement. Each unit sold
in the private placement consisted of one share of our
common stock and a warrant to purchase one-half (1/2) of one share of common stock at an
exercise price of $3.00 per share, subject to adjustment. In connection with the
private
|
|
|
|
placement, we also issued to Oppenheimer & Co. Inc., Sanders Morris Harris Inc.
and Roth Capital Partners, as partial consideration for acting as placement agents,
warrants to purchase in the aggregate 350,000 shares of our common stock at an exercise
price of $2.80 per share.
|
|
|
|
|
On October 1, 2007, we acquired Atiam Technologies, L.P., or Atiam, pursuant to an
Agreement and Plan of Merger, whereby System Consulting Associates, Inc., or SCA, the
majority owner of Atiam, was merged with and into one of our subsidiaries. We paid an
aggregate amount of $2,000,000 for all outstanding shares of capital stock of SCA,
which amount consisted of $850,000 in cash and a total of 515,697 unregistered shares
of our common stock, which number of shares had a value of $1,150,000 based on the
average closing price per share ($2.23) of our common stock on the OTCBB on the five
consecutive trading days preceding the closing date of the acquisition.
|
|
|
|
|
Immediately prior to the closing of the merger with SCA, we also entered into an
Agreement to Transfer Partnership Interests with the former partners of BileniaTech,
L.P., or Bilenia, whereby one of our subsidiaries purchased all of the outstanding
general and limited partnership interests of Atiam owned by Bilenia, the minority owner
of Atiam. We paid a total of $1,000,000 to the former partners of Bilenia for the
Atiam partnership interests, which amount consisted of $500,000.00 in cash and 224,216
unregistered shares of our common stock, which number of shares had an aggregate value
of $500,000 based on the average closing price per share ($2.23) of Company Common
Stock on the OTCBB on the five consecutive trading days preceding the closing date of
the acquisition.
|
|
|
|
|
In connection with each of the acquisitions, we entered into Registration Rights
Agreements with each of the former shareholders of SCA and with Computer Command and
Control Company, one of the former partners of Bilenia. Under the terms of these
Registration Rights Agreements, we granted to the former shareholders of SCA and to
Computer Command and Control Company piggy back registration rights with regard to
the shares that were issued to them.
|
No underwriters were involved in the above sales of securities. The securities described above
in this Item 26 were issued to investors in the United States in reliance on the exemption from the
registration requirements of the Securities Act, as set forth in Section 4(2) under the Securities
Act and/or Rule 506 of Regulation D promulgated under the Securities Act relative to sales by an
issuer not involving any public offering.
During the last three fiscal years, we also have issued the following securities that were not
registered under the Securities Act:
|
|
|
As of January 21, 2008, we had granted, pursuant to our 2006 Omnibus Equity
Compensation Plan, Directors Compensation Plan, 2005 Incentive Stock Plan and 2005
Non-Employee Director Stock Option Plan, options to purchase a total of 5,798,050
shares of common stock at a weighted average exercise price of $2.22 per share. Also as
of January 21, 2008, we had granted, pursuant to our 2006 Omnibus Equity Compensation
Plan, 265,000 restricted shares of common stock at a weighted average per share price
of $2.96 per share. For a more detailed description of our 2006 Omnibus Equity
Compensation Plan, Directors Compensation Plan, 2005 Incentive Stock Plan and 2005
Non-Employee Director Stock Option Plan, see Executive Compensation. The issuance of
stock options and the common stock issuable upon the exercise of such options as described in this Item 26 were
issued pursuant to written compensatory plans or arrangements with the registrants
employees,
|
|
|
directors and consultants, in reliance on the exemption provided by Rule 701
under the Securities Act.
|
Item 27. Exhibits.
The following is a list of exhibits filed as part of this registration statement. Where so
indicated by footnote, exhibits that were previously filed are incorporated by reference. For
exhibits incorporated by reference, the location of the exhibit in the previous filing is
indicated.
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated November 23, 2005, among
Darwin Resources Corp., Health Benefits Direct Corporation, and
HBDC II, Inc. (incorporated by reference to Exhibit 2.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated as of September 21, 2007, by
and among the Company, HBDC Acquisition, LLC, System Consulting
Associates, Inc. and the shareholders of System Consulting
Associates, Inc. party thereto (incorporated by reference from
Exhibit 2.1 to the Companys current report on From 8-K, filed
with the Commission on September 26, 2007).
|
|
|
|
3.1
|
|
Certificate of Incorporation (incorporated by reference to Exhibit
3.1 to the Registrants Current Report on Form 8-K filed with the
Commission on November 22, 2005).
|
|
|
|
3.2
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit
3.2 to the Registrants Current Report on Form 8-K filed with the
Commission on December 3, 2007).
|
|
|
|
3.3
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.3 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
3.4
|
|
Certificate of Merger of HBDC II, Inc. with and into Health
Benefits Direct Corporation (incorporated by reference to Exhibit
3.4 to the Registrants Current Report on Form 8-K filed with the
Commission on November 30, 2005).
|
|
|
|
3.5 **
|
|
Certificate of Amendment to Certificate of Incorporation.
|
|
|
|
4.1
|
|
Form of Private Placement Subscription Agreement (incorporated by
reference to Exhibit 10.5 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
4.2
|
|
Form of Common Stock Purchase Warrant Certificate (incorporated by
reference to Exhibit 4.1 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
4.3
|
|
Warrant to Purchase Common Stock issued to Alvin H. Clemens
(incorporated by reference to Exhibit 4.2 to the Registrants
Annual Report on Form 10-KSB for the fiscal year ended December
31, 2005, filed with the Commission on March 31, 2006).
|
|
|
|
4.4
|
|
Securities Purchase Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.1 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.5
|
|
Registration Rights Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.2 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.6
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.7
|
|
Form of Placement Agent Warrant (incorporated by reference to
Exhibit 4.4 to the Registrants Current Report on Form 8-K, filed
with the Commission on March 30, 2007).
|
|
|
|
4.8
|
|
Registration Rights Agreement, dated October 1, 2007, by and
between Health Benefits Direct Corporation and Computer Command
and Control Company (incorporated by reference from Exhibit 4.1 to
the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
4.9
|
|
Registration Rights Agreement, dated October 1, 2007, by and among
Health Benefits Direct Corporation and Robert J. Oakes, Jeff
Brocco, Tim Savery and Lisa Roetz (incorporated by reference from
Exhibit 4.2 to the Companys current report on From 8-K, filed
with the Commission on October 4, 2007).
|
|
|
|
5.1**
|
|
Opinion of Morgan, Lewis & Bockius LLP
|
|
|
|
10.1
|
|
Health Benefits Direct Corporation 2005 Incentive Stock Plan
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
10.2
|
|
Health Benefits Direct Corporation 2005 Non-Employee Directors
Stock Option Plan (incorporated by reference to Exhibit 10.1 to
the Registrants Current Report on Form 8-K/A filed with the
Commission on December 22, 2005).
|
|
|
|
10.3
|
|
Health Benefits Direct Corporation Compensation Plan for Directors
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on March 20,
2006).
|
|
|
|
10.4
|
|
Lease Agreement, dated February 9, 2004, between Case Holding Co.
and Platinum Partners, LLC (incorporated by reference to Exhibit
10.7 to the Registrants Form 8-K filed with the Commission on
November 30, 2005).
|
|
|
|
10.5
|
|
Lease between Health Benefits Direct Corporation and FG2200, LLC,
effective March 15, 2006 (incorporated by reference to Exhibit
10.1 to the Registrants Current Report on Form 8-K filed with the
Commission on March 6, 2006).
|
|
|
|
10.6
|
|
Employment Agreement, dated November 18, 2005, between Health
Benefits Direct Corporation and Charles A. Eissa (incorporated by
reference to Exhibit 10.15 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
10.7
|
|
Form of Director and Officer Indemnification Agreement
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on January
17, 2006).
|
|
|
|
10.8
|
|
Securities Contribution Agreement, dated September 9, 2005, among
Health Benefits Direct Corporation, Marlin Capital Partners I,
LLC, Scott Frohman, Charles A. Eissa, Platinum Partners II LLC and
Dana Boskoff (incorporated by reference to Exhibit 10.22 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
10.9
|
|
Lockup Agreement, dated November 23, 2005, among Health Benefits
Direct Corporation, Scott Frohman, Charles A. Eissa and Daniel
Brauser (incorporated by reference to Exhibit 10.24 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
10.10
|
|
Advisory Agreement, dated November 1, 2005, between Health
Benefits Direct Corporation and Warren V. Musser (incorporated by
reference to Exhibit 10.25 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.11
|
|
Merger Agreement, dated April 3, 2006, among Health Benefits
Direct Corporation, ISG Merger Acquisition Corp., Insurance
Specialist Group Inc. and Ivan M. Spinner (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2006).
|
|
|
|
10.12
|
|
Employment Agreement, dated April 3, 2006, between HBDC II, Inc.
and Ivan M. Spinner (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on April 6,
2006).
|
|
|
|
10.13
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on May 2,
2006).
|
|
|
|
10.14
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan Form of Nonqualified Stock Option Grant
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 2, 2006).
|
|
|
|
10.15
|
|
Sublease, dated March 7, 2006, between Health Benefits Direct
Corporation and World Travel Partners I, LLC (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on May 19, 2006).
|
|
|
|
10.16
|
|
First Amendment to Sublease, dated April 18, 2006, between Health
Benefits Direct Corporation ad World Travel Partners I, LLC
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 19, 2006).
|
|
|
|
10.17
|
|
Letter Agreement, dated April 18, 2006, among World Travel
Partners I, LLC, Health Benefits Direct Corporation, and 1120
Avenue of the Americas, LLC (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on May 19, 2006).
|
|
|
|
10.18
|
|
Software and Services Agreement, dated May 31, 2006, among Health
Benefits Direct Corporation, Insurint Corporation, and Realtime
Solutions Group, L.L.C. (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on June 2, 2006).
|
|
|
|
10.19
|
|
Lease, dated July 7, 2006, between Health Benefits Direct
Corporation and Radnor Properties-SDC, L.P. (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on July 10, 2006)
|
|
|
|
10.20
|
|
Separation Agreement, dated December 7, 2006, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on December 11, 2006).
|
|
|
|
10.21
|
|
Amendment No. 1 to Option, dated as of February 15, 2007,
delivered by Health Benefits Direct Corporation to Daniel Brauser
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on February 16, 2007).
|
|
|
|
10.22
|
|
Consent and Lock-Up Agreement, dated April 5, 2007, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2007).
|
|
|
|
10.23
|
|
Agreement to Transfer Partnership Interests, dated October 1,
2007, by and among HBDC Acquisition, LLC and the former partners
of BileniaTech, L.P. (incorporated by reference from Exhibit 10.1
to the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
10.24
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Alvin H.
Clemens (incorporated by reference to Exhibit 10.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.25
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Anthony R.
Verdi (incorporated by reference to Exhibit 10.2 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
10.26
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Ivan M.
Spinner (incorporated by reference to Exhibit 10.3 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
14**
|
|
Code of Business Conduct and Ethics.
|
|
|
|
21
|
|
Subsidiaries of Health Benefits Direct Corporation (incorporated
by reference to Exhibit 21 to the Registrants Annual Report on
Form 10-KSB for the fiscal year ended December 31, 2006, filed
with the Commission on April 2, 2007).
|
|
|
|
23.1**
|
|
Consent of Sherb & Co., LLP.
|
|
|
|
23.2**
|
|
Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1)
|
Item 28. Undertakings.
The undersigned Registrant undertakes:
(a) (1) To file, during any period in which it offers or sells securities, a post-effective
amendment to this registration statement to:
(i) Include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii) Reflect in the prospectus any facts or events arising after the effective date of the
registration statement (or most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and
any deviation from the low or high end of the estimated maximum offering range may be reflected in
the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the Calculation of Registration Fee table in the effective registration
statement;
(iii) Include any material information with respect to the plan of distribution not previously
disclosed in the registration statement or any material change to such information in the
registration statement;
(2) For determining liability under the Securities Act of 1933, to treat each post-effective
amendment as a new registration statement of the securities offered, and the offering of the
securities at that time to be the initial bona fide offering.
(3) To file a post-effective amendment to remove from registration any of the securities that
remain unsold at the end of the offering.
(b) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable.
(c) In the event that a claim for indemnification against such liabilities (other than the payment
by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
Registrant in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form SB-2 and authorizes this Amendment No. 1 to registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City of Radnor, Commonwealth of
Pennsylvania, on this 1
st
day of February, 2008.
|
|
|
|
|
|
HEALTH BENEFITS DIRECT CORPORATION
|
|
|
By:
|
ALVIN H. CLEMENS
|
|
|
|
Alvin H. Clemens
|
|
|
|
Chairman and Chief Executive Officer
|
|
|
Power of Attorney
We, the undersigned officers and directors of Health Benefits Direct Corporation, hereby
severally constitute and appoint Alvin H. Clemens and Anthony R. Verdi, and each of them singly,
our true and lawful attorneys with full power to them, and each of them singly, to sign for us and
in our names in the capacities indicated below, the Registration Statement on Form SB-2 filed
herewith and any and all subsequent amendments to said Registration Statement, and generally to do
all such things in our names and on our behalf in our capacities as officers and directors to
enable Health Benefits Direct Corporation to comply with the provisions of the Securities Act of
1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying
and confirming our signatures as they may be signed by our said attorneys, or any of them, to said
Registration Statement and any and all amendments thereto.
Pursuant to the requirements of the Securities Act of 1933, this report has been signed below
by the following persons on behalf of the registrant and in the capacities and on the dates
indicated.
|
|
|
|
|
ALVIN H. CLEMENS
Alvin H. Clemens
|
|
Chairman and Chief Executive Officer
(Principal Executive Officer)
|
|
February 1, 2008
|
|
|
|
|
|
ANTHONY R. VERDI
Anthony R. Verdi
|
|
Chief Financial Officer
(Principal Financial and Accounting
Officer)
|
|
February 1, 2008
|
|
|
|
|
|
WARREN V. MUSSER
Warren V. Musser
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
CHARLES A. EISSA
Charles A. Eissa
|
|
President and Chief Operating Officer
and Director
|
|
February 1, 2008
|
|
|
|
|
|
JOHN HARRISON
John Harrison
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
PAUL SOLTOFF
Paul Soltoff
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
C. JAMES JENSEN
C. James Jensen
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
SANFORD RICH
Sanford Rich
|
|
Director
|
|
February 1, 2008
|
|
|
|
|
|
FREDERICK C. TECCE
Frederick C. Tecce
|
|
Director
|
|
February 1, 2008
|
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated November 23, 2005, among
Darwin Resources Corp., Health Benefits Direct Corporation, and
HBDC II, Inc. (incorporated by reference to Exhibit 2.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated as of September 21, 2007, by
and among the Company, HBDC Acquisition, LLC, System Consulting
Associates, Inc. and the shareholders of System Consulting
Associates, Inc. party thereto (incorporated by reference from
Exhibit 2.1 to the Companys current report on From 8-K, filed
with the Commission on September 26, 2007).
|
|
|
|
3.1
|
|
Certificate of Incorporation (incorporated by reference to Exhibit
3.1 to the Registrants Current Report on Form 8-K filed with the
Commission on November 22, 2005).
|
|
|
|
3.2
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit
3.2 to the Registrants Current Report on Form 8-K filed with the
Commission on December 3, 2007).
|
|
|
|
3.3
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.3 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
3.4
|
|
Certificate of Merger of HBDC II, Inc. with and into Health
Benefits Direct Corporation (incorporated by reference to Exhibit
3.4 to the Registrants Current Report on Form 8-K filed with the
Commission on November 30, 2005).
|
|
|
|
3.5**
|
|
Certificate of Amendment to Certificate of Incorporation
|
|
|
|
4.1
|
|
Form of Private Placement Subscription Agreement (incorporated by
reference to Exhibit 10.5 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
4.2
|
|
Form of Common Stock Purchase Warrant Certificate (incorporated by
reference to Exhibit 4.1 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
4.3
|
|
Warrant to Purchase Common Stock issued to Alvin H. Clemens
(incorporated by reference to Exhibit 4.2 to the Registrants
Annual Report on Form 10-KSB for the fiscal year ended December
31, 2005, filed with the Commission on March 31, 2006).
|
|
|
|
4.4
|
|
Securities Purchase Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.1 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.5
|
|
Registration Rights Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.2 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.6
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.7
|
|
Form of Placement Agent Warrant (incorporated by reference to
Exhibit 4.4 to the Registrants Current Report on Form 8-K, filed
with the Commission on March 30, 2007).
|
|
|
|
4.8
|
|
Registration Rights Agreement, dated October 1, 2007, by and
between Health Benefits Direct Corporation and Computer Command
and Control Company (incorporated by reference from Exhibit 4.1 to
the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.9
|
|
Registration Rights Agreement, dated October 1, 2007, by and among
Health Benefits Direct Corporation and Robert J. Oakes, Jeff
Brocco, Tim Savery and Lisa Roetz (incorporated by reference from
Exhibit 4.2 to the Companys current report on From 8-K, filed
with the Commission on October 4, 2007).
|
|
|
|
5.1**
|
|
Opinion of Morgan, Lewis & Bockius LLP
|
|
|
|
10.1
|
|
Health Benefits Direct Corporation 2005 Incentive Stock Plan
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
10.2
|
|
Health Benefits Direct Corporation 2005 Non-Employee Directors
Stock Option Plan (incorporated by reference to Exhibit 10.1 to
the Registrants Current Report on Form 8-K/A filed with the
Commission on December 22, 2005).
|
|
|
|
10.3
|
|
Health Benefits Direct Corporation Compensation Plan for Directors
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on March 20,
2006).
|
|
|
|
10.4
|
|
Lease Agreement, dated February 9, 2004, between Case Holding Co.
and Platinum Partners, LLC (incorporated by reference to Exhibit
10.7 to the Registrants Form 8-K filed with the Commission on
November 30, 2005).
|
|
|
|
10.5
|
|
Lease between Health Benefits Direct Corporation and FG2200, LLC,
effective March 15, 2006 (incorporated by reference to Exhibit
10.1 to the Registrants Current Report on Form 8-K filed with the
Commission on March 6, 2006).
|
|
|
|
10.6
|
|
Employment Agreement, dated November 18, 2005, between Health
Benefits Direct Corporation and Charles A. Eissa (incorporated by
reference to Exhibit 10.15 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
10.7
|
|
Form of Director and Officer Indemnification Agreement
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on January
17, 2006).
|
|
|
|
10.8
|
|
Securities Contribution Agreement, dated September 9, 2005, among
Health Benefits Direct Corporation, Marlin Capital Partners I,
LLC, Scott Frohman, Charles A. Eissa, Platinum Partners II LLC and
Dana Boskoff (incorporated by reference to Exhibit 10.22 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
10.9
|
|
Lockup Agreement, dated November 23, 2005, among Health Benefits
Direct Corporation, Scott Frohman, Charles A. Eissa and Daniel
Brauser (incorporated by reference to Exhibit 10.24 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
10.10
|
|
Advisory Agreement, dated November 1, 2005, between Health
Benefits Direct Corporation and Warren V. Musser (incorporated by
reference to Exhibit 10.25 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
10.11
|
|
Merger Agreement, dated April 3, 2006, among Health Benefits
Direct Corporation, ISG Merger Acquisition Corp., Insurance
Specialist Group Inc. and Ivan M. Spinner (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2006).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.12
|
|
Employment Agreement, dated April 3, 2006, between HBDC II, Inc.
and Ivan M. Spinner (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on April 6,
2006).
|
|
|
|
10.13
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on May 2,
2006).
|
|
|
|
10.14
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan Form of Nonqualified Stock Option Grant
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 2, 2006).
|
|
|
|
10.15
|
|
Sublease, dated March 7, 2006, between Health Benefits Direct
Corporation and World Travel Partners I, LLC (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on May 19, 2006).
|
|
|
|
10.16
|
|
First Amendment to Sublease, dated April 18, 2006, between Health
Benefits Direct Corporation ad World Travel Partners I, LLC
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 19, 2006).
|
|
|
|
10.17
|
|
Letter Agreement, dated April 18, 2006, among World Travel
Partners I, LLC, Health Benefits Direct Corporation, and 1120
Avenue of the Americas, LLC (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on May 19, 2006).
|
|
|
|
10.18
|
|
Software and Services Agreement, dated May 31, 2006, among Health
Benefits Direct Corporation, Insurint Corporation, and Realtime
Solutions Group, L.L.C. (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on June 2, 2006).
|
|
|
|
10.19
|
|
Lease, dated July 7, 2006, between Health Benefits Direct
Corporation and Radnor Properties-SDC, L.P. (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on July 10, 2006)
|
|
|
|
10.20
|
|
Separation Agreement, dated December 7, 2006, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on December 11, 2006).
|
|
|
|
10.21
|
|
Amendment No. 1 to Option, dated as of February 15, 2007,
delivered by Health Benefits Direct Corporation to Daniel Brauser
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on February 16, 2007).
|
|
|
|
10.22
|
|
Consent and Lock-Up Agreement, dated April 5, 2007, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2007).
|
|
|
|
10.23
|
|
Agreement to Transfer Partnership Interests, dated October 1,
2007, by and among HBDC Acquisition, LLC and the former partners
of BileniaTech, L.P. (incorporated by reference from Exhibit 10.1
to the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
10.24
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Alvin H.
Clemens (incorporated by reference to Exhibit 10.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
10.25
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Anthony R.
Verdi (incorporated by reference to Exhibit 10.2 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.26
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Ivan M.
Spinner (incorporated by reference to Exhibit 10.3 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
14**
|
|
Code of Business Conduct and Ethics.
|
|
|
|
21
|
|
Subsidiaries of Health Benefits Direct Corporation, (incorporated
by reference to Exhibit 21 to the Registrants Annual Report on
Form 10-KSB for the fiscal year ended December 31, 2006, filed
with the Commission on April 2, 2007).
|
|
|
|
23.1**
|
|
Consent of Sherb & Co., LLP.
|
|
|
|
23.2**
|
|
Consent of Morgan, Lewis & Bockius LLP (included in Exhibit 5.1)
|